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Abstract 
The halophilic bacterium Vibrio parahaemolyticus is widely distributed as a natural 
inhabitant of marine and estuarine environments. Some strains cause 
gastroenteritis in humans. Clinical isolates are thought to possess virulence factors 
that are absent from the majority of environmental isolates. Studies were 
undertaken to differentiate clinical (virulent) and environmental (mainly avirulent) 
forms of Vibrio parahaemolyticus. Initially, identification and confirmation of a total 
of 55 V. parahaemolyticus isolates (23 clinical and 32 environmental) was carried 
out by using selective media, biochemical and nutritional tests. Identity was 
confirmed by specific polymerase chain reaction (PCR) targeting the toxR gene. In 
an attempt to differentiate between virulent and avirulent forms V. 
parahaemolyticus, potential virulence factors (enzyme activities), presence of 
plasmids and analyses of whole cell protein profiles and extracellular products 
(ECPs) by SDS-PAGE were performed. The results suggested that the presence 
of plasmids in isolates was not linked to virulence and SDS-PAGE profiles did not 
differentiate between virulent and avirulent forms, but a combination of enzyme 
activities may contribute to virulence. The ECPs of all 55 V. parahaemolyticus 
isolates were tested for their cytotoxicity towards two types of cell lines, the clinical 
isolates showed that 21 out of 23 (91%) and 2 out of 23 (8.69%) showed high and 
medium cytotoxicity, respectively. Amongst the environmental isolates 2 out of 32 
(6.25%), 2 out of 32 (6.25%) and 28 out of 32 (87.5%) showed high, medium and 
low cytotoxicity, respectively. Randomly amplified polymorphic DNA (RAPD)-PCR 
was used to analyse the two groups of isolates. Firstly a 600 bp band was 
recognised in mainly clinical isolates. This DNA fragment was cloned and 
sequenced and found to code for an outer membrane protein (OMP). Two PCR 
primers were designed to specifically amplify a 200bp unique sequence from 
presumptive virulent strains (PCR-OMP); however, not all clinical isolates were 
positive (21 out of 23, 91%). A second RAPD-PCR identified a further unique band 
of approximately 310 bp in mostly clinical isolates. After cloning this band’s DNA, 
the DNA sequence revealed a hypothetical gene, htp, whose function is not known. 
Specific primers, VPHTP1 and VPHTP2 were developed for the detection of the 
htp sequence, but again not all clinical isolates were positive (19 out of 23, 82.6%). 
This led to the development of a multiplex M-PCR which detects all isolates of V. 
parahaemolyticus and differentiates them into potentially virulent and avirulent 
forms. The M-PCR works by targeting the toxR gene, and sequences for omp and 
htp. The M-PCR was performed on all V. parahaemolyticus isolates used in this 
study, as well as other Vibrio species and a selection of non-Vibrio species. The 
amplification of toxR gene 367 bp fragment was found in all V. parahaemolyticus 
tested; all clinical isolates (100%) showed amplification of omp and/or htp. This 
multiplex PCR detected 3 (9.37%) environment isolates, which may potentially be 
able to cause disease. No amplification was seen for the other species tested. 
Thus, the M-PCR could be used for identifying V. parahaemolyticus and detecting 
/ differentiating potentially virulent and avirulent forms. This method should be 
useful for diagnostic purposes and epidemiological studies.   
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Chapter 1: Introduction and Literature Review  
1.1 Introduction 
Vibrio parahaemolyticus is a natural halophilic bacterial inhabitant of the marine 
environment. It causes food borne illness (gastroenteritis) and is attracting 
increasing interest worldwide where raw or undercooked seafood is often 
consumed (Chao et al., 2009). It has been found to be widely distributed in coastal 
waters in temperate zones and can be readily isolated from seafood (Honda and 
Iida, 1993). Not all V. parahaemolyticus strains are considered to be pathogenic. 
Pathogenic V. parahaemolyticus strains that cause gastroenteritis due to 
consumption of seafood that is contaminated or infected by this organism has 
gained significant worldwide attention due to the increasing trend of human 
incidences of food poisoning. 
The aim of this chapter is to review the characteristics of V. parahaemolyticus and 
other human pathogenic Vibrio species, review the virulence properties of V. 
parahaemolyticus, and review the techniques, including molecular typing methods 
for the detection and identification of this bacterium.  
1.2 Characteristics of V. parahaemolyticus 
V. parahaemolyticus is a member of the family Vibrionaceae. The genus Vibrio 
includes 11 species of clinical importance (Janda et al., 1988). These species 
have been reported to be associated with human infection by consumption of 
contaminated food, untreated water or by contact directly with these species 
through skin wounds (Table 1.1).  
V. parahaemolyticus causes seafood-borne disease (Feldhusen, 2000, Boyd et al., 
2008). This bacterium is a Gram-negative, short, slender, curved rod. It is non-
spore forming, and requires salt for optimal growth (Hayes, 1985). It causes 
Chapter 1 
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gastroenteritis, which is characterised by diarrhoea, vomiting, headache and 
abdominal cramps after consumption of contaminated food or water (Eley, 1992). 
This illness is often not treated and there is no vaccine available (Black, 1999). 
However, virulent strains of V. parahaemolyticus are often susceptible to 
antibiotics or the disease can be treated with oral rehydration alone (Daniels et al., 
2000b). This organism also infects skin wounds of people who are exposed to 
contaminated water (Black, 1999, Miyoshi et al., 2008). It can cause septicemia 
particularly in those that are immunocompromised (Daniels et al., 2000a). V. 
parahaemolyticus multiplies very rapidly, therefore preventing V. parahaemolyticus 
gastroenteritis is difficult, as contaminated seafood may contain relatively large 
numbers of the bacteria after a short time (Ingraham and Ingraham, 1995). 
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Table 1.1 Vibrio species pathogenic for humans1 
Species Key features 
1- V. cholerae  
     a. (O1/O139 serotypes) 
 
Cause of classical cholerae 
     b. (non O1/non O139 serotypes) Wound infection and gastroenteritis 
2- Virulent strains of V. parahaemolyticus Gastroenteritis and wound infection  
3- V. vulnificus  Primary septicemia and wound 
infection 
4- V. alginolyticus Ear infection and wound infection 
5- V. mimicus  Gastroenteritis 
6- V. fluvialis Gastroenteritis 
7- V. furnissii Gastroenteritis  
8- V. hollisae Gastroenteritis and septicemia 
9- V. metschnikovii Gastroenteritis 
10- V. damsela 
11- V. cincinnatiensis                                                
Wound infection 
Septicemia 
1
Data from Janda et al., (1988). 
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1.3 Genome analysis of V. parahaemolyticus 
Genomic and comparative analyses of vibrios have revealed that vibrios possess 
two distinct chromosomes, confirmed by the whole genome sequencing of V. 
cholerae (Heidelberg et al., 2000), V. parahaemolyticus (Makino et al., 2003) and 
V. vulnificus (Chen et al., 2003). Furthermore, Okada et al., (2005) have 
demonstrated that vibrios commonly have two chromosomes. Among the vibrios, 
the size of the large chromosomes is relatively constant from 3.0 to 3.3 Mb; while 
the size of the small chromosomes varies from 0.8 to 2.4 Mb; and it is suggested 
that the small chromosome seems to be structurally more flexible than the large 
one. Essential genes are present on both chromosomes (Heidelberg et al., 2000, 
Makino et al., 2003).  
Prior to genomic sequencing, genome analysis of V. parahaemolyticus showed 
that V. parahaemolyticus possess two circular chromosomes of approximately 3.2 
and 1.9 Mb as characterised by pulse-field gel electrophoresis of whole genomic 
DNA (Yamaichi et al., 1999).  
The whole genome sequencing of clinical strain RIMD2210633 confirmed that V. 
parahaemolyticus contained two circular chromosomes [chromosome 1 (3,288,558 
bp) is larger than chromosome 2 (1,877,212 bp)] and showed that V. 
parahaemolyticus harboured genes for type three secretion systems clustered 
together with pathogenicity islands and virulence effectors. A G+C content of 45·4% 
for each chromosome, and ten copies of rRNA operons were found on 
chromosome 1 while only one copy on chromosome 2 (Makino et al., 2003).  
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1.4 Human pathogenic Vibrio species  
Vibrio species are important bacteria that are extensively distributed in the marine 
environment, and pathogenic strains are of worldwide concern for the seafood 
industry (Jones et al., 2012). V. parahaemolyticus, toxigenic strains of V. cholerae 
(O1 and O139 serotype), and V. vulnificus are considered the main pathogenic 
Vibrio species that cause human disease. These bacteria are natural members of 
the marine environment and only certain virulent forms of these bacteria are 
responsible for human diseases. Other vibrios that cause human infection include 
V. mimicus and V. alginolyticus (Thompson et al., 2006). 
Makino et al., (2003) have compared the genome of V. parahaemolyticus with the 
genome of V. cholerae and reported that the size of chromosome 1, 3.3 and 3.0 
Mb respectively, does not differ much between of them, whereas chromosome 2 in 
V. parahaemolyticus (1.9 Mb) is much larger than in V. cholerae (1.1 Mb) 
(Heidelberg et al., 2000, Makino et al., 2003). The number of unique genes on 
chromosome 2 of V. parahaemolyticus (56.8%) and V. cholerae (41.9%) is higher 
than that found in chromosome 1 of V. parahaemolyticus (29.5%) and V. cholerae 
(16.2%) suggesting that chromosome 2 is more different in structure and gene 
content than chromosome 1 (Makino et al., 2003). Serotypes O1 and O139 of V. 
cholerae cause cholera that is characterised by dehydration because of the 
passage of voluminous watery stools, hypovolemic shock, and acidosis; and 
without prompt treatment can cause death (Kaper et al., 1995). These V. cholerae 
bacteria produce cholera toxin which is encoded by the lysogenic bacteriophage 
CTXФ (Waldor and Mekalanos, 1996).  
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V. vulnificus is found in temperate estuarine ecosystems throughout the world. 
This bacterium is similar phenotypically to V. parahaemolyticus; however, based 
on lactose fermentation via β-D- galactosidase production, it can be distinguished 
from V. parahaemolyticus (Hollis et al., 1976). This organism causes wound 
infections through contact with contaminated estuarine waters (Smith and Oliver, 
2006). V. vulnificus also causes gastroenteritis and septicemia following 
consumption of contaminated seafood, especially raw oysters by 
immunocompromised people (Cañigral et al., 2010). It has a number of virulence 
factors including haemolysin which is a heat labile lytic enzyme (Bang et al., 1999); 
capsular polysaccharide (Wright et al., 1990), protease (Miyoshi et al., 1987), 
cytolysin (Gray and Kreger, 1985), phospholipase (Testa et al., 1984) and 
siderophore (Okujo and Yamamoto, 1994).  
V. alginolyticus has been found in seawater worldwide and causes wound infection 
(Spark et al., 1979). It is isolated from marine organisms as part of their 
saprophytic  microbiota (Carli et al., 1993). Most V. alginolyticus infections are self-
limiting and opportunistic. Zen-Yoji et al., (1973) first characterised V. alginolyticus 
as a human pathogen. Both virulent and avirulent forms of V. alginolyticus exist; 
the virulent forms cause disease in both human and certain marine organisms (Cai 
et al., 2009). Furthermore, it is also potentially pathogenic to shellfish, such as 
shrimp (Wang and Chen, 2005), and fish (Balebona et al., 1998). V. alginolyticus 
is phenotypically close to V. parahaemolyticus; however, sucrose fermentation and 
other phenotypic characteristics can be used to distinguish it from V. 
parahaemolyticus (Hollis et al., 1976). Blake et al., (1979) have used four 
biochemical tests (fermentation of sucrose and lactose, tolerance to NaCl and 
Voges-Proskauer test) to distinguish V. alginolyticus, V. parahaemolyticus and V. 
vulnificus.  
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V. mimicus is frequently distributed in estuarine environments and fresh water. V. 
mimicus and V. cholerae O1 and O139 serotypes are similar in most biochemical 
pathways and some O antigens; but differ in sucrose fermentation on 
thiosulfate/citrate/bile salt/sucrose agar (TCBS), V. cholerae exhibit sucrose 
positive (yellow) colonies, where V. mimicus strains exhibit sucrose negative 
(green to blue) colonies (Davis et al., 1981). Virulence genes detected in some V. 
mimicus clinical strains are found to be similar to those present in heat-stable 
enterotoxin producing Escherichia coli (Shi et al., 1998), and homologous to the 
cholera toxin and enterotoxin genes in V. cholerae (Shi et al., 1998); and the tdh 
gene in V. parahaemolyticus (Terai et al., 1990).  
V. fluvialis causes gastroenteritis after consumption of raw or undercooked 
seafood, it was first isolated and identified in 1975 in a patient with diarrhoea in 
Bahrain (Furniss et al., 1977). Between 1976 and 1977, this bacterium caused an 
outbreak of diarrhoea in more than 500 patients in Bangladesh (Huq et al., 1980). 
V. fluvialis also caused an outbreak of gastroenteritis in India in 1981 (Thekdi et al., 
1990). It has also been isolated from seafood, water, aquatic animals, sediment 
and from human with diarrhea (Pruzzo et al., 2005). V. fluvialis produces 
metalloprotease similar to that of V. vulnificus (Miyoshi et al., 2002). Furthermore, 
Lockwood et al., (1982) showed that this bacterium produces four factors including 
a factor that elongates Chinese hamster ovary (CHO) cells, a cytolysin (haemolytic 
factor), non-haemolytic CHO cell-killing factor, and a protease. 
V. furnissii was described in 1983 and classified as an aerogenic biogroup of V. 
fluvialis that produced gas from glucose. Based on genetic analysis, V. furnissii 
was found to be as a new species of Vibrio. The isolation frequency of  V. furnissii 
is less than that for V. fluvialis, however, it has often been isolated from 
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environmental and rarely cases of gastroenteritis  (Brenner et al., 1983). It has 
been isolated from stool of patient with diarrhoea (Hickman-Brenner et al., 1984). 
Furthermore, Dalsgaard et al., (1997) have reported that V. furnissii has been 
isolated from 14 patients (6 with diarrhoea and 8 without symptoms) during a 
cholera surveillance program in Peru. The virulence of this bacterium is associated 
with a haemolytic factor; and extracellular products were shown to damage HeLa 
cells (Magalhães et al., 1993). Phosphomannomutase (PPM) also plays a role in 
virulence of V. furnissii inducing intestinal damage in mice after oral uptake (Kim et 
al., 2003a).  
V. hollisae is associated with consumption of raw seafood (Carnahan et al., 1994). 
V. hollisae commonly cause gastroenteritis but rare of cases of septicaemia and 
wound infection (Hickman et al., 1982, Hlady and Klontz, 1996). This bacterium 
produces a haemolysin similar to that of the TDH of V. parahaemolyticus (Yoh et 
al., 1986, Nishibuchi et al., 1988). This haemolysin encoded by tdh gene that 
shows to be 93% identical to the tdh gene of V. parahaemolyticus (Yamasaki et al., 
1991). Moreover, V. hollisae produces an extracellular toxin factor that elongates 
CHO cells and induces intestinal fluid accumulation in suckling mice. 
V. metschnikovii is occasionally isolated from human cases but is frequently 
isolated from the environment. This bacterium is potentially pathogenic to larval 
giant clams with infection leading to general disintegration of the tissue and total 
mortality (Sutton and Garrick, 1993). It has been isolated from fish in Brazil (Matte 
et al., 2007). Dalsgaard et al., (1996) have detected plasmids in V. metschnikovii 
but their functions were not investigated. This bacterium produces alkaline serine 
proteases and a metalloprotease (Kwon et al., 1994, Kwon et al., 1995). V. 
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metschnikovii produces a cytolysin that is able to induce haemolysis of rabbit 
erythrocytes (Miyake et al., 1989).  
V. damsela is a member of the microflora of healthy carcharhinid sharke (Pruzzo 
et al., 2005). V. damsela can cause fatal wound infection (Clarridge and 
Zighelboim-Daum, 1985). It has been recorded that this bacterium was 
responsible for two cases of fatal necrotising fasciitis in Japan (Yamane et al., 
2004). This bacterium produces a cytolysin toxin involved in its pathogenicity. This 
toxin is cytotoxic to CHO cells and lethal to mice (Kreger, 1984, Kothary and 
Kreger, 1985). Extracellular products of V. damsel have been tested in vivo and 
found to exhibit phospholipase, haemolytic and cytotoxic activities (Fouz et al., 
1993). A siderophore-mediated iron sequestering system is also considered as a 
virulence factor of V. damsela (Fouz et al., 1997). 
V. cincinnatiensis is the most recently described Vibrio human pathogen in 1986, it 
was isolated from a case of septicemia and meningitis in a 70 year old patient 
(Bode et al., 1986). V. cincinnatiensis has infrequently been isolated from human, 
and the pathogenicity of this bacterium is still questionable (Nishibuchi, 2006). It 
has been also isolated from Mytilus galloprovincialis harvested from the Adriatic 
Sea in Italy (Ripabelli et al., 1999). Furthermore, this bacterium was found in fresh 
water of Ohta River in Japan and demonstrated haemolytic and cytotoxic activities 
(Venkateswaran et al., 1989).    
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1.5 The incidence and a brief history of Vibrio parahaemolyticus infections 
1.5.1 The incidence in seafood 
Many researchers worldwide are interested in the incidence of V. 
parahaemolyticus and identify the ecological factors that affect it including 
temperature, salinity, turbidity and chlorophyll a (Julie et al., 2010). Depaola et al., 
(2000) have demonstrated that warm temperature and low salinity have been 
found to influence the incidence of this bacterium in North America when the 
authors collected the samples during the summer where the temperature and 
salinity of the seawater ranged from 27.8 to 31.7°C and 14.9 to 29.3 parts per 
thousand (ppt), respectively. Moreover, the highest incidence of total V. 
parahaemolyticus in Alabama oysters was in May and June with water 
temperature over 25 and salinity 17 ppt (Depaola et al., 2003a). 
Furthermore, this organism has been mainly found in temperate water regions 
(Duan and Su, 2005a). Kaneko and Cowell, (1973) recorded that much higher 
levels of V. parahaemolyticus were detected in samples of oyster, water and 
sediment in the Chesapeake Bay (USA Atlantic coast) within the summer months, 
while very low levels were detected in these samples during the winter. Duan and 
Su., (2005a) have reported that when the water temperature is low, the sediment 
provides a protective environment for the survival of this bacterium. The densities 
of V. parahaemolyticus in oyster were positively associated with water temperature, 
turbidity and dissolved oxygen (Parveen et al., 2008). When water is more turbid 
and richer in organic matter this leads to an increase in the presence of bacteria 
(Parveen et al., 2008). However, turbidity is less important than temperature, with 
the detection of V. parahaemolyticus in oysters harvested from warm waters more 
likely than those from cold water (Kaysner and Depaola, 2000).  
Chapter 1 
12 
 
In Europe, the increasing incidence of V. parahaemolyticus infection has been 
found to be attributed to the emergence of the O3:K6 serotype, for example, the 
O3:K6 serotype was related to an outbreak in Spain (Martinez-Urtaza et al., 2005), 
and the authors reported that the emergence of O3:K6 pandemic strains in Europe 
is a public health concern.  
1.5.2 Outbreaks of illness 
V. parahaemolyticus gastroenteritis was first described in Japan, in 1951 (Eley, 
1992). Since then, cases of food poisoning caused by V. parahaemolyticus have 
been reported from many maritime Asian countries, including India (Yeung and 
Boor, 2004, Alagappan et al., 2010), China (Wang et al., 2007, Liu et al., 2009, 
Chen et al., 2012), Korea (Lee et al., 2008, Jun et al., 2012), Japan (Alam et al., 
2003, Kubota et al., 2011), Taiwan (Pan et al., 1997, Chang et al., 2011) and 
Thailand (Yamamoto et al., 2008, Jatapai et al., 2010). In Korea, Laos, and 
Indonesia, V. parahaemolyticus outbreaks are recorded as due to a pandemic 
strain (Matsumoto et al., 2000). In Japan, about 70% of gastroenteritis cases are 
due to V. parahaemolyticus (Kaneko and Colwell, 1973). In Taiwan, it caused 
outbreaks of food borne disease between 1986 to 1995 (Pan et al., 1997). In Iran, 
few studies on the incidence of this bacterium in seafood have been reported, for 
example, V. parahaemolyticus was isolated 9.3% from shrimp (Rahimi et al., 2010), 
and 11% from retail shrimp (Zarei et al., 2012).  
V. parahaemolyticus causes infection in the United States, first reported in 1971 
(Molenda et al., 1972), and a number of common source gastroenteritis outbreaks 
are attributed to this organism (Spite et al., 1978). Two outbreaks in Texas (416 
cases) and in Washington (43 cases) were after consumption of raw oysters 
(Depaola et al., 2000). Mclaughlin et al., (2005) also described that V. 
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parahaemolyticus caused gastroenteritis related to the consumption of raw oysters 
(Su and Liu, 2007). 
1.6 Prevalence and occurrence of V. parahaemolyticus in Europe 
Food borne disease caused by V. parahaemolyticus is rarely identified in 
European countries. However, the increase in consumption of raw or undercooked 
seafood and the phenomenon of global warming and increased water temperature 
has led to increase concern about V. parahaemolyticus and the enhanced risk of V. 
parahaemolyticus infection. Hooper et al., (1974) recorded the first outbreak in the 
UK in 1974.  
In Galicia, Northern Spain in 1999, an outbreak of 64 cases of V. 
parahaemolyticus gastroenteritis due to consumption of raw oysters was recorded 
(Lozano-León et al., 2003). In 2004, another outbreak of 80 cases in Spain related 
with consumption of boiled crab has been reported by Martinez-Urtaza et al., 
(2005). Pathogenic V. parahaemolyticus has also been detected in Italy (Di Pinto 
et al., 2008, Caburlotto et al., 2009, Ottaviani et al., 2010, Fabbro et al., 2010, 
Serracca et al., 2011), Denmark (Kristensen, 1974) and France (Hervio-Heath et 
al., 2002, Robert-Pillot et al., 2004).  
Prevalence of potentially pathogenic V. parahaemolyticus in Chinese mitten crabs 
has been reported in England by Wagley et al., (2009). In Norway, the occurrence 
of potentially pathogenic V. parahaemolyticus in blue mussels has been also 
reported (Bauer et al., 2006).  
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1.7 Global climate change and Vibrio infections 
Although, the risk of V. parahaemolyticus infections in Europe is considered to be 
low (Wagley et al., 2008), Baker-Austin et al., (2010) have reported that V. 
parahaemolyticus and V. vulnificus infections are increasing in Europe and likely to 
be related with regional climatic trends. The geographical range of vibrios may 
vary with climate change, leading to increase exposure and human risk of infection 
(Lipp et al., 2002). Studying the impact of climate change on human health and 
infectious diseases spreading is central (Cook, 1992). Disease risks caused by 
vibrios are increasing worldwide with global warming (Harvell et al., 2002). Indeed, 
consideration of the link between global warming and disease emergence caused 
by vibrios is interesting.  
Global climate change especially increasing seawater temperature may play an 
important role in increasing the incidence of Vibrio infections, for example, 
increases in water temperature are significantly associated with cholera epidemics 
(Colwell, 1996). An increase of temperature (5°C) can be major factor with regards 
to the incidence of human infection and is related to a risk ratio for cholera 
infection (Huq et al., 2005).  The highest densities of vibrios in seawater occur 
when the temperature ranged between 20°C and 30°C (Tantillo et al., 2004). 
Increasing temperatures are related to a higher risk of V. parahaemolyticus in 
water, and pathogenic strains of this bacterium have been detected in French 
coastal water (Robert-Pillot et al., 2004). Infection caused by V. parahaemolyticus 
was also reported in Spain (Martinez-Urtaza et al., 2008). In Israel, the increasing 
risk of V. vulnificus infection as a result of change in climate and altered the levels 
of V. vulnificus populations in the seawater has also been reported (Paz et al., 
2007). In Germany, an increase in wound infection associated with V. vulnificus 
has been linked to contact with the Blatic sea as a result of warm water (Frank et 
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al., 2006). Furthermore, Fouz et al., (2006) have reported that infections by V. 
vulnificus have been spread in the summer of 2004 in Denmark.  
For 25 years sea surface temperature has risen in UK waters (between 0.6 and 
0.8 °C) per decade in the southern North Sea (Mccip, 2010).  Increases in marine 
vibrios and incidences of their infections around the coastal North Sea have been 
associated significantly with increasing sea surface temperature (Vezzulli et al., 
2012).  
1.8 Serotypes of Vibrio parahaemolyticus  
V. parahaemolyticus serotypes have been classified on the basis of the antigenic 
qualities of the somatic (O) and capsular (K) antigens. In Japan, specific antisera 
are used to differentiate between 13 O groups and 71 K types (Iguchi et al., 1995, 
Yeung and Boor, 2004). Historically, serotypes O4:K68, and O1: K untypeable 
(KUT) of V. parahaemolyticus cause disease, and are genetically related to the 
emerging O3:K6 serotype. Moreover, it has been found that they share similar 
pulsed field gel electrophoresis and ribotyping patterns (Chowdhury et al., 2000). 
The O3:K6 V. parahaemolyticus has been revealed as the main serotype in a 
1996 outbreak in India (Okuda et al., 1997b). V. parahaemolyticus serotype O3:K6 
has also caused epidemics of gastroenteritis in North America, Japan and 
Southeast Asia (Nasu et al., 2000). Furthermore, in the United States, three 
outbreaks have been recorded on the Gulf, Atlantic, and Pacific coasts, and 
molecular analysis of these strains shows that they may have diverged from 
O3:K6 strains (Chowdhury et al., 2000). Very recently, it was revealed that V. 
parahaemolyticus O3:K6 serotype caused about 79% of the cases of 
gastroenteritis from 2004 to 2010 in Sinaloa, Mexico (Velazquez-Roman et al., 
2012). In Europe, the pandemic strains of V. parahaemolyticus O3:K6 serotype 
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was revealed to be present and persistent in French coastal areas (Quilici et al., 
2005). Pandemic V. parahaemolyticus O3:K6 strains have been also detected in 
Italy (Ottaviani et al., 2008) and Russia (Nair et al., 2007). Furthermore, in Spain, 
Martinez-Urtaza et al., (2005) have reported that a unique clone of the virulent V. 
parahaemolyticus O4:K11 serotype has been found to be related with most clinical 
isolates and concurrent with the arrival of warmer tropical waters to the Galician 
coast. 
1.9 Virulence factors and pathogenicity  
Makino et al., (2003) have reported that more than 50 genes were identified in the 
genome sequence of V. parahaemolyticus that could possibly contribute to 
pathogenicity. These genes include those responsible for the biosynthesis of 
numerous pili, responsible for bacterial adherence and for numerous toxin 
homologues. The relationship between pathogenicity and the presence of these 
recently identified genes remains to be studied.  
Virulence factors are considered to be the unique molecular features of a 
pathogen used to achieve colonisation, infection of the host and cause damage to 
a host. A comprehensive understanding of V. parahaemolyticus infection and what 
virulence factors are involved is still elusive. The following sections describe 
factors have been reported previously and are thought to contribute to the 
virulence and pathogenicity of V. parahaemolyticus. 
1.9.1 Thermostable direct haemolysin (TDH) and thermostable related 
haemolysin TRH 
Virulent and avirulent forms of V. parahaemolyticus have been revealed by many 
studies. Most virulent strains of V. parahaemolyticus are reported to carry the tdh 
gene that encodes TDH or trh gene that codes for the TRH; some strains carry 
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both (Shirai et al., 1990, Ohnishi et al., 2011). V. parahaemolyticus isolates that 
carry both tdh and trh genes are strongly associated with clinical cases (Nishibuchi 
and Kaper, 1995). The presence of V. parahaemolyticus carrying tdh and/or trh 
pathogenicity genes in seafood has been considered as a public health risk (Zarei 
et al., 2012). Yamazaki et al., (2010) have reported that THD and TRH are main 
virulence factors in this bacterium. Furthermore, Wagley et al., (2009) have used 
TDH and TRH as  putative pathogenicity markers to detect the pathogenic strains 
of V. parahaemolyticus in seafood. Both TDH and TRH are comprised of 165 
amino acid residues and have about 67% identity in their amino acid sequences 
(Honda and Iida, 1993). Kamruzzaman et al., (2008) have reported that TDH is a 
marker of virulent strains of V. parahaemolyticus. It shows a beta-type haemolysis 
on Wagatsuma agar, called the Kanagawa phenomenon positive phenotype (KP+) 
(Honda and Iida, 1993). Miyamoto et al., (1969) reported that only 1 to 2% of 
strains from non-clinical (environmental) sources are KP+. However, Cabrera-
Garcia et al., (2004) have reported that the presence of the tdh gene that 
correlates with KP+ phenotype has been reported in 9 % of environmental V. 
parahaemolyticus isolates around Mexico; and Cook et al., (2002) reported that 
only 6 % of isolates found in molluscan shellfish on the Atlantic and Gulf Coast 
were KP+. The tdh gene was present in 10.5% of V. parahaemolyticus isolated 
from the environment (Rojas et al., 2011). However, Wagley et al., (2008) have 
detected tdh gene in 12% of the environmental isolates of V. parahaemolyticus. 
Furthermore, Velazquez-Roman et al., (2012) have reported that 52% (75 out of 
144) of V. parahaemolyticus environmental isolates carry tdh and/or trh genes and 
are considered as pathogenic strains. The tdh gene has been detected in (81/97) 
clinical isolates and (10/45) isolates from sea fish and none from fresh water 
(Hongping et al., 2011).  
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TRH is associated with the Kanagawa phenomenon negative phenotype (KP-) 
and/or with urease positive phenotype (Kelly and Stroh, 1989). Honda et al., (1988) 
have reported that KP- strains of this organism have caused food poisoning 
outbreaks. In Japan, Shirai et al., (1990) have reported that the presence of the trh 
gene has been demonstrated in 7 % of environmental strains of V. 
parahaemolyticus. Furthermore, Caburlotto et al., (2009) have demonstrated that 6% 
of the environmental V. parahaemolyticus isolates around Italy carried trh gene. 
Recently, the trh gene has been detected in 12% of clinical and 3.6% of 
environmental isolates of V. parahaemolyticus in eastern China (Vongxay et al., 
2008). In Spanish Mediterranean coast, Roque et al., (2009) have detected the 
virulent strains of V. parahaemolyticus that carry tdh and trh genes in cultured 
bivalves.  
TDH and TRH biological activities include haemolytic character, cytotoxicity, 
enterotoxicity and cardiotoxicity (Shirai et al., 1990, Nishibuchi et al., 1992). 
Adherence to cultured cells has also been assessed to measure bacterial 
virulence abilities (Baffone et al., 2000). TDH is a homo-dimer protein that has a 
molecular mass of 46 kDa. It is a pore-forming toxin, which is capable of causing 
haemolysis of erythrocytes from a number of mammalian species (Fabbri et al., 
1999). A series of experiments employing rabbit intestinal loop tests with TDH-
producing or non-producing V. parahaemolyticus isolates have been used to study 
enterotoxicity of TDH. Only TDH-producing V. parahaemolyticus isolates can 
induce fluid accumulation (Honda and Iida, 1993). 
The cytotoxicity of V. parahaemolyticus has been tested on different host cell lines, 
including human colorectal epithelial cells (Caco-2) (Raimondi et al., 2000), and 
human epithelial cells (HeLa) (Yeung et al., 2002). Yeung et al., (2002) have 
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reported that cytotoxicity and adherence of V. parahaemolyticus O3:K6 isolates to 
human epithelial (HeLa) cells was shown to be statistically higher than that for 
non-O3:K6 isolates.  
TDH and TRH have been studied and considered as virulence factors to detect the 
pathogenic V. parahaemolyticus isolates (Kaneko and Colwell, 1973, Matsuda et 
al., 2010). However, isolates lacking TDH and/or TRH still play a role in 
pathogenicity of V. parahaemolyticus. Virulence determinants other than TDH and 
TRH in V. parahaemolyticus strains remain to be investigated (Makino et al., 2003, 
Lynch et al., 2005, Vongxay et al., 2008). 
1.9.2 Enzyme activity  
Urease is defined as an enzyme from bacteria, fungi and plants that catalyses the 
hydrolysis of urea to carbon dioxide and ammonia (Olivera-Severo et al., 2006). 
The ability to hydrolyse urea can be used to predict potential pathogenicity of 
bacteria and hence the urease enzyme may be an important virulence marker for 
virulent V. parahaemolyticus strains (Kelly and Stroh, 1989). Urease activity is 
associated with the presence of the trh gene (Okuda et al., 1997a). It has been 
purified from culture supernatant of KP negative, urease positive V. 
parahaemolyticus isolates by Sodium dodecyl sulphate - polyacrylamide gel 
electrophoresis (SDS-PAGE), and has a high molecular weight of 275 kDa, 
containing three subunits of 33 kDa, 59 kDa and 85 kDa (Cai and Ni, 1996). Cai 
and Ni, (1996) studied its contribution to pathogenicity showing that it can cause 
intestinal fluid accumulation and was considered an important marker of 
pathogenesis. However, pandemic O3:K6 strains that were isolated from patients 
were found to be urease negative and the link between pathogenesis and urease 
was unclear (Yeung and Boor, 2004). Urease producing can be involved in the 
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pathogenicity of shiga toxin-producing Escherichia coli (Steyert and Kaper, 2012). 
Furthermore, urease has been considered as an important pathogenic factor for 
Proteus mirabilis (Jones et al., 1990) and Helicobacter pylori (Eaton et al., 1991). 
Virulent strains of V. parahaemolyticus produce several extracellular proteases, 
such as a 62 kDa zinc metalloprotease (PrtV) (Lee et al., 1995b, Yu and Lee, 
1999). Indeed, extracellular proteases present in the extracellular products (ECPs) 
and the possible role of proteases as virulence determinants of V. 
parahaemolyticus to tiger prawn have been reported by Sudheesh and Xu, (2001). 
Moreover, a serine protease has been detected in the extracellular proteins of V. 
parahaemolyticus which is a monomeric protein that has a molecular mass of 43 
kDa, and recognised as one of a number of putative virulence factors associated 
with pathogenesis. It was purified from a clinical isolate that was negative for tdh 
and trh genes and has been found to exert a cytotoxic effect on Chinese hamster 
ovary, HeLa, Vero, and Caco-2 cells, and caused lysis of erythrocytes leading to 
haemorrhage and death in mice (Lee et al., 2002a). More recently, Liu et al., (2011) 
have purified and identified a new extracellular serine protease (63 kDa) from a 
pathogenic strain of V. parahaemolyticus and found it to be toxic to zebra fish. 
Furthermore, proteases were found to play an important role in the virulence of 
clinical isolates of V. parahaemolyticus lacking tdh and trh genes and were shown 
to exhibit cytotoxic activity on Vero and CHO-K1 cells (Ottaviani et al., 2005). 
Recently, Chakraborty and Surendran (2009) concluded that not only TDH and 
TRH, but also proteases, play a main role in the pathogenicity of V. 
parahaemolyticus and contribute to enteropathogenicity. In addition, a V. 
parahaemolyticus zinc metalloprotease (VppC, 87 kDa) was also found in ECPs of 
virulent V. parahaemolyticus strains and is thought to play a role in fish 
pathogenicity (Kim et al., 2002, Luan et al., 2007). V. vulnificus also produces 
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protease, it has been purified and characterised by Miyoshi et al., (1987) who 
reported that the protease have caseinolytic, elastolytic and collagenolytic 
activities. Nottage and Birkbeck, (1987) have reported that the proteinase of V. 
alginolyticus contributes to pathogenesis of bivalve vibriosis. Furthermore, a 
cysteine protease has been demonstrated as important pathogenicity factor in 
Vibrio harveyi, and is considered a major exotoxin affecting the tiger prawn (Liu 
and Lee, 1999). 
Phospholipases can be virulence factors for some bacterial species; these species 
cause infection and massive tissue destruction, such as skin and lung infections 
caused by Pseudomonas aeruginosa. Many other bacteria secrete phospholipase 
that is cytolytic and causes tissue damage within infection (Songer, 1997). 
Phospholipases have been considered as a virulence factor in V. 
parahaemolyticus and are associated with pathogenicity (Guhathakurta et al., 
1988). The relationship between haemolytic and phospholipase activity has been 
demonstrated in some vibrios such as toxigenic V. cholerae O139 whereby the 
haemolysin exhibited phospholipase activity (Pal et al., 1997). Furthermore, the 
haemolysin of V. harveyi strongly correlated with phospholipase activity (Zhong et 
al., 2006). Lee et al., (2002b) have reported that the phospholipase of V. mimicus 
showed haemolytic activity. Phospholipase plays a role as a putative virulence 
factor in V. vulnificus (Koo et al., 2007). Furthermore, phospholipase is one of the 
virulence factors that contribute to pathogenicity of V. harveyi in the tiger prawn 
(Liu et al., 1996). 
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1.9.3 Adherence and colonisation factors 
Adherence and colonisation factors of enteropathogenic bacteria play an important 
role in the colonisation of the host gut epithelial surface (Dai et al., 1992). Yeung et 
al., (2002) have hypothesised that the positive motility phenotype of V. 
parahaemolyticus O3:K6 isolates correlated with virulence. Nakasone and 
Lwanaga, (1990) have purified pili of V. parahaemolyticus from a KP+ strain and 
found them to be adhesive to the rabbit intestine, and they suggested that pili of 
this bacterium play an important role in colonisation.  
V. parahaemolyticus is motile due to possessing both polar and lateral flagella that 
enable it to swim and swarm, respectively (Mccarter and Silverman, 1990, Stewart 
and Mccarter, 2003). Genes on chromosome 1 or 2 of V. parahaemolyticus are 
found to be responsible for biosynthesis of the polar or lateral flagella, respectively. 
Zorrilla et al., (2003) have reported that swarming could be used as a marker to 
distinguish the virulent forms of V. harveyi and V. parahaemolyticus isolates. 
Moreover, the lateral flagellum has been demonstrated as an important 
colonisation factor. 
V. parahaemolyticus has recently been shown to possess a capsule that may 
contribute to pathogenicity (Broberg et al., 2011). The capsular polysaccharide of 
V. vulnificus is considered a virulence factor and it is important for colonisation, 
uptake and survival of this bacterium in oysters (Srivastava et al., 2009). A capsule 
also acts as a virulence factor in V. cholerae O139 and plays a role in intestinal 
colonisation (Waldor et al., 1994), adherence (Yamamoto et al., 1994) and makes 
the bacteria partially resistant to phagocytosis (Albert et al., 1999). 
Another potential pathogenicity determinant of V. parahaemolyticus is the 
siderophore (Tanabe et al., 2003) which is a low molecular mass microbial 
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compound with a very high affinity for binding iron (Winkelmann, 2002). Dai et al., 
(1992) have reported that the siderophore and two higher molecular mass (77 and 
80 kDa) outer membrane proteins (OMPs) could play a role as virulence factors 
since Iron is necessary in the pathogenesis of V. parahaemolyticus. Production of 
a siderophore is significantly enhanced with Iron limited in vitro culture. 
Siderophores are necessary for infection in other human pathogens such as 
Burkholderia, Pseudomonas and mycobacteria (Ratledge and Dover, 2000). 
Siderophores may be important to the virulence of a number of enteropathogenic 
bacteria (Dai et al., 1992). 
1.9.4 Mobile genetic elements  
Bacteriophages are generally isolated from the ecosystem which is the habitat for 
the host strains of bacteria (Baross et al., 1978, Shivu et al., 2007). Phages are 
present among V. parahaemolyticus bacteria. Two filamentous phages Vf12 and 
Vf33 have been found in V. parahaemolyticus strains (Chang et al., 1998). 
Nevertheless, these two phages do not bear the tdh and trh genes, but the 
genome of these phages can integrate into plasmids or chromosomal DNA of V. 
parahaemolyticus and other Vibrio species. Therefore, these filamentous phages 
could contribute to the mobilisation of virulence genes (Chang et al., 1998). 
Furthermore, a filamentous phage, f237, from O3:K6 V. parahaemolyticus has 
been isolated by Nasu et al., (2000). The open reading frame, ORF8 in this phage 
is not found in other filamentous phages. Consequently, the orf8 gene has been 
demonstrated as a genetic marker for pandemic O3:K6 strains (Iida et al., 2001).  
Lysogenic CTXø bacteriophage carry a cholera toxin that is found in O1 and O139 
serotypes of V. cholerae (Waldor and Mekalanos, 1996, Faruque et al., 1998). The 
pattern of genomic organisation of phage f237 is similar to that of CTXø phage; 
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both of these phages are single stranded DNA and integrate into the genome of 
bacteria. Emergence of new pathogenic strains of V. parahaemolyticus may result 
from exchange of mobile genetic elements (Chang et al., 1998). The O4:K68 
serotype of V. parahaemolyticus has filamentous phage, Vf O4:K68 (Chang et al., 
2002). Seguritan, et al., (2003) have isolated two phages, VP16T and VP16C from 
an environmental isolate of V. parahaemolyticus. The gene structures and the 
distribution among Vibrio species of Vf12 and Vf33 have been analysed by Chang, 
et al., (1998).  
Interestingly, phages carry out a process known as lysogenic conversion that 
plays a role in the virulence of pathogenic V. harveyi; this bacterium is found in the 
intestinal tract of marine fauna and in tropical warm marine environments (Oakey 
and Owens, 2000). Strains of this bacterium have caused significant mortalities in 
the shrimp culture industry worldwide (Alabi et al., 1999). V. harveyi myovirus like 
virus (VHML) is a phage that is able to infect a narrow host range and has shown 
a preference for certain strains of V. harveyi (Oakey and Owens, 2000). The 
infection of VHML phage in V. harveyi strains cause up-regulation of protein 
excretion, and up-regulation of haemolysin production and a rise in virulence 
towards prawns. Moreover, the existence of this phage may confer virulence to V. 
harveyi strain 642, that has been studied by Munro et al., (2003). 
A plasmid is an extrachromosomal covalently closed deoxyribonucleic acid 
molecule that can range in size from 2 Kbp – 200/300 Kbp (Kado, 1998). The 
genes carried on a plasmid tend not to be essential for the existence of the 
bacteria, but can convey a useful characteristic to the host bacterium (Brown, 
2001). The copy number of a plasmid is the number of copies of a particular 
plasmid per cell; this can vary between very high with hundreds of copies per cell 
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to very low with only one or two copies per cell. By the host machinery, a plasmid 
can be replicated independently of the main bacterial genome as it possesses an 
origin of replication. Some plasmids (the episomes) can be replicated by 
integrating themselves into a bacterial chromosome and are replicated along with 
it, much like lysogenic phage (Brown, 2001). Guerry and Colwell, (1977) and 
Twedt, et al., (1981) have reported two plasmids of about 24 Mdal (36.5 Kbp) and 
60 Mdal (91 Kbp) in KP+ strains of V. parahaemolyticus O3:K6 isolated from 
patients.  
Insertion sequences are the simplest of the mobile DNA elements and are usually 
distributed between bacterial genomes (Mahillon and Chandler, 1998). Honda et 
al., (1988) have demonstrated that non-O1 V. cholera, V. mimicus and V. hollisae 
strains causing diarrhoea, produce haemolysins similar to TDH. Terai et al., (1991) 
have described the involvement of insertion sequences in the spread of the tdh 
gene among Vibrio species. The genome structure of V. parahaemolyticus can be 
changed by insertion sequences that lead to loss of main virulence features 
(Kamruzzaman et al., 2008, Kamruzzaman and Nishibuchi, 2008). Seven tdh 
genes and their flanking regions have been analysed by Terai et al., (1991); this 
analysis revealed insertion sequence like elements which are collectively called 
ISVs for insertion sequences in vibrios or sequences that were derived from the 
genetic rearrangement of the ISVs.  
1.9.5 Type III secretion system of V. parahaemolyticus 
The type III secretion system (T3SS) is an apparatus which is capable of causing 
direct protein secretion into a host organism e.g. eukaryotic cell. The T3SS is a 
main virulence factor of pathogenic bacteria that cause gastroenteritis including 
Salmonella, Shigella and enteropathogenic Escherichia coli (Hueck, 1998). 
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Genomic sequencing of V. parahaemolyticus RIMD2210633 revealed two T3SSs, 
namely, T3SS1 and T3SS2 (Makino et al., 2003). Park et al., (2004a) have 
recorded that T3SS homologues are found in V. parahaemolyticus and other 
Vibrio species including V. tubiashii and V. alginolyticus.  
Furthermore, V. cholerae non-O1 and non-O139 are shown to have genes for 
T3SS as determined by genomic characterisation (Dziejman et al., 2005). Henke 
and Bassler, (2004) characterised three type III secretion gene clusters in V. 
harveyi but their contribution to the pathogenesis of this bacterium is unknown.  
Park et al., (2004a) have found the T3SS1 is located on the large chromosome of 
V. parahaemolyticus while T3SS2 is found on the small chromosome of this 
bacterium. T3SS1 plays a role in cytotoxic activity, while T3SS2 is responsible for 
enterotoxicity. T3SS1 is found in clinical and environmental V. parahaemolyticus 
strains (Thompson et al., 2006). T3SS2 has been identified only in clinical V. 
parahaemolyticus strains that are positive for KP reaction (Makino et al., 2003), 
and play a role in the pathogenicity to humans as reported by Hiyoshi et al., (2010). 
However, Caburlotto et al., (2010) have reported that a number of environmental 
strains isolated from the North Adriatic sea around Italy carry T3SS2 and tested 
their pathogenicity on Caco-2 cells; the results indicated that these strains are 
considered to be a risk for human health. However, Kodama et al., (2007) have 
suggested that there are other unknown effectors involved in the pathogenic 
mechanism of this organism. 
1.10 Identification and detection methods  
Development methods for the detection of V. parahaemolyticus in seafood 
samples are necessary to reduce the risk of this organism and to ensure the safety 
of foods (Hara-Kudo et al., 2001).  
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1.10.1 Traditional methods for identification 
V. parahaemolyticus is halophilic, growing best with 3-6 % NaCl. This organism 
grows even at high pH 9.0. The optimum temperature for growth is 37°C and the 
temperature range of growth is 8-44 °C (Hayes, 1985). The growth of V. 
parahaemolyticus can be enriched with media such as alkaline peptone water at 
37 °C (Dupray and Cormier, 1983).  
The US Food and Drug Administration Bacterial Analytical Manual described the 
most probable number method (MPN) that is usually used for detection of V. 
parahaemolyticus (Elliot et al., 1995). However, this method is time-consuming 
and labour intensive (Su and Liu, 2007). The international standard ISO/TS 21872-
1 has been used to detect V. parahaemolyticus in seafood, Rosec et al., (2012) 
have reported that this method failed to detect V. parahaemolyticus in 44% to 53% 
of the living bivalve molluscs where specific PCR based method detected the 
specific gene toxR of V. parahaemolyticus, the authors have suggested that the 
need for a revision of the ISO/TS 21872-1 standard.  
Chun et al., (1974) prepared a medium containing NaCl, phosphate buffer and 
teepol. This enrichment medium is used to isolate V. parahaemolyticus from 
marine samples. Another medium less frequently used for isolating this organism, 
is mannitol salt agar (Carruthers and Kabat, 1976). 
Since then, thiosulfate citrate bile salts sucrose agar (TCBS) has been 
conventionally used for isolating and enumerating this bacterium, however other 
enteropathogenic vibrios grow well on it (Adams and Moss, 2000). The quality and 
recovery of growth of V. cholerae, V. fluvialis, V. parahaemolyticus and V. 
vulnificus varied significantly on different brands of TCBS agar tested (West et al., 
1982). However, it is not a differential medium for V. parahaemolyticus. A selective 
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medium was developed for the culture of V. parahaemolyticus, Hara-Kudo et al., 
(2001) and Blanco-Abad et al., (2009) have found that an agar medium named 
CHROMagar Vibrio (CV) agar contains a substrates for the bacterial β-
galactosidase is a very useful medium to distinguish V. parahaemolyticus from 
other Vibrio species by producing a purple colour on this medium due to the 
reaction of β-galactosidase in this bacterium with the medium substrate. Despite 
the development of a selective medium, the traditional methods for isolation and 
identification of V. parahaemolyticus remain expensive, time consuming and prone 
to contamination. 
Many Vibrio species have variable characters, therefore biochemical and 
nutritional tests are not sufficient to differentiate them (Glenn, 1976). For example, 
the phenotypic and genotypic characteristics of V. harveyi and V. camphellii are 
close and they exhibit very similar characteristics in biochemical characterisation 
tests (Pace and Chai, 1989).  A set of 28 tests are used for an initial identification 
of Vibrio species. The tests are used on isolates that are suspected of being a 
Vibrio species i.e. Gram-negative, oxidase-positive, glucose-fermenting and grow 
on any Vibrio medium (Alsina and Blanch, 1994). Croci et al., (2007) have 
reported that false positive results were obtained with using biochemical methods 
for identification of V. parahaemolyticus. Furthermore, identification of 
environmental Vibrio species by using the biochemical tests is time consuming, 
problematic and difficult due to their great diversity.        
To identify and differentiate marine bacteria, the API style of biochemical test kit 
includes 20 reactions and the profiles are given for clinically important bacteria 
including V. parahaemolyticus, V. alginolyticus and V. vulnificus. Several kits for 
biochemical tests have been used to identify suspected isolates of V. 
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parahaemolyticus, including API 20E and API NE and the Crystal Enteric/Non-
Fermenter ID Kit (BioMetrix). These kits can identify V. parahaemolyticus in 1-2 
days (API 20E), 4 hours (API NE and RapIDTM NF PLUS) and 18 hours (Crystal 
E/NF) (Su and Liu, 2007). Characteristics of V. parahaemolyticus are listed in 
Table 1.2. 
Honda et al., (1980) have characterised immunological techniques as reproducible 
for detection of the haemolysin-producing pathogenic V. parahaemolyticus. 
Moreover, Honda et al., (1982) have reported immunological methods for 
identification of the Kanagawa phenomenon in modified traditional selective media, 
i.e. bromthymol blue (BTB) - teepol agar and arabinose-ammonium sulphate-
cholate agar, for V. parahaemolyticus. These methods are helpful to isolate V. 
parahaemolyticus and identify the Kanagawa phenomenon on the same plate. The 
immune-halo test was performed by inoculating bacteria onto an agar medium that 
contained either anti-haemolysin immunoglobulin G (IgG) or anti-haemolysin 
antiserum (Honda et al., 1980). Honda, et al., (1985) have recorded the 
development of an enzyme-linked immunosorbent assay (ELISA) to detect the 
TDH. 
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Table 1.2 Biochemical characteristics of V. parahaemolyticusa, adapted from 
(Lam and Yeo, 1980). 
Positive Negative  
Indole  
Simmons citrate. 
Motility  
Oxidation-fermentation. 
Lysine decarboxylase. 
Ornithine decarboxylase. 
Catalase  
Acid production from:  
Glucose, maltose, mannitol, arabinose, 
trehalose,  
Growth in 1% peptone water with: 3 
and 7% NaCl. 
Methyl red. 
Voges-Proskauer. 
Hydrogen sulfide. 
Arginine dihydrolase. 
Phenylalanine. 
Malonate. 
No acid production from: 
Lactose, rhamnose, sucrose, adonitol, 
inositol, xylose, sorbitol 
 
No growth in 0% and 10% NaCl 
aAll tubed media for the biochemical tests were with 3% NaCl.  
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1.10.2 Molecular identification and detection methods 
Proposals for diagnostic techniques involve the use of gene probes. These 
techniques use oligonucleotide sequences of DNA or RNA, which hybridise to 
target sequences of the bacterial genome. The use of synthesised 
oligodeoxyribonucleotide probes labelled with 32P to detect tdh gene in V. 
parahaemolyticus has been described by Nishibuchi et al., (1986). Furthermore, 
Lee et al., (1992) have constructed an oligonucleotide probe labelled with 32P as a 
method to detect the tdh gene of V. parahaemolyticus in foods that were 
contaminated artificially. Mccarthy et al., (1999) have developed two non-
radioactive probes including digoxigenin (DIG)–labelled and Alkaline Phosphatase 
(AP)-labelled probes to detect tlh gene in V. parahaemolyticus to identify V. 
parahaemolyticus. More recently, Islam et al., (2004) have used such methods for 
detection of pathogenic V. parahaemolyticus isolated from the marine environment 
in Bangladesh which possess tdh gene.  
The use of amplification techniques such as polymerase chain reaction (PCR) may 
permit identification and detection of the bacterium in clinical and environmental 
samples. Many PCR-based assays have been established to assist in the specific 
identification of V. parahaemolyticus. DNA gyrase subunit B encoded by the 
gyrase B (gyrB) gene that is responsible for DNA replication has been proposed 
by Venkateswaran et al., (1998) to distinguish V. parahaemolyticus from V. 
alginolyticus. The specific PCR to target gyrB gene to identify V. parahaemolyticus 
in shrimp has been developed despite the homology of the gyrB sequences 
between both these bacteria is being 86.8% (Venkateswaran et al., 1998). 
However, the gyrB PCR also detected V. alginolyticus isolates as reported by Kim 
et al., (1999). The Tox R transmembrane protein encoded by the toxR gene is 
concerned with the regulation of genes in Vibrio species. A specific PCR to target 
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the toxR gene to identify V. parahaemolyticus has been developed by Kim et al., 
(1999). Rosec et al., (2009) have reported that the PCR targeting the toxR gene is 
an efficient and reliable tool for the identification of V. parahaemolyticus (Croci et 
al., 2007). Another specific PCR which targets the tlh gene, encoding the 
thermolabile haemolysin in V. parahaemolyticus has been developed by Bej et al., 
(1999) and Sakata et al., (2012). However, tlh was also found in V. alginolyticus 
(Robert-Pillot et al., 2002). Another PCR target is the pR72H fragment, which 
contains a phosphatidylserine synthetase gene, and non-coding region. The 
primers are used to amplify an amplicon of either 320 bp or 387 bp in length, that 
are considered specific for identifying V. parahaemolyticus (Robert-Pillot et al., 
2002).  
Importantly, a multiplex PCR (M-PCR) provides a valuable tool for the quick 
detection of a strain or species. A M-PCR has for V. parahaemolyticus been 
developed and used to detect tdh, trh and tlh genes simultaneously in samples 
from shellfish (Bej et al., 1999, Terzi et al., 2009). Recently, M-PCR has supplied a 
rapid and sensitive technique to detect specific pathogenic bacteria in marine 
environments (Kong et al., 2002). A M-PCR has been developed by Espiñeira et 
al., (2010) to detect simultaneously the five pathogenic Vibrio species in seafood 
samples by M-PCR to target the dnaJ gene in a single reaction producing species-
specific amplicon 450 bp for V. parahaemolyticus, 144 bp for V. alginolyticus, 564 
bp for toxigenic V. cholerae O1, 177 bp for V. mimicus and 412 bp for V. vulnificus; 
and applied this PCR to detect directly all these pathogenic species from stool 
samples (Nhung et al., 2007). Tyagi et al., (2009) have detected pathogenic V. 
parahaemolyticus by a Quantitative PCR (Q-PCR) method that was established to 
detect tdh positive V. parahaemolyticus bacteria in oysters and in pure cultures 
(Blackstone et al., 2003). Moreover, this technique requires less time and appears 
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to be reliable and accurate (Wittwer et al., 2001, Parveen et al., 2008). A multiplex 
Q-PCR has been demonstrated to detect tdh, trh, tlh, and ORF8 in the same 
reaction by using four sets of primers and four probes labelled with four different 
fluorophores for more rapid detecting of total and virulent forms of V. 
parahaemolyticus in oysters. This assay has applications in the seafood industries 
to ensure food safety (Ward and Bej, 2006).  
More recently, a quick, cheap, highly sensitive and specific nucleic acid 
amplification technique, named loop-mediated isothermal amplification (LAMP), 
has been developed using a DNA polymerase which has strand displacement 
activity, and 4-6 designed primers that specifically recognise the 6-8 regions of the 
target DNA under isothermal conditions (Notomi et al., 2000). It has been used for 
detecting many bacteria such as Salmonella (Hara-Kudo et al., 2005), V. vulnificus 
(Han and Ge, 2008), and Porphyromonas gingivalis, Treponema denticola and 
Tannerella forsythia from periodontal infections (Yoshida et al., 2005). 
Promising results have been yielded for detection of total V. parahaemolyticus in 
seafood samples using the LAMP method (Yamazaki et al., 2008, Sun et al., 
2012). Additionally, Chen and Ge, (2010) have developed a toxR-based LAMP 
method for total detection of V. parahaemolyticus in oysters, and reported that 
toxR-based LAMP is more sensitive than toxR-based PCR. LAMP is also used for 
detection of pathogenic V. parahaemolyticus targeting tdh gene (Nemoto et al., 
2009). 
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1.10.3 Molecular typing techniques 
1.10.3.1 Randomly amplified polymorphic DNA analysis (RAPD) 
Typing techniques that investigate the entire genome are frequently more 
discriminatory than techniques that investigate variation at a specific locus. RAPD-
PCR is one such technique that is described as a sensitive method for detecting 
slight differences in genomic structure in different bacteria by employing short 
oligonucleotide primers of random sequence (Welsh and Mcclelland, 1990). This 
method has been successfully used in the analysis V. parahaemolyticus and other 
Vibrio species (Wong and Lin, 2001). This technique distinguishes strains of food 
borne pathogens such as V. parahaemolyticus depending on differences in 
nucleotide sequences in the whole genome. Sudheesh et al., (2002) have used 
RAPD-PCR for typing and differentiating between V. parahaemolyticus and V. 
alginolyticus strains isolated from cultured shrimps. Bilung, et al., (2005a) have 
examined the genetic relatedness among the V. parahaemolyticus strains by 
RAPD-PCR. It was revealed to be a robust, quick and sensitive typing technique to 
discriminate V. parahaemolyticus strains. Najiah et al., (2003) have demonstrated 
that no correlation exists between genetic and geographic origins of V. 
parahaemolyticus isolates from diseased fish and shrimp in brackish water ponds 
in Malaysia. In addition, in Taiwan, Wong, et al., (1999) described that 
geographical distances of clinical V. parahaemolyticus strains involved in 
gastroenteritis outbreaks did not have any important effect on the group of the 
RAPD types. Ultimately, the important advantages of RAPD-PCR are (i) its 
applicability to problems where limited quantities of DNA are available (ii) its 
suitability for working on anonymous (unknown) genomes and (iii) its low expense 
and good efficiency (Hadrys et al., 1992).  
Chapter 1 
35 
 
1.10.3.2 Pulse field gel electrophoresis (PFGE) 
Pulse field gel electrophoresis (PFGE) for V. parahaemolyticus was first reported 
in 1996 (Lu et al., 2000). PFGE is used to distinguish isolates of the same species 
of pathogenic bacteria (Bohm and Karch, 1992), including numerous Vibrio 
species, e.g. cholerae (Mahalingam et al., 1994). It has been used relatively little 
in environmental research, however, Tamplin et al., (1996) have used it 
extensively in epidemiological studies. This technique depends on the migration of 
large restriction endonuclease DNA fragments in gels. This migration occurs after 
cleavage of genome DNA with site-specific and low frequency cutting restriction 
endonucleases (Bohm and Karch, 1992). In recent years, PFGE has been used to 
detect and identify V. parahaemolyticus (Wong et al., 2000). It has high 
discrimination, reproducibility and is useful for typing pathogenic strains of V. 
parahaemolyticus (Liu et al., 2009). Furthermore, Ellingsen et al., (2008) have 
used PFGE to examine Norwegian V. parahaemolyticus isolated from the 
environment including that carry trh gene, and compare them to clinical isolates, 
the authors did not find any evidence that these isolates have contributed to 
disease and there were no obvious similarities between clinical and environmental 
of V. parahaemolyticus isolates tested. Wagley et al., (2008) have reported that 
PFGE showed a high degree of genetic diversity in V. parahaemolyticus isolates 
and it was not found relationship between isolates that isolated from similar 
seafood or origins. However, Miah (2009) have used PFGE for typing of V. 
parahaemolyticus and found difficulties such as a lack of typing in many samples 
of DNA of V. parahaemolyticus.  
1.10.3.3 Restriction fragment length polymorphism (RFLP) 
Restriction fragment length polymorphism (RFLP) uses a restriction enzyme to cut 
purified genomic DNA at specific sites. Electrophoresis is used to separate the 
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DNA fragments generated (Linton et al., 1995). This technique is a valuable tool 
for typing strains of some species of bacteria including V. cholerae (Dalsgaard et 
al., 1995). The RFLP-PCR has been used to amplify the 16S rRNA and 
subsequent restriction of the PCR products with endonuclease to create banding 
patterns when separated on agarose gel (Chun et al., 1999). In addition, this 
method has been used to characterise genes encoding components of polar 
flagella in V. parahaemolyticus (Marshall et al., 1999). Figure 1.1 shows the 
procedural steps of molecular typing methods. 
 
 
RAPD PFGE RFLP 
PCR Amplification  
↓ 
Gel Electrophoresis 
↓ 
Gel Staining 
↓ 
Interpretation 
Embed organisms 
in agarose plug 
↓ 
Protease digestion 
↓ 
Restriction 
Endonuclease digestion 
↓ 
Electrophoresis 
↓ 
Interpretation 
PCR Amplification  
↓ 
Restriction 
Endonuclease digestion 
↓ 
Gel Electrophoresis 
↓ 
Gel Staining 
↓ 
Interpretation 
 
Figure 1.1 The technical stages for three molecular typing methods.  
Modified from Olive and Bean, (1999).  
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1.10.3.4 Enterobacterial repetitive intergenic consensus PCR (ERIC-PCR) 
The ERIC sequence was first defined in E. coli, and is found in Salmonella 
typhimurium and other species including Klebsiella pneumonia and V. cholerae 
(Hulton et al., 1991). ERIC sequences are 126 bp long and seem to be restricted 
to transcribed genomic regions, either in un-translated regions upstream or 
downstream of open reading frames or in the intergenic regions of operons of 
polycistrons (Hulton et al., 1991). ERIC-PCR is helpful for assessing 
epidemiological and genetic relationships among V. parahaemolyticus isolates 
(Marshall et al., 1999). Bhowmick et al., (2008) used ERIC-PCR as a rapid method 
for molecular epidemiological typing of V. parahaemolyticus because it has a 
potential discriminating ability. Khan et al., (2002) have used ERIC-PCR to find a 
unique sequence band at 850 bp and using this sequence they developed a rapid 
PCR method to precisely classify O3:K6 isolates of V. parahaemolyticus that were 
isolated from a United States outbreak. 
1.10.3.5 Repetitive extragenic palindromic PCR (REP-PCR).  
REP elements were first described in E. coli as 35 bp sequences composed of a 
high conserved inverted repeat with the potential of forming a stem-loop structure 
(Stern et al., 1984). Moreover, Aranda-Olmedo, et al., (2002) have found this 
element in Pseudomonas putida repeated with a high degree of sequence 
conservation. Both REP-PCR and ERIC-PCR have been applied to study the 
genetic variation among non-O1 and non-O139 V. cholerae at higher sensitivity 
levels (Rao and Surendran, 2010). Moreover, Brocchi et al., (2006) have used 
REP-PCR to differentiate between pathogenic and non-pathogenic of E. coli 
strains. The similarities and differences between ERIC and REP are summarised 
in Table 1.3. 
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Table 1.3 The similarities and differences between ERIC and REP1. 
The similarities The differences 
1- Their chromosomal locations differ 
between species. 
2- Both are located in non-coding 
transcribed regions of the 
chromosome. 
3- Both include a potential stem-loop 
structure. 
4- Both can occur in either orientation 
with respect to transcription. 
1- ERIC sequences are much longer 
(126 bp and REP is 33 bp). 
2- The estimated number of REP 
sequences per chromosome is at 
least 10 times than that of ERIC. 
3- Multiple REP sequences are often 
found at a single chromosomal 
location whereas all the ERIC 
identified so far occur singly.  
1
Data from Hulton et al., (1991).  
1.10.3.6 Multilocus enzyme electrophoresis (MLEE) and multilocus sequence 
typing (MLST) 
MLEE has also been reported as a molecular typing method to study the genetic 
relationship between isolates the same species (Vieira et al., 1998). While, Maiden 
et al., (1998) have established MLST as an enhanced variation of MLEE. It has 
been promoted as the most reliable molecular tool for epidemiological studies. 
MLEE compares the electrophoretic mobility of genes coding the enzyme, 
whereas MLST allocates alleles directly from the nucleotide sequences (Walk et 
al., 2007). Vieira et al., (2001) have used the MLEE method to provide an accurate 
molecular method for distinguishing between V. cholerae and V. mimicus isolates 
that are especially helpful for identifying of atypical forms. MLST has been applied 
to study the differentiation between the pandemic and non-pandemic strains of V. 
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cholerae (Kotetishvili et al., 2003). MLST has also been applied to Salmonella 
(Kotetishvili et al., 2002), and V. parahaemolyticus (González-Escalona et al., 
2008). Allelic variations in the nucleotide sequences of several loci have been 
observed to discriminate strains by using MLST. Interestingly, diverse typing 
methods are frequently used in different laboratories for the same pathogens, thus 
the data are difficult to compare between laboratories and are usually inconvenient 
for population genetics, evolutionary or phylogenetic studies. In addition, MLEE is 
used for typing and population genetic analyses of parasites and fungal pathogens 
(Maiden et al., 1998). 
1.11 High throughput sequencing  
A new DNA sequencing method, high throughput (or ‘next generation’) sequencing 
technique is faster and more cost effective to allow quick sequencing of whole 
genomes. The sequence reaction contains the template (single stranded DNA), 
primer, DNA polymerase, and the enzymes sulfurylase and luciferase. One of the 
DNA synthesis products and the DNA chain itself is pyrophosphate which is 
released every time a nucleotide is added to a growing DNA chain. Addition of a 
nucleotide to the growing DNA chain is signaled by release of pyrophosphate  
(Lodge et al., 2007).  
In terms of high throughput sequencing application, it can be applied to bacteria 
isolated in pure culture to provide high resolution diagnostic and epidemiological 
information. Furthermore, high throughput sequencing can be also applied in 
pathogen biology to screen transposon libraries to identify genes and pathogens 
that contribute to fitness in different environments (Van Opijnen et al., 2009, 
Langridge et al., 2009, Goodman et al., 2009, Gawronski et al., 2009). 
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Azhikina et al., (2010) have used this method to obtain whole pathogen 
transcriptomes from infected host tissues. It has been also used for RNA 
sequencing to assess gene expression profiles (Han et al., 2007, Galindo et al., 
2009). Simen et al., (2009) have applied high throughput sequencing to the 
detection of resistance in viral pathogens, such as human immunodeficiency virus.  
In recent years, development of next generation sequencing (NGS) has been 
applied to whole genome sequencing and enabled the rapid construction of many 
complete microbial genomes. Hu et al., (2011) have used NGS for pathogen 
comparative genomics and comparing pathogens to less, or non-pathogenic near 
neighbors. Genome sequence differences between pathogens and non-pathogens 
have been previously studied but did not give which sequence may be responsible 
for a specific phenotype, for example, small genomic differences between closely 
related species of the same genus such as between Yersinia pestis and Yersinia 
pseudotuberculosis (Chain et al., 2004), and large genomic differences such as 
genomic islands within a single species of Escherichia coli (Perna et al., 2001). 
However, using NGS provides more investigation of human pathogens and their 
mechanisms of virulence and can be applied to pathogen genome comparison and 
determine pathogenic phenotypes in bacteria.   
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1.12 Aim and objectives 
The overall aim of this work was to develop reliable methods for distinguishing 
pathogenic and non-pathogenic isolates of Vibrio parahaemolyticus.  
Project Objectives 
i) Collect and check Vibrio parahaemolyticus isolates. Confirm 
identification using the following tests:- 
(a) Gram stain, biochemical & nutritional tests. 
(b) PCR to identify V. parahaemolyticus isolates.  
ii) Test clinical and environmental Vibrio parahaemolyticus isolates for 
differences in enzyme activities.  
iii) Look for carriage of plasmids and bacteriophages which might carry 
genes for virulence factors. (a) Use agarose gel electrophoresis to 
check for the presence of plasmids. (b) Take culture supernatant from 
different isolates and assay for phage. 
iv) Analysis of whole cell proteins and extracellular proteins by SDS-PAGE 
to look for differences between virulent and avirulent isolates. 
v) Test cytotoxic effects of extracellular products of V. parahaemolyticus on 
Caco-2 and CHO-K1 cell lines with view to producing a measure of 
virulence.  
vi) Clone regions of DNA unique to clinical (pathogenic) isolates of Vibrio 
parahaemolyticus, including DNA bands of interest identified in 
molecular typing methods, and sequence the gene(s) of interest in order 
to develop PCR detection methods. 
vii) Use identified gene sequences as a molecular tool to identify Vibrio 
parahaemolyticus and distinguish virulent and avirulent forms through 
the development of a multiplex-PCR. 
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Chapter 2: General Materials and Methods  
2.1 Chemicals and reagents 
Unless stated otherwise all general laboratory chemicals were obtained from 
Amersham Biosciences, Bio-Rad Laboratory, Invitrogen, Thermo-Fisher Scientific, 
or Sigma Aldrich and if possible, were of molecular biology grade. All 
bacteriological culture media were purchased from Oxoid. PCR related reagents 
were obtained from Roche Biosciences. Formation and preparation of laboratory 
reagents, buffers and growth media and the suppliers’ details are shown in 
Appendix 1. Details of the use of specific reagents can also be found in the 
Materials and Methods section of individual chapters. 
2.2 Bacteriology 
2.2.1 Isolates of V. parahaemolyticus and growth media 
V. parahaemolyticus isolates are listed in Table 2.1. All isolates were maintained 
on slants of Marine Salts Agar (MSA) with a final salt concentration of 2 % (w/v), at 
room temperature (21°C) in the dark. Broth cultures were grown at 37 °C in 
Tryptone Soya Broth (TSB) supplemented with NaCl 3% (w/v), shaking in a water 
bath (Clifton NE5-28D) at 70 rpm. A selection of biochemical tests and growth 
characteristics on several bacteriological media were performed regularly to 
confirm identity and purity of the cultures. 
2.2.2 Additional bacterial species and growth media 
Other species and non-Vibrio bacteria are listed in Table 2.2. All halophilic Vibrio 
species were grown in TSB and MSA supplemented with the appropriate 
concentration of NaCl. Aeromonas hydrophila and A. salmonicida were grown TSB 
and TSA at room temperature (21 °C) for two days. Non-Vibrio bacteria were 
grown in Luria-Bertani (LB) broth overnight at 37 °C. 
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Table 2.1 Vibrio parahaemolyticus isolates used in this study 
Strain CEFAS reference Obtained 
from
1
 
Location Reference Strain/Clinical/ 
Environmental 
PCR
2
  
 
tdh   trh  
R1 V05/001 PHLS PHLS, UK  Clinical, NCIMB Reference 
Strain 
- - 
C1 V05/009 NSVS Oslo, Norway Clinical,  - - 
C2 V05/010 NSVS Oslo, Norway Clinical + - 
C3 V05/011 NSVS Oslo, Norway Clinical - + 
C4 V05/012 NSVS Oslo, Norway Clinical + + 
C5 V05/013 NSVS Oslo, Norway Clinical + - 
C6 V05/014 NSVS Oslo, Norway Clinical + + 
C7 V05/015 NSVS Oslo, Norway Clinical + - 
C8 V05/016 NSVS Oslo, Norway Clinical + - 
C9 V05/017 NSVS Oslo, Norway Clinical + - 
C10 V05/018 NSVS Oslo, Norway Clinical - + 
C11 VP 2053 KUMS Kyoto, Japan Clinical + - 
C12 VP 5421 KUMS Kyoto, Japan Clinical + - 
C13 VP 6134 KUMS Kyoto, Japan Clinical + - 
C14 VP 6136 KUMS Kyoto, Japan Clinical - - 
C15 VP E155855 PHLS Unknown Clinical + - 
C16 V05/062 USC Spain Clinical + - 
C17 V05/063 USC Spain Clinical + - 
C18 V05/064 USC Spain Clinical + - 
C19 V05/065 USC Spain Clinical + - 
C20 V05/066 USC Spain Clinical + - 
C21 V05/081 CEFAS Italy Clinical - + 
C22 VP F3305 CEFAS Norfolk, UK Clinical,  + + 
R2 VP10885 PHLS PHLS, UK Environmental, NCTC 
Reference Strain,  
- - 
E1 1022/4 CEFAS Galicia, Spain Environmental  - - 
E2 1024/5 CEFAS Galicia, Spain Environmental - - 
E3 1021/5 CEFAS Galicia, Spain Environmental  - - 
E4 1023/1 CEFAS Galicia, Spain Environmental - - 
E5 1023/3 CEFAS Galicia, Spain Environmental - - 
E6 1103/9 CEFAS Galicia, Spain Environmental - - 
E7 Vib9 PHLS Southampton, PHL Environmental + - 
E8 VP1 PHLS Southampton, PHL Environmental - - 
E9 V05/027 CEFAS Southampton, UK Environmental + + 
E10 VP4 CEFAS Southampton, UK Environmental - - 
E11 VP5 CEFAS Southampton, UK Environmental - - 
E12 VP6 CEFAS Southampton, UK Environmental - - 
E13 VP3 CEFAS Southampton, UK Environmental - + 
E14 V05/025 CEFAS Southampton, UK Environmental + + 
E15 V05/022 CEFAS Southampton, UK Environmental - + 
E16 V05/023 CEFAS Southampton, UK Environmental - + 
E17 VP 02/331 CEFAS Holes Bay BOM Atlantic Environmental (G)  - - 
E18 V05/028 CEFAS Shellfish, UK Environmental (G) + - 
E19 VP 02/346 CEFAS Dom Fota Farm, UK Environmental (G)  - - 
E20 V05/029 CEFAS Holes Bay, UK Environmental (G)  + - 
E21 V05/030 CEFAS Arne, UK Environmental (G)  + - 
E22 VP 02/377 CEFAS Shellfish, UK Environmental (G)  - - 
E23 VP 02/378 CEFAS Dom Fota Farm, UK Environmental (G)  - - 
E24 Vib6 CEFAS Southampton, PHL Environmental  - - 
E25 VP 02/939 CEFAS Coedcanlas spit Environmental (E) - - 
E26 Vib8 CEFAS Southampton, PHL Environmental - - 
E27 V05/070 CEFAS Portugal Environmental (E) - + 
E28 V05/071 CEFAS Portugal Environmental (G)  - + 
E29 Vib2 CEFAS Southampton, PHL Environmental  - - 
E30 VP SCl CEFAS Portland Area, UK Environmental (S)  - - 
E31 VP 491(V05/031) CEFAS Weymouth, UK Environmental (M) - - 
1
CEFAS, Centre for Environment, Fisheries and Aquaculture Science, Weymouth, UK; PHLS, Public Health 
Laboratory Service, Southampton, UK (now Health Protection Agency); KUMS, Kyoto University Medical 
School, Japan; NSVS, Norwegian School of Veterinary Science, Oslo, Norway; USC, Universidad de Santiago 
de Compostela, Spain. 
2
PCR data for virulence tdh and trh genes were provided (see chapter 4). Source of 
environmental isolates (where known) from following species: G: Crassostrea gigas (Pacific oyster), M: Pecten 
maximus (Great scallop), S: Maja squinado (Common spider crab), E: Mytilus edulis (blue mussel).   
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Table 2.2 Vibrio species non-Vibrio bacteria strains that used in this study 
Strain ID Bacterial Strain Obtained from Origin 
VC V. cholerae NCTC
1
 Reference strain 
VM V. mimicus NCTC Reference strain 
VV1 
VV2 
VV3 
VV4 
VV5 
VV6 
V. vulnificus 
V. vulnificus 
V. vulnificus 
V. vulnificus 
V. vulnificus 
V. vulnificus 
NCTC 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
CEFAS 
Reference strain 
Environmental   
Clinical, Japan 
Clinical, Israel 
Clinical, Taiwan 
Clinical, USA 
VA1 
VA2 
V. alginolyticus 
V. alginolyticus 
CEFAS 
CEFAS 
Clinical isolate 
Clinical, Japan 
VA3 V. alginolyticus FDL
2
 Fish 
VA4 V. alginolyticus FDL Fish 
VA5 V. alginolyticus FDL Fish 
VA6 V. alginolyticus FDL Fish 
VH1 V. harveyi UoP
3
 Coral 
VH2 V. harveyi UoP Coral 
VH3 V. harveyi UoP Coral 
VH4 V. harveyi UoP Coral 
VH5 V. harveyi UoP Coral 
VN1 V. anguillarum UoP Fish 
VN2 
VS 
V. anguillarum 
V. shiloi 
UoP 
UoP 
Fish 
Coral 
Ah1 
Ah2 
As1 
As2 
Pf1 
Pf2 
St 
Pv 
Kp 
Ec1 
Ec2 
Aeromonas hydrophila 
A. hydrophila 
A. salmonicida 
A. salmonicida 
Pseudomonas flourescence 
P. flouresecence 
Salmonella typhimurium 
Proteus vulgaris 
Klebsiella pneumoniae 
Eschericia coli 
E. coli 
UoP 
UoP 
UoP 
UoP 
NCIMB
4 
NCIMB
 
NCIMB
 
UoP 
UoP 
NCIMB 
UoP 
Fish 
Fish 
Fish 
Fish 
Reference strain  
Reference strain  
Reference strain  
N/A 
N/A 
Reference strain  
K12 wild type 
1
NCTC National Collection of Type Cultures; 
2
 FDL, Fish diseases laboratory.WV, USA; 
3
UoP, 
University of Plymouth; 
4
NCIMB, National Collections of Industrial Food and Marine Bacteria. 
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2.3 Extraction of DNA 
Genomic DNA was extracted from V. parahaemolyticus and other species using 
“DNeasy® Blood & Tissue Kit” for Gram-negative bacteria” following the 
manufacturer’s instruction. 
A 5 ml overnight culture of the organism was placed into a 15 ml Falcon tube, and 
centrifuged at 2,800 x g for 10 min at 4 Cº. Next, the cell pellet was resuspended 
in 180 µl ATL buffer (cell lysis solution) with gentle pipetting. Samples were mixed 
with 20 µl proteinase K and vortexed and incubated at 56 ºC to lyse the cells until 
the solution mixture became clear. A 4 µl volume of Rnase ‘A’ solution (100 mg/ml) 
was mixed with the cell lysate and left for 2 min at room temperature. A 200 µl 
volume of AL Buffer and 200 µl of ethanol were added and vortexed to yield a 
homogeneous solution. 
Following this, the mixture above was pipetted into a DNeasy Mini spin column 
and placed in a 2 ml collection tube, centrifuged at 2,400 x g for 2 min and the flow 
through was discarded. The column was placed in a fresh 2 ml collection tube and 
500 µl of AW1 Buffer was added and centrifuged at 2,400 x g for 2 min. The 
DNeasy Mini spin column was placed in a fresh 2 ml collection tube and 500 µl of 
AW2 Buffer was added and centrifuged for 4 min at 9,500 x g. To elute DNA, the 
DNeasy Mini spin column was placed in a fresh microcentrifuge tube and 50 µl 
molecular grade water was added onto the DNeasy membrane and incubated at 
room temperature for 1 min and then centrifuged for 1 min at 9,500 x g. 
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2.4 DNA quantification 
The quantity and quality of genomic DNA was established by agarose gel 
electrophoresis (section 2.9). The genomic DNA was visualised and images of 
each gel were captured after electrophoresis with a Gel Documentation system 
(Uvi-Tech, UK) (Appendix I), and the DNA concentration was determined for each 
isolate by comparison with a range of the following known amounts of standard 
bacteriophage λ: 0.552 µg, 0.276 µg, 0.138 µg using ‘U.V. Photo’ software (UVi-
Tech). Genomic DNA was also quantified with a UV spectrophotomer using 2 µl 
volumes (Nano-drop 100 spectrophotometer Lab-Tech, UK).  
2.5 PCR primers design  
Unless stated otherwise, primers for PCR reactions were designed by using 
Primer3 software (http://biotools.umassmed.edu/bioapps/primer3_www.cgi), a lack 
of primer-dimer formation was assessed using DNA calculator (Sigma-Genosys). 
Primer sequences were then run through BLAST (http://blast.ncbi.nlm.nih. 
gov/Blast.cgi). Primers were purchased from MWG Biotech Ltd., Germany.  
2.6 Polymerase chain reaction (PCR) 
PCR reactions were prepared within a PCR cabinet (Heto-Holten, Denmark) and 
performed with a DNA thermal cycler MWG Primus 96 Plus (MWG Biotech). Each 
reaction contained 1x PCR reaction buffer (Roche Applied Science, UK) (Appendix 
I), 50 pmol of each primer, each deoxynucleoside triphosphate (dNTP) at a 
concentration of 0.2 mM, 1U of Taq DNA polymerase, 20 ng of bacterial genomic 
DNA, and the mixture was completed to 50 µl with addition of molecular grade 
water. To monitor for contamination, a negative control was set up in exactly the 
same way except that the addition of DNA template was replaced with an 
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equivalent volume of PCR grade water. Various cycling conditions were used as 
described elsewhere. Specific details are provided in each individual chapter.  
2.7 Extraction of DNA from agarose gels 
The Agarose Gel DNA Extraction Kit (Roche Applied Science) was used for 
extraction of DNA as follows: DNA fragments of interest were separated on an 
agarose gel using 1x TRIS- borate EDTA buffer (TBE) (Appendix I) running buffer, 
visualised and isolated by cutting out with a sharp clean and sterile scalpel. These 
were transferred to pre weighted reaction tubes. A 300 µl of the Agarose 
Solubilisation Buffer (vial 2) were applied per 100 mg of agarose gel. The Silica 
Suspension (vial1) was resuspended to obtain a homogeneous suspension, and a 
10 µl volume was added, and incubated at 56-60°C for 10 min, with vortexing 
every 2-3 min. Next, samples were centrifuged for 1 min at 9,500 x g. The pellet 
was resuspended in 500 µl Nucleic Acid Binding Buffer (vial 3) using a vortex 
mixer, and centrifuged for 1 min at 9,500 x g. Washing buffer (vial 4) 500 µl was 
used twice for washing the pellet. Next the tubes were inverted on a tissue to allow 
pellet to dry at room temperature for 10-16 min. A 25 µl volume of molecular grade 
water was used to elute DNA and left for 10 min at 56-60° and vortexed every 2-3 
min. After centrifugation at 9,500 x g for 1 min the DNA containing solution was 
transferred to a fresh tube.  
2.8 Purification of PCR products 
PCR products were purified using the ‘High pure PCR Product Purification Kit’ 
(Roche Applied Science) following the manufacturers’ instruction. Details of the 
individual solutions included in this kit can be found in appendix I. The final volume 
of the reaction mixture of PCR products was adjusted with PCR grade water to 
100 µl. A 500 µl volume of Binding Buffer was mixed thoroughly with the PCR 
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product. The mixture was centrifuged at 9,500 x g for 1 min, on a column 
(containing the manufacturers filter) and the flow through solution was removed, 
and the filter washed firstly with 500 µl of Wash Buffer and centrifuged at 9,500 x g 
for 1 min, and secondly with 200 µl of Wash Buffer and centrifuged at 9,500 x g for 
1 min. A 25 µl volume of molecular grade water was added onto the column and 
placed in a clean 1.5 ml microcentrifuge tube and left at room temperature for 1 
min. The DNA was eluted by centrifugation at 9,500 x g for 1 min. This DNA was 
quantified using the procedure in section 2.4. 
2.9 Agarose gel electrophoresis  
Agarose gel electrophoresis was performed using a TBE buffer. Depending upon 
the application, it was performed using 0.8%-2% (w/v) agarose made with 1 x TBE 
buffer. Two sizes of agarose gel were used, 60 ml or 250 ml volume approximately 
80 x 100mm or 200 x 200mm slabs. Agarose gels of 60 ml were run for 1 hour at 
120V, while 250 ml gels were electrophoresed at 95 V for 5 h using Pharmacia 
tanks (Biotech, Sweden). Prior to electrophoresis, the samples were loaded with 
6x gel loading solution. The sample volumes and concentrations varied according 
to each analysis and are stated in the Material and Methods section of each 
chapter. DNA molecular size standards, either 100 bp or 1 kbp (0.3µg) (Invitrogen, 
UK) (Appendix I) were included on gels to assist in the estimation of the sizes of 
DNA fragments. Following electrophoresis, the DNA bands were stained by 
immersing the gel for 20 min in a TBE buffer containing Red gel stain or ethidium 
bromide (0.5µg/ml), followed by 10 min destaining in distilled water to remove any 
unbound stain. The stained bands were visualised with UV light (309 nm) using a 
trans-illuminator and gels were recorded as digital TIFF images using a gel 
documentation system (UVI-Tech).  
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2.10 DNA manipulation methods 
2.10.1 Ligation of DNA molecules 
T4 DNA Ligase was used to ligate DNA fragments of interest to pGEM-T Easy 
vector (vector). The reaction mixture contained 5µl of 2X Rapid Ligation Buffer, 1µl 
of vector (50 ng), 3 µl of purified of DNA (insert) and 1µl of T4 DNA Ligase. In 
control reactions insert DNA provided in the kit was used. The ligation mixture was 
kept at 4°C overnight. 
2.10.2 Transformation of Escherichia coli 
E. coli JM109 was used for transformation of ligation products as follows: 2µl of 
the ligation reaction were added to 50 µl of competent cells and mixed gently. To 
determine the transformation efficiency of the E. coli JM109, a 0.1 µg sample of 
uncut plasmid was also used. The tubes were placed on ice for 20 min, next the 
tubes were incubated at 42 ºC for 1 min (heat shocked), and then the tubes 
returned to ice for 2 min. A 950 µl volume of SOC medium (Appendix I) was added 
to the tubes containing cells transformed with ligation reaction and 900 µl to the 
tube containing cells transformed with uncut plasmid and incubated for 1.5 hour at 
37ºC with shaking 150 rpm.  
2.10.3 Blue/white screening for recombinant clones 
A 50 µl and 100 µl samples of each transformation culture of transformants were 
spread onto duplicate LB/Ampicillin/X-Gal/IPTG plates (Appendix I). Plates were 
incubated at 37 ºC for 24 - 48 h, and examined for the presence of blue (lac+, non-
recombinant), and white (lac-, recombinant) colonies. Following the transformation 
of E. coli JM109 with ligated DNA the recombinants (white colonies) was selected.  
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2.10.4 Purification of plasmid DNA 
Recombinant plasmid DNA was isolated from E. coli using the Miniprep plasmid 
DNA extraction kit (GenEluteTM Plasmid Miniprep Kit) (Sigma, UK) as follows: 
Recombinant E. coli cultures were grown in LB medium overnight at 37 °C. A 5 ml 
volume of recombinant E. coli culture was centrifuged and 200 µl of the 
resuspention solution was used to resuspend the bacterial pellet until homogenous. 
A 200 µl volume of the lysis solution was added. The contents were mixed by 
gentle inversion (6-8 times) without vortexing. A 350 µl volume of the 
Neutralisation/Binding Solution was added. Tubes were inverted about 6 times. 
The cell debris was pelleted by centrifuged at 9,500 x g for 10 min and the 
supernatant was recentrifuged to give clear lysats. Next, a column of 
GenEluteMiniprep Binding was inserted into a provided microcentrifuge tube to 
prepared by adding 500 µl volume of the Column Preparation Solution, and 
centrifuged at 9,500 x g for 1 min. Afterwards clear lysates were transferred to the 
columns and centrifuged at 9,500 x g for 1 min and the flow-through liquid was 
discarded. A 500 µl volume of the Optional Wash Solution was added and 
centrifuged at 9,500 x g for 1 min and the flow-through liquid discarded. A 750 µl 
volume of Wash Solution was added and centrifuged at 9,500 x g for 1 min to 
remove residual salt and other contaminants, and then recentrifuged to remove 
ethanol. The column was transferred to a clean tube and 50 µl of molecular 
biology reagent water was added to the column. The eluted plasmid DNA was 
recovered by centrifugation at 9,500 x g for 1 min.  
2.10.5 Verifying cloning by using restriction enzyme analysis 
The cloning was verified by digestion with restriction enzymes. Restriction 
digestion with EcoR1 was performed in a volume of 20µl containing 100 ng of 
plasmid DNA, 2µl of restriction endonuclease buffer, 0.2µl of Acetylated BSA, 
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10µg/µl, 1µl of EcoR1 (10µ/µl) and to complete the final volume with analytical 
grade H2O to 20µl. The digest was incubated overnight at 37 °C to ensure 
complete digestion. Agarose gel electrophoresis was used to analyse the products 
of endonuclease digestion (section 2.9). 
2.11 DNA sequencing and sequence analysis 
The cloned DNA was sequenced by MWG-Biotech Ltd., Germany. Computer 
analysis of the DNA sequence data was performed via the National Centre for 
Biotechnology Information (NCBI) using GenBank databases search and BLAST 
programs (NCBI) and the nucleotide sequences were submitted to GenBank. 
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Chapter 3: Identification and Confirmation of Vibrio parahaemolyticus 
Isolates  
3.1 Introduction  
There are many techniques used to identify V. parahaemolyticus. The selective 
medium thiosulfate/citrate/bile salt/sucrose agar (TCBS) has been extensively 
used for the identification of V. parahaemolyticus by producing blue green colonies 
because this organism does not ferment sucrose. CHROMagarTM Vibrio (CV) 
medium is also used to identify and confirm V. parahaemolyticus by revealing 
purple colonies using a chromogenic substrate (Hara-Kudo et al., 2003).  
O'hara et al., (2003) have reported that Vibrio species that were isolated from 
patients can be traditionally identified by commercial identification systems and 
biochemical tests, but may not always be accurate. Moreover, the biochemical 
tests are not sufficient or accurate enough to identify all V. parahaemolyticus 
isolates (Robert-Pillot et al., 2002). Furthermore, Takahashi et al., (2005) have 
reported that traditional typing methods such as conventional culture methods and 
biochemical profiles have failed to distinguish between virulent and avirulent 
strains of V. parahaemolyticus because there are no clear growth features for 
virulent strains that could be distinguished from avirulent strains. Nowadays, a 
specific PCR can be used to confirm the identification of V. parahaemolyticus. 
A number of species specific PCR tests are available to identify the presence of 
specific genes in V. parahaemolyticus. Gene tlh encoding thermolabile haemolysin 
is present in virulent and avirulent strains of V. parahaemolyticus but this 
haemolysin does not contribute to the pathogenicity of this organism and has led 
workers to develop a PCR using this gene to identify V. parahaemolyticus 
(Taniguchi et al., 1986, Bej et al., 1999). Moreover, a specific PCR targeting 
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pR72H fragment was also developed for detection V. parahaemolyticus in shellfish 
(Lee et al., 1995a, Cordova et al., 2002). A specific PCR which detects toxR gene 
that encodes the Tox R transmembrane protein have been developed for detection 
V. parahaemolyticus, however, tlh is also found among V. alginolyticus (Xie et al., 
2005). Moreover, a specific PCR to detect the gyrB gene for identifying V. 
parahaemolyticus has been developed by Venkateswaran et al., (1998). Recently, 
Croci et al., (2007) have compared PCR for detection of toxR gene, tlh gene, and 
the pR72H fragment for identification of V. parahaemolyticus. They found the PCR 
that detected toxR gene gave the optimal results for concordance, inclusivity and 
exclusivity as confirmed by Rosec et al., (2009). 
A collection of V. parahaemolyticus isolations was obtained from CEFAS, Centre 
for Environment, Fisheries and Aquaculture Science, Weymouth, UK; PHLS, 
Public Health Laboratory Service, Southampton, UK (now Health Protection 
Agency); KUMS, Kyoto University Medical School, Japan; NSVS, Norwegian 
School of Veterinary Science, Oslo, Norway, as previously described (A. Miah, 
PhD thesis, University of Plymouth). 
Before proceeding with the present study, it was necessary to assess phenotypic 
characters amongst clinical and environmental isolates of this organism, and to 
confirm the identity of V. parahaemolyticus isolates by selective media, standard 
biochemical tests including Gram staining, oxidase, catalase, motility, sucrose and 
lactose fermentative, and confirm by specific PCR targeting toxR gene.  
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3.2 Materials and methods 
3.2.1 Subculture and identification of V. parahaemolyticus on selective 
media and biochemical test  
All bacterial isolates were recovered for use from marine salts agar (MSA) slopes 
and cultured overnight at 37°C in appropriate volumes of marine salt broth (MSB) 
shaking at 70 rpm or Tryptone Soy Broth (TSB) with a final NaCl concentration of 
3 % (w/v). Bacterial isolates were streaked on thiosulphate citrate bile sucrose 
agar (TCBS) and HiCromeTM Vibrio agar plates and incubated for 24 hours at 
37°C. The pure colonies were streaked onto fresh HiCromeTM Vibrio agar for 
purity. Stained slide smears from pure cultures were examined under the 
microscope for their Gram reaction. The following biochemical tests (oxidase, 
catalase, motility, sucrose and lactose fermentative) were also performed as 
further characters to identify the isolates. 
3.2.2 Confirmation by PCR assay  
All V. parahaemolyticus isolates were tested by specific PCR for the toxR gene to 
confirm identity as V. parahaemolyticus. DNA was extracted from all the isolates 
as described in section 2.3 to use it as a template for PCR. Specific primers ToxR-
4 (F: 5’-GTCTTCTGACGCAATCGTTG -3’) and ToxR-7 (5’- R: 
ATACGAGTGGTTGCTGTCATG -3’) to target regulatory gene ToxR (Kim et al., 
1999) were used to perform a specific PCR for identification V. parahaemolyticus 
isolates. The PCR reaction was performed as described in section 2.6. The PCR 
cycling condition was 5 min at 94 °C followed by 30 cycles of 1 min at 94 °C, 1 min 
at 59 °C and 2 min at 70 °C followed by a final extension at 70 °C for 5 min. The 
PCR products were electrophoresed as described in section 2.9. For confirmatory 
purposes, the PCR products produced by selected isolates were sequenced by 
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MWG Biotech. These sequences, together with the nucleotide sequences of V. 
parahaemolyticus strain RIMD 2210086 ToxR gene were aligned using the online 
programs using software Multalin http://www-archbac.u-
psud.fr/genomics/multalin.html (Corpet, 1988). GenBank database was used to 
compare the sequences with those from other organisms. 
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3.3 Results 
3.3.1 Subculture on selective media and biochemical tests.  
Isolates were previously identified and confirmed as V. parahaemolyticus by a 
previous study in this school (Miah, 2009) and by colleagues at CEFAS. The 
results here confirmed the identity of isolates before using in the current study. 
All 55 strains of V. parahaemolyticus formed green colonies on TCBS (Figure 3.1 
and Table 3.1). V. mimicus and V. vulnificus are also formed green colonies (Table 
3.2). TCBS cannot differentiate V. parahaemolyticus from V. mimicus and V. 
vulnificus. While, V. cholerae and V. alginolyticus isolates exhibit distinct yellow 
colonies upon acid production with sucrose fermentation which alters the pH and 
is indicated by the dyes bromothymol blue and thymol blue. As illustrated in Figure 
3.1 and Table 3.1, V. parahaemolyticus formed green or blue green colour on 
HiCromTM Vibrio agar. Therefore, depending on the formation of blue green 
colonies on this medium, it could differentiate V. parahaemolyticus from V. 
mimicus and V. vulnificus. In terms of biochemical tests, all V. parahaemolyticus 
isolates were Gram-negative curved rods, catalase and oxidase positive and 
motile (Table 3.1). 
3.3.2 PCR 
PCR was performed to confirm phenotypic identification of V. parahaemolyticus 
isolates. The specific PCR targeted the toxR gene to produce a 368 bp amplicon 
which was found in all V. parahaemolyticus isolates tested (Figure 3.2 and Table 
3.1). No band was seen with any of the other Vibrio and non-Vibrio species tested 
(Figure 3.2 and Table 3.2). The nucleotide sequence analysis confirmed the 
identity of selected PCR products (Figure 3.3). 
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Table 3.1 Biochemical and nutritional tests of Vibrio parahaemolyticus 
isolates that used in this study 
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R1 Clinical, NCIMB Reference 
Strain, UK 
Green Blue green - + + + - - + 
C1 Clinical, Norway Green Blue green - + + + - - + 
C2 Clinical, Norway Green Blue green - + + + - - + 
C3 Clinical, Norway Green Blue green - + + + - - + 
C4 Clinical, Norway Green Blue green - + + + - - + 
C5 Clinical, Norway Green Blue green - + + + - - + 
C6 Clinical, Norway Green Blue green - + + + - - + 
C7 Clinical, Norway Green Blue green - + + + - - + 
C8 Clinical, Norway Green Blue green - + + + - - + 
C9 Clinical, Norway Green Blue green - + + + - - + 
C10 Clinical, Norway Green Blue green - + + + - - + 
C11 Clinical, Japan Green Blue green - + + + - - + 
C12 Clinical, Japan Green Blue green - + + + - - + 
C13 Clinical, Japan Green Blue green - + + + - - + 
C14 Clinical, Japan Green Blue green - + + + - - + 
C15 Clinical, UK Green Blue green - + + + - - + 
C16 Clinical, Spain Green Blue green - + + + - - + 
C17 Clinical, Spain Green Blue green - + + + - - + 
C18 Clinical, Spain Green Blue green - + + + - - + 
C19 Clinical, Spain Green Blue green - + + + - - + 
C20 Clinical, Spain Green Blue green - + + + - - + 
C21 Clinical, Italy Green Blue green - + + + - - + 
C22 Clinical, UK Green Blue green - + + + - - + 
R2 Environmental, NCTC 
Reference Strain, UK 
Green Blue green - + + + - - + 
E1 Environmental, Spain Green Blue green - + + + - - + 
E2 Environmental, Spain Green Blue green - + + + - - + 
E3 Environmental, Spain  Green Blue green - + + + - - + 
E4 Environmental, Spain Green Blue green - + + + - - + 
E5 Environmental, Spain Green Blue green - + + + - - + 
E6 Environmental, Spain Green Blue green - + + + - - + 
E7 Environmental, UK Green Blue green - + + + - - + 
E8 Environmental, UK Green Blue green - + + + - - + 
E9 Environmental, UK Green Blue green - + + + - - + 
E10 Environmental, UK Green Blue green - + + + - - + 
E11 Environmental, UK Green Blue green - + + + - - + 
E12 Environmental, UK Green Blue green - + + + - - + 
E13 Environmental, UK Green Blue green - + + + - - + 
E14 Environmental, UK Green Blue green - + + + - - + 
E15 Environmental, UK Green Blue green - + + + - - + 
E16 Environmental, UK Green Blue green - + + + - - + 
E17 Environmental, UK  Green Blue green - + + + - - + 
E18 Environmental, UK Green Blue green - + + + - - + 
E19 Environmental, UK  Green Blue green - + + + - - + 
E20 Environmental, UK  Green Blue green - + + + - - + 
E21 Environmental, UK  Green Blue green - + + + - - + 
E22 Environmental, UK  Green Blue green - + + + - - + 
E23 Environmental, UK  Green Blue green - + + + - - + 
E24 Environmental, UK  Green Blue green - + + + - - + 
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Table 3.1 continued 
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E25 Environmental, UK  Green Blue green - + + + - - + 
E26 Environmental, UK  Green Blue green - + + + - - + 
E27 Environmental, Portugal Green Blue green - + + + - - + 
E28 Environmental, Portugal Green Blue green - + + + - - + 
E29 Environmental, UK Green Blue green - + + + - - + 
E30 Environmental, UK Green Blue green - + + + - - + 
E31 Environmental, UK Green Blue green - + + + - - + 
           
+, positive; -, negative 
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Table 3.2 Biochemical and nutritional tests of Vibrio species and non-Vibrio 
bacteria strains that used in this study 
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VC V. cholerae Yellow Purple - + + + + - - 
VM V. mimicus Green Creamy - + + + - - - 
VV1 V. vulnificus Green Pale green - + + + - + - 
VV2 V. vulnificus Green Pale green - + + + - + - 
VV3 V. vulnificus Green Pale green - + + + - + - 
VV4 V. vulnificus Green Pale green - + + + - + - 
VV5 V. vulnificus Green Pale green - + + + - + - 
VV6 V. vulnificus Green Pale green - + + + - + - 
VA1 V. alginolyticus Yellow Pale green - + + + + - - 
VA2 V. alginolyticus Yellow Pale green - + + + + - - 
VA3 V. alginolyticus Yellow Pale green - + + + + - - 
VA4 V. alginolyticus Yellow Pale green - + + + + - - 
VA5 V. alginolyticus Yellow Pale green - + + + + - - 
VA6 V. alginolyticus Yellow Pale green - + + + + - - 
VH1 V. harveyi Yellow  - + + + + - - 
VH2 V. harveyi Yellow  - + + + + - - 
VH3 V. harveyi Yellow  - + + + + - - 
VH4 V. harveyi Yellow  - + + + + - - 
VH5 V. harveyi Yellow  - + + + + - - 
VN1 V. anguillarum   - + + + + - - 
VN1 V. anguillarum   - + + + + - - 
VS V. shiloi   - ND ND + ND + - 
Ah1 Aeromonas hydrophila   - + + + + + - 
Ah2 A. hydrophila   - + + + + + - 
As1 A. salmonicida   - + + - - - - 
As2 A. salmonicida   - + + - - - - 
Pf1 Pseudomonas flourescence   - + + + - - - 
Pf2 Psue. flouresecence   - + + + - - - 
St Salmonella typhimurium   - - + + - - - 
Pv Proteus vulgaris   - - + + + - - 
Kp Klebsiella pneumoniae   - - + - + + - 
Ec1 Eschericia coli   - - + ND + + - 
Ec2 E. coli   - - + ND + + - 
+, positive; -, negative; ND; Not determined 
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(a)  
 
 
(b)  
Figure 3.1 Appearance of Vibrio parahaemolyticus (a) on TCBS agar medium 
(b) on HiCromTM Vibrio agar medium. 
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(a)  
 
(b)  
 
  (c)  
 
Figure 3.2 Agarose gel electrophoresis of PCR amplified products using 
specific primers to detect toxR gene in V. parahaemolyticus. 
Lanes M, 100-bp molecular mass marker. (a) Lane 1, negative control; Lanes 2-12 clinical 
V. parahaemolyticus isolates; Lane 13, NCTC Reference strain; Lanes 14-28 
environmental V. parahaemolyticus. (b) Lanes 1-11 clinical; Lanes (12-27) environmental 
V. parahaemolyticus Lane 28, negative control. (c) Lane 1, NCIMB Reference strain (R1); 
Lanes 2-23 Vibrio species, lanes 23-27 non-Vibrio bacteria including (A. hydrophila, A. 
salmonicida, P. fluorescence, S. typhimurium, Pro. vulgaris, K. pneumoniae, E. coli); lane 
28, negative control.  
 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  28 M 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  28 M 
M 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27  28 M 
368 bp 
368 bp 
368 bp 
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                                                         1                       10                         20                          30                          40                          50                          60 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210086       GCCTTCTGACGCAATCGTTGAACCAGAAGCGCCAGTAGTACCTGAAAAAGCACCTGTGGC 
R1                  TCTTCTGACGCAATCGTTGAACCAGAAGCGCCAGTAGTACCTGAAAAAGCACCTGTGGC 
C10                 TCTTCTGACGCAATCGTTGAACCAGAAGCGCCAGTAGTACCTGAAAAAGCACCTGTGGC 
E6                  -CTTCTGACGCAATCGTTGAACCAGAAGCGCCAGTAGTACCTGAAAAAGCACCTGTGGC 
CONSENSUS           cCTTCTGACGCAATCGTTGAACCAGAAGCGCCAGTAGTACCTGAAAAAGCACCTGTGGC 
                     ********************************************************** 
 
                                                         61                      70                         80                          90                         100                        110                       120 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210086       TTCTGCTGTGAATCCTTGGATTCCACGCGTTATTTTATTTTTGGCACTATTACTACCGAT 
R1                 TTCTGCTGTGAATCCTTGGATTCCACGCGTTATTTTATTTTTGGCACTATTACTACCGAT 
C10                TTCTGCTGTGAATCCTTGGATTCCACGCGTTATTTTATTTTTGGCACTATTACTACCGAT 
E6                 TTCTGCTGTGAATCCTTGGATTCCACGCGTTATTTTATTTTTGGCACTATTACTACCGAT 
CONSENSUS          TTCTGCTGTGAATCCTTGGATTCCACGCGTTATTTTATTTTTGGCACTATTACTACCGAT 
                   ************************************************************ 
 
                                                        121                     130                      140                        150                       160                        170                       180 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210086       TTGCGTACTGCTGTTTACAAACCCAGCGGAATCTCAGTTCCGTCAGATTGGTGAGTATCA 
R1                 TTGCGTACTGCTGTTTACAAACCCAGCGGAATCTCAGTTCCGTCAGATTGGTGAGTATCA 
C10                TTGCGTACTGCTGTTTACAAACCCAGCGGAATCTCAGTTCCGTCAGATTGGTGAGTATCA 
E6                 TTGCGTACTGCTGTTTACAAACCCAGCGGAATCTCAGTTCCGTCAGATTGGTGAGTATCA 
CONSENSUS          TTGCGTACTGCTGTTTACAAACCCAGCGGAATCTCAGTTCCGTCAGATTGGTGAGTATCA 
                   ************************************************************ 
                                                         
                                                        181                    190                      200                        210                       220                        230                       240 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210086       GAATGTACCAGTGATGACACCTGTAAATCACCCGCAAATAAACAACTGGCTGCCTTCTAT 
R1                 GAATGTACCAGTGATGACACCTGTAAATCACCCGCAAATAAACAACTGGCTGCCTTCTAT 
C10                GAATGTACCAGTGATGACACCTGTAAATCACCCGCAAATAAACAACTGGCTGCCTTCTAT 
E6                 GAATGTACCAGTGATGACACCTGTAAATCACCCGCAAATAAACAACTGGCTGCCTTCTAT 
CONSENSUS          GAATGTACCAGTGATGACACCTGTAAATCACCCGCAAATAAACAACTGGCTGCCTTCTAT 
                   ************************************************************ 
 
                                                        241                   250                      260                        270                       280                        290                       300 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210086       TGAGCAGTGCATTGAACGCTACGTTAAGCACCATGCAGAAGACTCGTTACCAGTGGAAGT 
R1                 TGAGCAGTGCATTGAACGCTACGTTAAGCACCATGCAGAAGACTCGTTACCAGTGGAAGT 
C10                TGAGCAGTGCATTGAACGCTACGTTAAGCACCATGCAGAAGACTCGTTACCAGTGGAAGT 
E6                 TGAGCAGTGCATTGAACGCTACGTTAAGCACCATGCAGAAGACTCGTTACCAGTGGAAGT 
CONSENSUS          TGAGCAGTGCATTGAACGCTACGTTAAGCACCATGCAGAAGACTCGTTACCAGTGGAAGT 
                   ************************************************************  
 
                                                        301                   310                      320                        330                       340                        350                       360 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210086       GATTGCCACTGGCGGACAAAATAACCAGTTGATTTTGAACTACATTCATGACAGCAACCA 
R1                 GATTGCCACTGGCGGACAAAATAACCAGTTGATTTTGAACTACATTCATGACAGCAACCA 
C10                GATTGCCACTGGCGGACAAAATAACCAGTTGATTTTGAACTACATTCATGACAGCAACCA 
E6                 GATTGCCACTGGCGGACAAAATAACCAGTTGATTTTGAACTACATTCATGACAGCAACCA 
CONSENSUS          GATTGCCACTGGCGGACAAAATAACCAGTTGATTTTGAACTACATTCATGACAGCAACCA 
                   ************************************************************ 
 
                                                        361                 368                       
                                                         +-------+ 
RIMD 2210086       CTCGTATGA 
R1                 CTCGTATG 
C10                CTCGTATG-GAA 
E6                 CTCGTA--- 
CONSENSUS          CTCGTAtga 
                   ****** 
 
Figure 3.3 Alignment of the toxR sequence in isolates of V. 
parahaemolyticus. RIMD 2210086 is a sequenced V. parahaemolyticus strain 
ToxR gene under accession number AY527397.1.  
Sequences C10 and E6 from clinical and environmental isolates respectively and R1 is 
NCTC reference strain. Consensus regions are shown in red and denoted by asterisk; 
black and blue show deletions or substitutions.   
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3.4 Discussion 
All V. parahaemolyticus isolates formed green colonies on TCBS. However, V. 
mimicus and V. vulnificus also formed green colonies, that leads to problems to 
distinguish them from V. parahaemolyticus, consequently TCBS may not 
differentiate V. parahaemolyticus from other enteropathogenic vibrios (Duan and 
Su, 2005b). Moreover, a number of researchers reported that using this medium 
lead to several limitations and difficulties for the isolation of this bacterium for 
example, Miwa et al., (2003) have used MPN-TCBS method for isolation and 
enumeration of V. parahaemolyticus from seafood samples that were spiked and 
naturally contaminated with this bacterium, authors have found difficulties because 
many colonies other than V. parahaemolyticus such as those of V. alginolyticus 
have overgrown on TCBS medium with this method, Miwa et al., (2003) have also 
used a MPN-PCR method for detection and enumeration of V. parahaemolyticus 
in seafood. The authors found that MPN-PCR more reliable than the MPN-TCBS 
method.  
A new chromogenic medium was developed by Hara-Kudo et al., (2001) for 
identification V. parahaemolyticus and specifically differentiate this bacterium from 
other bacteria (Blanco-Abad et al., 2009). Furthermore, Eddabra et al. (2011) have 
reported that the specificity of chromID Vibrio medium for V. parahaemolyticus 
was more than TCBS medium. 
In order to enhance the identification of V. parahaemolyticus (compare with TCBS 
medium) HiCromTM Vibrio agar was used to distinguish V. parahaemolyticus from 
other bacteria based on the reaction between the chromogenic substrate in the 
medium and β-galactosidase in bacteria rather than sucrose fermentation in TCBS 
agar (Hara-Kudo et al., 2001). The results of current study indicated that HiCromTM 
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Vibrio agar could be used for identification of V. parahaemolyticus because it could 
distinguish V. parahaemolyticus from V. mimicus and V. vulnificus depending on 
the formation of blue green colonies on this medium, while V. mimicus gave 
creamy colonies and V. vulnificus gave pale green colonies on HiCromTM Vibrio 
agar. While using TCBS did not differentiate V. parahaemolyticus from V. mimicus 
and V. vulnificus because all these three species do not ferment sucrose and 
therefore gave green colonies. Recently, Eddabra et al., (2011) have reported that 
isolation of V. parahaemolyticus from stool samples was 100% accurate by 
chromID Vibrio medium, while only 93% by TCBS medium.  
A limited number of methods were used to study the biochemical characteristics of 
V. parahaemolyticus to assess any differences between clinical and environmental 
isolates. Initial confirmatory biochemical test results were reliable with the typical 
features of V. parahaemolyticus including (Gram negative, motile, oxidase and 
catalase positive, sucrose and lactose negative). These six biochemical tests were 
performed with associated with selective media and species specific PCR targeted 
toxR gene. Sucrose fermentation was used to differentiate V. parahaemolyticus 
from V. alginolyticus, V. cholerae and V. harveyi. Lactose fermentation was used 
to differentiate V. parahaemolyticus from V. vulnificus. Gram stain, catalase, 
oxidase and motility were traditionally used to check the isolates. 
However, difficulties are found with the identification of V. parahaemolyticus 
strains isolated from foodstuffs using biochemical tests because the samples may 
contain related Vibrio species or yet uncharacterised bacteria that may give similar 
results (Thompson et al., 2006).   
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The growth characteristics that obtained in the present study did not distinguish 
between clinical and environmental isolates. Kelly and Stroh, (1989) have 
demonstrated that conventional tests of the clinical and environmental isolates of 
V. parahaemolyticus showed similar reaction. Furthermore, during an outbreak of 
V. parahaemolyticus food poisoning in Madrid and Barcelona, there were similar 
biochemical reactions amongst clinical and environmental isolates from marine 
environments near the outbreak place (Lozano-León et al., 2003). Furthermore, 
Robert-Pillot et al., (2002) have reported that using biochemical tests to identify 
clinical V. parahaemolyticus isolates were direct and accurate, while, with 
environmental isolates is difficult to differentiate them correctly from other Vibrio 
species, particularly V. alginolyticus because the phenotypic inconsistency of 
environmental isolates. Robert-Pillot et al., (2002) have used Api 20E to 
differentiate between V. parahaemolyticus and V. alginolyticus by sucrose 
fermentation, however, most V. parahaemolyticus and few strains of V. 
alginolyticus cannot ferment sucrose, therefore, sucrose fermentation is not 
enough and may result in misidentification of these strains (Alsina and Blanch, 
1994). The biochemical and nutritional tests have drawbacks that they are time 
and labour consuming (i.e., isolation, purification and incubation of reactions 
require 2 to 6 days), not reliable, expensive, may lead to false negative or false 
positive results, and that the analysis of results needs particular training (Tarr et 
al., 2007). Therefore, nowadays workers use molecular techniques to overcome 
the limitation of phenotypic techniques and any ambiguous identification.  
Identification V. parahaemolyticus isolates by using a PCR method to detect the 
specific toxR gene (368 bp PCR product) was more reliable and quicker than 
biochemical tests, and successfully amplified from all V. parahaemolyticus 
isolates, these results supported that this gene is used to identify V. 
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parahaemolyticus isolates (Kim et al., 1999, Sujeewa et al., 2009, Zulkifli et al., 
2009). Sequencing of selected PCR products and sequence analysis for homology 
was performed to verify the identity of PCR products and confirm the results.  
 A PCR targeting toxR gene is a simple, quick and specific technique; it can 
identify the isolates in one day and it was used in this study because it is highly 
specific and reliable (Dileep et al., 2003). Therefore, PCR targeting toxR gene was 
successfully used in current study to confirm all isolates of V. parahaemolyticus. 
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CHAPTER 4 
SURVEYING VIBRIO PARAHAEMOLYTICUS 
ISOLATES FOR PUTATIVE VIRULENCE FACTORS 
Results from this Chapter have been presented at SfAM 2010 Summer 
Conference, Applied microbiology, Brighton, 2010, UK, and Vibrio 2010,  
Biloxi, Mississippi, USA, 2010 and Marine Institute Conference 2010, 
Plymouth University, 2010. 
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Chapter 4: Surveying Vibrio parahaemolyticus Isolates for Putative Virulence 
Factors  
4.1 Introduction 
Many human pathogenic species of the genus Vibrio produce various virulence 
factors; for example, haemolysin is an exotoxin that lyses erythrocyte membranes 
with the liberation of haemoglobin. There are two types of haemolysis. The 
complete degradation of haemoglobin is called β-haemolysis and the incomplete 
degradation of haemoglobin is known as α-haemolysis (Zhang and Austin, 2005). 
Wagatsuma has classified V. parahaemolyticus isolates into two types: haemolytic 
and non-haemolytic on special high salt medium named Wagatsuma agar 
(Miyamoto et al., 1969). Almost all clinical V. parahaemolyticus isolates exhibit the 
Kanagawa phenomenon (KP) beta-type haemolysis on Wagatsuma agar (Izutsu et 
al., 2008). 
Virulent strains of V. parahaemolyticus carry haemolysin genes (tdh and/or trh). 
These genes are considered as markers for pathogenicity (Sujeewa et al., 2009). 
Some other Vibrio species also possess the tdh gene including V. mimicus and V. 
hollisae (Nishibuchi and Kaper, 1995). The presence of KP+ strains carrying the 
tdh gene in V. parahaemolyticus isolated from the environment was reported by 
Cabrera-Garcia et al., (2004). Thus KP+ has been used as a clinical indicator for 
the virulence of V. parahaemolyticus. It has been recognised as a marker for 
discriminating pathogenic from non-pathogenic strains (Miyamoto et al., 1969, 
Honda and Iida, 1993). However, Izutsu et al., (2008) have reported that strains of 
human pathogenic V. parahaemolyticus include both KP+ and KP- isolates. While 
haemolysins and proteases have been considered principal virulence factors of 
pathogenic V. parahaemolyticus (Miyamoto et al., 1969, Park and Chang, 2003), 
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other factors may be of importance. Many urease positive bacteria are pathogenic 
to humans, and it is considered as a marker of virulence in those bacteria (Jones 
et al., 1990, Johnson et al., 1993, Mobley et al., 1995). For example, urease is 
essential for colonisation of the stomach and plays a role in Helicobacter pylori 
pathogenicity (Hawtin et al., 1990, Evans et al., 1991). Suthienkul et al., (1995) 
have reported that the urease positive phenotype of V. parahaemolyticus isolated 
from patients strongly correlated with the presence of the trh gene. But KP- V. 
parahaemolyticus isolates that are positive for urease have been described in 
several reports (Magalhães et al., 1992, Honda et al., 1992a, Cai and Ni, 1996, 
Okuda et al., 1997a).  
Microbial phospholipases are also known to disrupt host cell membranes and may 
play a main role in the infection process (Titball, 1993). Interestingly, a connection 
between haemolysis and phospholipase has been demonstrated in a number of 
studies of V. parahaemolyticus (Shinoda et al., 1991, Lee et al., 2002b, Zhong et 
al., 2006).  
High throughput sequencing based methods have been used to differentiate 
between pathogenic and non-pathogenic strains, for example, it has been apply to 
investigate a putative methicillin-resistant Staphylococcus aureus (MRSA) 
outbreak and differentiate between outbreak and non-outbreak isolates (Köser et 
al., 2012). It has also been used for Mycobacterium tuberculosis outbreak 
investigation (Gardy et al., 2011) and Acinetobacter baumannii (Lewis et al., 2010). 
Furthermore, high throughput sequencing has recently been applied to vibrios 
such as V. vulnificus for comparative analysis of clinical and environmental 
genotypes (Morrison et al., 2012). 
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There are a number of studies of the incidence of plasmids within Vibrio species 
(Pedersen and Larsen, 1995, Depaola et al., 2003b, Di Lorenzo et al., 2003, Dunn 
et al., 2005), particularly pathogenic vibrios. Both plasmids and bacteriophages 
can encode virulence factors which convey pathogenicity to bacterial hosts (Betley 
et al., 1986). The cryptic plasmid of V. cholerae is frequently associated with 
filamentous phages; it has been detected in all toxigenic strains of this bacterium 
and contributes in the biology of CTXø phages (Rubin et al., 1998). There are 
some phages that infect V. parahaemolyticus such as VpV262 (Hardies et al., 
2003). Crothers-Stomps et al.,(2010) have isolated lytic phage from V. harveyi, 
and Vidgen et al., (2006) reported that phage VHML of V. harveyi causes changes 
in the phenotypic profile of this bacterium. 
Many clinical Vibrio species of marine fish have plasmids (Tsai and Yeh, 1993). 
Pedersen and Larsen, (1995) reported that the virulence plasmid pJM1 has been 
found in pathogenic strains of V. anguillarum, but not in non-pathogenic forms of 
the bacterium. Furthermore, Di Lorenzo et al., (2003) confirmed that plasmid pJM1 
of V. anguillarum plays a role in pathogenicity of this organism. Terai et al., (1991) 
have demonstrated that tdh genes can sometimes be found on plasmid DNA, 
despite most copies of these genes being located on chromosomal DNA. Guerry 
and Colwell (1977) have suggested that plasmids in V. parahaemolyticus may be 
involved in the production of Kanagawa haemolysis. 
Sodium dodecyl sulphate - poly acrylamide gel electrophoresis (SDS-PAGE) is 
one of the most performed molecular methods to characterise macromolecules of 
bacteria (Durrani et al., 2008). SDS-PAGE has been used to characterise the 
soluble whole cell protein profiles of bacteria such as Corynebacterium (Jackman 
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and Pelczynska, 1986) Lactococcus species (Elliott et al., 1991) and Leuconostoc 
species (Elliott and Facklam, 1993).  
Some pathogenic bacteria produce extracellular products (ECPs) that contain 
important virulence factors. SDS-PAGE has also been used to examine the ECPs 
profile and determine the molecular weight of proteins. For example, Takeda et al., 
(1978) have used SDS-PAGE to determine the molecular weight of TDH in V. 
parahaemolyticus and found it to be composed of two subunits of 21 kDa. 
Furthermore, Lee et al., (2002a) have purified serine protease (protease A) from 
ECPs of V. parahaemolyticus and its molecular weight was found to be 43 kDa, 
and it is suggested to play a role in pathogenicity of V. parahaemolyticus. 
Furthermore, Labreuche et al., (2006) have demonstrated that ECPs harvested 
from a 2 day old culture of pathogenic V. aestuarianus were found to be lethal to 
oysters, and suggested that ECPs contributed to the pathogenicity of this 
pathogen. 
This chapter uses a number of techniques to look for differences between virulent 
clinical isolates and mainly avirulent environmental forms. Notably it:-  
i) Compares clinical and environmental isolates of Vibrio parahaemolyticus 
for activities of a variety of enzymes that may contribute to pathogenicity.  
ii) Investigates the presence of plasmid and phage which might carry genes 
for virulence factors. 
iii) Analyses whole cell protein and extracellular products by SDS-PAGE to 
look for differences between clinical and environmental isolates of V. 
parahaemolyticus. 
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4.2 Material and methods 
4.2.1 Kanagawa phenomenon  
KP haemolysis was examined as previously described (Wagatsuma, 1968, 
Takeda, 1983). Briefly, aliquots (10 µl) of overnight cultures were streaked on to 
Wagatsuma agar medium containing 5% (v/v) fresh rabbit defibrinated blood (or 
saline suspension of red blood cells) (Appendix I) and incubated at 37 °C for 48 h. 
The isolates exhibiting clear beta-haemolytic zones were designed as positive for 
the KP. The haemolysis around the bacterial growth was registered as: +++, 
strong (large >3 mm, clear zone of β-type haemolysis); ++, moderate (medium 2-3 
mm, clear zone of β-type haemolysis); +, weak reaction (clear but small zone 1 
mm of β-type haemolysis); and - negative (no haemolysis or non-β-type 
haemolysis) (Wong et al., 1992). 
4.2.2 Phospholipase assay 
The phospholipase activity of V. parahaemolyticus was measured by inoculating 
isolates onto a phospholipase assay medium containing peptone, NaCl, agar and 
egg yolk emulsion (Appendix I). A clear lytic halo around the colonies indicated 
phospholipase activity. This method was a modification of Sudheesh and Xu, 
(2001) who used 25 µl of ECP and placed it in wells cut in agarose that contained 
2.5% egg yolk.  
4.2.3 Urease assay 
Urease activity was observed on urea agar base plates containing peptone, NaCl, 
Na2HPO4, glucose, KH2PO4, phenol red, agar and urea solution (Appendix I). 
Production of urease was determined by a pink colour (alkaline) to the medium. 
Release of ammonia due to urease activity was detected by a change of pH 
indicator colour from yellow to pink (Atlas, 1997).  
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4.2.4 Protease assay  
Protease activity was measured on a skim milk agar medium containing skim milk, 
NaCl and agar (Appendix I) (Wong et al., 1992). The positive results were 
recorded when a clear halo was detected around the growth. 
4.2.5 Lipase assay 
The lipase assay medium containing peptone, NaCl, CaCl2, H2O, agar and tween 
80 (Appendix I) was used to determine the lipase activity by incubating at 37ºC for 
24-48 h (Wong et al., 1992). A positive result was indicated by a white precipitation 
around colonies. 
4.2.6 V. parahaemolyticus putative virulence genes tdh and trh  
Data of PCR targeting tdh and trh genes were provided by A. Miah, PhD thesis, 
University of Plymouth, and C. Baker-Austin, CEFAS Laboratories, Weymouth, 
Dorset, UK. 
 
Table 4.1 Sequences of previously described PCR primers for putative V. 
parahaemolyticus virulence gene tdh and trh. 
Primers Sequence gene (5’ to 3’) Reference  Target 
genes  
Tdh-D3 
Tdh-D5 
F: CCACTACCACTCTCATATGC 
R: GGTACTAAATGGCTGACATC 
Tada et al., 
(1992) 
tdh 
Trh-R2 
Trh-R6 
F: GGCTCAAAATGGTTAAGCG 
R: CATTTCCGCTCTCATATGC 
Tada et al., 
(1992) 
trh 
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4.2.7 Screening for plasmids 
All isolates of V. parahaemolyticus were screened for plasmid DNA according to 
two procedures:-  
1- Bimboim and Doly, (1979); a single colony from overnight bacterial plate 
culture was grown in 5 ml TSB with shaking overnight at 37 °C. The 
organisms in 1.5 ml of the culture were harvested by centrifugation at 2,400 
x g for 2 min and the cell pellet resuspended in 100 µl of B&D solution I 
(Appendix I). Next, 200 µl of B&D solution II (Appendix1) was added, mixed 
by gentle inversion and the tube left at room temperature for 5 min. Then 
150 µl of ice-cold B&D solution III (Appendix I) was added and the tubes 
shaken gently and left on ice for 5 min. To yield a fresh supernatant, the 
tubes were then centrifuged at 9,500 x g for 3 min. Next, 400 µl of the 
supernatant was transferred to a clean 1.5 ml Eppendorff tube. Plasmids 
were precipitated by the addition of 1 ml of ice-cold absolute ethanol and 
placed on ice for at least 5 min. Following centrifugation for 3 min at 9,500 x 
g to collect precipitated nucleic acids, the supernatant was discarded and 
the tube placed upside-down on a piece of tissue for a few minutes to drain 
the pellet of ethanol. The dried pellet was resuspended in 10 µl TE buffer 
(Appendix I). Extracted plasmid DNA was electrophoresed at 90 V in 0.7 % 
(w/v) agarose gel containing ethidium bromide (0.5 µg/ml). A 1 kilobase-
ladder nucleic acid molecular weight standard (Invitrogen, UK) was included 
on each gel to confirm successful running of the gel. The plasmids were 
visualised using a UV transilluminator (Photodyne), and were photographed 
by UV light (309 nm) with a Gel Documentation system (Uvi-Tech, UK). This 
method was particularly suitable for screening for smaller sized plasmids. 
The approximate plasmid sizes were estimated by comparing with 
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supercoiled DNA ladder. Plasmids (pUC18, pBR322 and pBR328) with 
known molecular sizes (2.7 kb, 4.2 kb and 4.8 kb) respectively were 
extracted and used as control positive for the plasmid extraction procedure. 
 
2- Pedraza and Díaz Ricci, (2002), the cell pellets were harvested in the same 
way as above and washed twice by gently suspending to safe avoid a 
premature cell destruction in cold 0.3 % Sodium Lauroyl Sarcosinate 
(sarkosyl) in TBE buffer and then centrifuged 2,400 x g for 7 min. A 20 µl of 
lysis solution (Appendix I) was used to suspend the pellet, and mixed with 
30 µl of loading buffer and the agarose gel (0.7%) was prepared with 1 % 
SDS and run as above but at 60 V. This method was used to search for 
larger sized plasmids. 
4.2.8 Preparation of extracellular products (ECPs)  
Tubes containing 10 ml of TSB were inoculated with bacteria from single colonies 
from 24 h cultures on TSA and incubated at 37 °C for 24 - 48 h with shaking. The 
cultures were centrifuged at 2,800 x g for 15 min, and the supernatants were 
transferred to a fresh tube and re-centrifuged as before. Minicon B15 Clinical 
Sample Concentrators (Millipore, USA) were used to concentrate the supernatants 
according to the manufacturer’s instructions. All stages were performed at 4°C to 
reduce sample degradation. 
4.2.9 Examination for the presence of bacteriophages 
A 400 µl aliquot of an overnight broth culture of each the appropriate V. 
parahaemolyticus isolates was added separately to 5 ml molten soft Tryptone Soy 
agar, and used to overlay TSA plates. The concentrated supernatant from all 
isolates were tested for the presence of bacteriophage by spotting 2-4 µl on to 
Chapter 4 
78 
 
surface of an agar plate overlaid separately with each of the V. parahaemolyticus 
isolates, and plates were incubated overnight at 37 °C. 
4.2.10 Preparation of whole cell proteins  
Each bacterial isolate was grown in TSB (10 ml) at 37°C for 24 - 48 h, and 
centrifuged at 2,800 x g for 10 min at 4 °C. Pellets were washed once in PBS and 
resuspended in 500 µl of SDS-PAGE sample loading buffer (Appendix I), boiled for 
5 min (to denature and solubilise the proteins) and centrifuged at 2,400 x g to 
remove insoluble cell debris. Approximately 16 μl of the sample was taken and 
subjected to SDS-polyacrylamide gel electrophoresis (SDS-PAGE) (Laemmli, 
1970). 
4.2.11 SDS-PAGE  
The cell pellets and ECPs were analysed by SDS-PAGE using the discontinuous 
buffer system of Laemmli, (1970). In this project, the mini-protein II system (Bio-
Rad, Herts, UK) was used as electrophoresis apparatus.  
4.2.11.1 Gel preparation 
Spacers were placed on to one glass plate and the rubber gasket was fixed. The 
second glass plate was placed on top and all was clipped together. All solutions 
and composition of the gel used here are given in Appendix I. The bis-acrylamide 
(12.5%) was used as a uniform separating gel. All the components of the gel were 
mixed together except N,N,N′,N′-tetramethylethylenediamine (TEMED) and 10% 
ammonium peroxodisulfate (APS) (must be fresh) which were added at the end. 
The gel mix was poured into the gel former and water saturated isobutanol was 
added gently on the top of the separating gel to exclude air and promote gel 
polymerisation and to give a very sharp gel liquid interface. Polymerisation of the 
separating gel took about 45 min. To remove traces of isobutanol, the surface of 
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the gel was rinsed with distilled water before pouring the stacking gel (5%). A 
plastic comb was inserted into the gel prior to polymerisation to form sample wells. 
4.2.11.2 Electrophoresis conditions 
The comb and elastic gasket spacer were removed and the wells were rinsed with 
distilled water. The gel sandwich was placed into the electrophoresis apparatus 
and the tank filled with electrode buffer taking care to eliminate bubbles from the 
bottom of the gel. Samples were loaded into the wells and electrophoresis was 
performed at room temperature using constant voltage 125 V. Electrophoresis was 
stopped when the tracking dye was about one cm from the bottom of the gel. A 
ColorBurst™ Electrophoresis Marker (M.W. 8,000-220,000) (Sigma, UK) was used 
to estimate the molecular weight of protein bands. The gel apparatus and the 
glass sandwich were disassembled. The glass plates were gently prized apart by 
using the spacer as a lever. The gel was transferred on one plate to a container 
filled with staining solution.  
4.2.11.3 Staining of SDS-PAGE gels and destaining  
The gels were stained with Coomassie brilliant blue R-250 (Fisher Scientific Ltd., 
UK) (Appendix I). Gels were stained overnight at ambient temperature with gentle 
agitation. Gels were destained using destaining solution (Appendix I) with gentle 
agitation being exchanged every half an hour until protein bands were resolved. 
4.2.12 Assessment of cell viability of V. parahaemolyticus 
This a quick test that was carried out to assess if ECPs caused the cell damage or 
if apparent ECPs were as a result of autolysis. To assess V. parahaemolyticus cell 
viability, the cultures were grown on Tryptone soya broth (TSB; Oxoid, 
Basingstoke, UK) supplemented with 3% (w/v) sodium chloride at 37 °C for 24 h 
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and 48 h. An equal volume (200µl) of 0.4% trypan blue was added to 200 µl of cell 
suspension (24 h and 48 h), the mixture were incubated at room temperature for 3 
min and loaded into a haemocytometer. The non-viable (deep blue cells) and 
viable (clear cells) were counted. Viability of cells was calculated as follow: % 
viable= (number viable cells/number total cells) x 100. 
4.2.13 Statistical analysis 
Data were compared statistically using the Chi-Square (Χ2) test. The relationships 
between Kanagawa phenomenon and tdh gene; urease and trh gene were 
assessed by correlation; the correlation coefficient “r” is a qualitative measure of 
association and relationship between variables. The relationship between the 
plasmid and putative virulence factors was also investigated. Statistical analyses 
were performed using Minitab 16.0 software (Plymouth University, UK). (Appendix 
II).   
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4.3 Results 
4.3.1 Assay of Kanagawa haemolysis activity 
Kanagawa haemolysis activity on Wagatsuma agar was assessed in all 55 isolates 
of V. parahaemolyticus. KP+ tests were obtained in 82.60% and 15.62% which 
were from clinical and environment V. parahaemolyticus isolates, respectively. KP+ 
rates were significantly different in isolates from these two sources (p < 0.001) 
(Table 4.3).  
However, V. parahaemolyticus showed varying degrees of haemolysis as 
indicated in Table 4.2. Of all isolates tested, only 5 isolates of clinical V. 
parahaemolyticus, showed strong haemolysis (indicated +++). Moderate (++) and 
weak (+) haemolysis were exhibited in 10 isolates (7 clinical, 3 environmental) and 
9 isolates (7 clinical, 2 environmental) respectively. However, there was no 
haemolytic activity in 31 isolates, of which 4 were clinical, and 27 environmental.  
A selection of Vibrio species isolates were tested for Kanagawa haemolysis, the 
results showed that V. alginolyticus (VA3) exhibited moderate haemolysis, V. 
vulnificus (VV2) exhibited weak haemolysis, while there was no haemolysis in V. 
cholerae (VC), V. mimicus (VM), V. alginolyticus (VA6), V. harveyi (VH4) and V. 
anguillarum (VN1) (Table 4.4).     
4.3.2 Assay of enzymatic activities 
All the clinical V. parahaemolyticus isolates and 15 environmental isolates were 
able to hydrolyse urea. Some isolates exhibited positive results after 24 h. While 
other isolates showed urease positive after two days (Table 4.2).  
However, V. parahaemolyticus isolates that hydrolyse urea rates in clinical and 
environment V. parahaemolyticus isolates were 100 % and 46.87%, respectively. 
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Urease positive rate in clinical isolates was significantly different from 
environmental isolates (p < 0.001) (Table 4.3). 
Four Vibrio species isolates tested including V. cholerae (VC), V. mimicus (VM), V. 
alginolyticus (VA3) and V. vulnificus (VV2) exhibited positive urease after 48 h, 
while V. alginolyticus (VA6), V. harveyi (VH4) and V. anguillarum (VN1) did not 
show any urease activity (Table 4.4).     
All isolates were also tested for phospholipase activity, it has been found that the 
phospholipase positive in clinical and environmental isolates were 82.60% and 
15.62%, respectively. Phospholipase positive rate in clinical isolates was 
significantly different from environmental isolates (p < 0.001). V. cholerae (VC) and 
V. vulnificus (VV2) exhibited phospholipase activity, while other Vibrio species 
tested did not. 
Protease activity was tested for all V. parahaemolyticus isolates, the results 
showed that the protease positive in clinical and environmental isolates were 
82.60% and 43.75%, respectively. Protease positive rates in isolates from these 
two sources were significantly different from each other (p < 0.01). Amongst of a 
selection of Vibrio species, only V. vulnificus (VV2) and V. alginolyticus (VA3) 
showed protease activity. 
Lipase activities were obtained in 26 % and 15.62% which were from clinical and 
environment V. parahaemolyticus isolates, respectively. Lipase positive rates were 
not significantly different in isolates from these two sources (p-value = 0.339). All 
selection of Vibrio species isolates tested did not show lipase activity. 
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Correlation of specific phenotypes and genotypes 
a) Correlation of KP test and tdh gene:  
The Pearson correlation-coefficient was high (r =0.741, p = 0.0001). 
b) Correlation of urease test and trh gene:  
The Pearson correlation-coefficient was low (r =0.280, p = 0.03).   
4.3.3 Investigation into the presence of bacteriophages in V. 
parahaemolyticus 
All isolates of V. parahaemolyticus were tested for bacteriophages. No 
bacteriophages were found in any of the isolates, using the simple method 
employed. 
4.3.4 Investigation into the presence of plasmids in V. parahaemolyticus 
Among the clinical isolates, 8 out of 23 (C17, C19, C16, C21, R1, C1, C7 and C14) 
(34.78%) had plasmids. Likewise, 10 out of 32 environmental isolates (E1, E30, 
E31, E7, E10, E2, E26, E9, E5, and E19) (31.25%) were found to have plasmids. 
Some possessed multiple plasmid bands (Figure 4.1). The approximate sizes and 
number of plasmid were indicated in Table 4.5. 
Based on the geographical origin, two out of ten (20%) isolates from Norway had 
different size of plasmids, one out of four (25%) isolates from Japan had two 
plasmids, seven out of 25 (28%) isolates from UK had different size of plasmids, 
except two environmental isolates (E9 and E19) had similar size at approximately 
16 kb. Amongst Spanish isolates, 6 (3 clinical and 3 environmental) out of 11 
(54.54%) isolates had different size of plasmids except two clinical isolates (C17 
and C19) had similar size at approximately 2.6 kb, however, clinical isolate C16 
Chapter 4 
84 
 
had multiple plasmids at approximately 3.6; 6.6; 26.5; 70 kb, and E2 had two 
plasmids at approximately 14 and 75 kb.   
Correlations of plasmid and putative virulence factors 
The relationship between the plasmid and putative virulence factors such as KP, 
urease, tdh and trh genes was investigated.  
a) Correlation of plasmid and KP test:  
There was no correlation (r = 0.011, p = 0.934). 
b) Correlation of plasmid and tdh gene: 
          There was no correlation (r = - 0.120, p = 0.383).  
c) Correlation of plasmid and urease activity:  
         There was no correlation (r = - 0.120, p = 0.381). 
d) Correlations of plasmid and trh gene: 
          There was no correlation (r = - 0.206, p = 0.132). 
  
4.3.5 Whole cell protein profiles 
Initially, whole cell protein samples of two isolates of V. parahaemolyticus 
reference strain (R1) and clinical isolate (C5) were applied into SDS-PAGE with 
different amounts (2µl, 4µl, 8µl, 10µl, 12µl, 16µl, 18µl and 20µl) in order to 
determine how much was needed to use to get comparable intensity of bands 
(Figure 4.2). Whole cell protein samples of additional four isolates (C1, C7, E16 
and C4) were also applied into SDS-PAGE with different amounts (Appendix II). 
The results showed that 16 µl was suitable amount to show clearly all the bands. 
Then, 16 µl of whole cell protein samples of all isolates (23 clinical and 32 
environmental) were applied into SDS-PAGE to reveal protein profiles of isolates 
tested. The results of SDS-PAGE of whole cell proteins showed many discrete 
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bands ranging in molecular weight of 8 kDa to 220 kDa. All isolates had many 
common bands (Figure 4.3). Moreover, whole cell protein patterns of clinical V. 
parahaemolyticus isolates were generally similar to environmental V. 
parahaemolyticus. There were no obvious differences between clinical and 
environmental isolates; but there were minor differences in the number of bands 
produced in some isolates, for example there was extra band at 90 kDa found in 
only four environmental isolates (E12, E13, E14 and E15). A band at 60 kDa was 
detected in only one clinical (C1) and one environmental (E16) isolates. 
4.3.6 ECPs profile 
The ECP profile was also examined by SDS-PAGE. The ECPs of reference strain 
of V. parahaemolyticus (R1) was harvested at different times (2h, 4h, 8h, 16h, 24h, 
32, 40h and 48h). As shown in Figure 4.4, there was a very faint band detected at 
41 kDa after 16h, while this band was clearly detected at 24 h. Another band at 40 
kDa was detected in 32 h. However, about 7-11 bands were found in ECPs 
harvested from 40 and 48 h cultures, however, the bands that shown in 48 h were 
clearer than in 40 h.  
4.3.6.1 ECPs harvested from 24 hours cultures 
Comparative protein bands of the ECPs of 23 clinical and 32 environmental 
isolates of V. parahaemolyticus that were harvested in 24 hours incubation of the 
culture at 37°C were observed by SDS-PAGE. The ECPs exhibited diversity 
among the isolates; however, most shared a band at 41 kDa that was produced by 
11 clinical (C7, C5, C14, C12, R1, C2, C8, C9, C11, C17 and C18) isolates and 
one environmental isolate (E3). Two clinical isolates (C3 and C6) produced this 
band but it was very faint. However, a few strains did not produce any band 
(Figure 4.5). 
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4.3.6.2 ECPs harvested from two day cultures  
The ECPs of 23 clinical and 32 environmental isolates of V. parahaemolyticus 
exhibited diversity between the isolates. The ECPs of most isolates generated less 
than 12 bands, ranging from 10-190 kDa. The ECP of five clinical isolates (C8, C1, 
C13, C5, and C7) and two environmental isolates (E4 and E15) generated a 
prominent band at 60 kDa. 
A protein band at 41 kDa was found in 14 clinical isolates (C2, C8, C9, C11, R1, 
C1, C12, C13, C14, C15, C3, C4, C5, C7), but not in all clinical isolates; and only 
in two environmental isolates (E3 and R2). Different protein profiles were observed 
among the remainder of clinical and environmental isolates of V. parahaemolyticus 
tested Figure 4.6. 
4.3.7 The viability of bacterial cells 
The results showed that the percentage of viability of V. parahaemolyticus cell in 
triplicate was 77% and 66.5% in 24 h and 48 h consequently.  
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Table 4.2 Kanagawa haemolysis of V. parahaemolyticus on Wagatsuma agar 
and urease activity of V. parahaemolyticus isolates 
Strain 
 
Type and source  
(where known) 
Kanagawa haemolysis Urease activity 
> 3 mm 2-3 mm 1 mm Negative 24 h 48 h Negative 
R1 Clinical, NCIMB Reference 
Strain, UK 
  +  +   
C1 Clinical, Norway    - +   
C2 Clinical, Norway   +   +  
C3 Clinical, Norway    - +   
C4 Clinical, Norway +++     +  
C5 Clinical, Norway   +   +  
C6 Clinical, Norway  ++   +   
C7 Clinical, Norway +++     +  
C8 Clinical, Norway +++    +   
C9 Clinical, Norway  ++    +  
C10 Clinical, Norway    -  +  
C11 Clinical, Japan   +   +  
C12 Clinical, Japan  ++    +  
C13 Clinical, Japan  ++   +   
C14 Clinical, Japan  ++   +   
C15 Clinical, UK +++    +   
C16 Clinical, Spain   +   +  
C17 Clinical, Spain    -  +  
C18 Clinical, Spain  ++    +  
C19 Clinical, Spain +++     +  
C20 Clinical, Spain  ++    +  
C21 Clinical, Italy   +   +  
C22 Clinical, UK   +  +   
R2 Environmental, NCTC 
Reference Strain, UK 
   -  +  
E1 Environmental, Spain    -   - 
E2 Environmental, Spain    -   - 
E3 Environmental, Spain     -   - 
E4 Environmental, Spain    -   - 
E5 Environmental, Spain    -   - 
E6 Environmental, Spain    -   - 
E7 Environmental, UK  ++     - 
E8 Environmental, UK    -   - 
E9 Environmental, UK   +    - 
E10 Environmental, UK    -   - 
E11 Environmental, UK  ++     - 
E12 Environmental, UK    -   - 
E13 Environmental, UK    - +   
E14 Environmental, UK    -  +  
E15 Environmental, UK    - +   
E16 Environmental, UK    -  +  
E17 Environmental, UK     -   - 
E18 Environmental, UK   +   +  
E19 Environmental, UK     -   - 
E20 Environmental, UK   ++   +   
E21 Environmental, UK     -   - 
E22 Environmental, UK     -   - 
E23 Environmental, UK     -  +  
E24 Environmental, UK     - +   
E25 Environmental, UK     -   - 
E26 Environmental, UK     -  +  
E27 Environmental, Portugal    - +   
E28 Environmental, Portugal    - +   
E29 Environmental, UK    - +   
E30 Environmental, UK    -  +  
E31 Environmental, UK    -  +  
Total   5  
(9.09%) 
10 
(18.18%) 
9 
(16.36%) 
31 
(56.36%) 
16 
29.09% 
22 
40% 
17 
30.90% 
+++, Strong; ++, moderate; +, weak; -, negative. 
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Table 4.3 Kanagawa Phenomenon and enzyme activities of V .parahaemolyticus 
 
Isolated source  Total KP KP+ 
percentage 
 
Ure Ure+ 
percentage 
Lip Lip+ 
percentage 
Pro Pro+ 
percentage 
PPL PPL+ 
percentage 
     
KP 
+ 
KP 
- 
 Ure 
+ 
Ure 
- 
 
 Lip 
+ 
Lip 
- 
 Pro 
+ 
Pro 
- 
 PPL 
+ 
PPL 
- 
 
Clinical  
 
23 19 4 82.60 23 0 100 6 17 26 19 4 82.60 19 4 82.60 
Environmental 
 
32 5 27 15.62 15 17 46.87 5 27 15.62 14 18 43.75 5 27 15.62 
Total  55 24 31  38 17  11 44  33 22  24 31  
For Kanagawa Phenomenon tests, X2 = 24.412, p < 0.001; for Urease tests, X2 = 17.685, p < 0.001; for Lipase tests, X2 = 0.915, p > 0.01; for protease 
tests, X2 = 8.419, p < 0.01; for phospholipase tests, X2 = 24.412, p < 0.001 
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Table 4.4 Kanagawa Phenomenon and enzyme activities of a selection of 
Vibrio species isolates 
 
Strain 
ID 
 
Bacterial 
Strain 
Virulence Characteristics 
KP (β-haemolysis) Ure Lip Pro PPL 
      
>3mm 2-3mm 1 mm Negative  24h 48h Negative    
 
VC 
 
V. cholerae 
 
    
- 
  
+ 
  
- 
 
- 
 
+ 
 
VM 
 
V. mimicus 
 
    
- 
  
+ 
  
- 
 
- 
 
- 
 
VV2 
 
V. vulnificus 
 
   
+ 
   
+ 
  
- 
 
+ 
 
+ 
 
VA3 
 
V. alginolyticus 
 
  
++ 
    
+ 
  
- 
 
+ 
 
- 
 
VA6 
 
V. alginolyticus 
 
    
- 
   
- 
 
- 
 
- 
 
- 
 
VH4 
 
V. harveyi 
 
    
- 
   
- 
 
- 
 
- 
 
- 
 
VN1 
 
V. anguillarum 
 
    
- 
   
- 
 
- 
 
- 
 
- 
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Table 4.5 Putative virulence factors and genes, and plasmid possession of 
Vibrio parahaemolyticus isolates 
Strain 
 
Type and source  
(where known) 
       Virulence Characteristics and virulence genes
1
 Plasmid DNA 
KP  
(β-haemolysis) 
Ure Lip     Pro PPL tdh trh Number 
of bands 
Approximate size of 
plasmid (kb) 
R1 Clinical, NCIMB  
Reference Strain, UK 
+ + - - + - - + (1) 43 
C1 Clinical, Norway - + - + + - - + (1) 38  
C2 Clinical, Norway + + - + + + - -  
C3 Clinical, Norway - + - - + - + -  
C4 Clinical, Norway + + + + + + + -  
C5 Clinical, Norway + + - + + + - -  
C6 Clinical, Norway + + + + + + + -  
C7 Clinical, Norway + + - + + + - + (2) 39; 75  
C8 Clinical, Norway + + - + + + - -  
C9 Clinical, Norway + + - + + + - -  
C10 Clinical, Norway - + + + - - + -  
C11 Clinical, Japan + + - - + + - -  
C12 Clinical, Japan + + + + + + - -  
C13 Clinical, Japan + + - + + + - -  
C14 Clinical, Japan + + - - + - - + (2) 32; 75  
C15 Clinical, UK + + + + + + - -  
C16 Clinical, Spain + + - + + + - + (4) 3.6; 6.6; 26.5; 70  
C17 Clinical, Spain - + - + - + - + (1) 2.6  
C18 Clinical, Spain + + - + + + - -  
C19 Clinical, Spain + + + + + + - + (1) 2.6  
C20 Clinical, Spain + + - + + + - -  
C21 Clinical, Italy + + - + - - + + (1) 13.3  
C22 Clinical, UK + + - + - + + -  
R2 Environnemental, 
NCTC Reference 
Strain, UK 
- + - + + - - -  
E1 Environmental, Spain - - - - - - - + (1) 26 
E2 Environmental, Spain - - - + - - - + (2) 14; 75 
E3 Environmental, Spain  - - - + + - - -  
E4 Environmental, Spain - - - - - - - -  
E5 Environmental, Spain - - - - - - - + (1) 32 
E6 Environmental, Spain - - - - - - - -  
E7 Environmental, UK + - - + + + - + (1) 39 
E8 Environmental, UK - - - - - - - -  
E9 Environmental, UK + - - - + + + + (1) 16  
E10 Environmental, UK - - - - - - - + (3) 9; 43; 70  
E11 Environmental, UK + - - + - - - -  
E12 Environmental, UK - - - - - - - -  
E13 Environmental, UK - + - + - - + -  
E14 Environmental, UK - + - + - + + -  
E15 Environmental, UK - + - + - - + -  
E16 Environmental, UK - + - + - - + -  
E17 Environmental, UK  - - - - - - - -  
E18 Environmental, UK + + - + + + - -  
E19 Environmental, UK  - - - - - - - + (1) 16  
E20 Environmental, UK  + + - + - + - -  
E21 Environmental, UK  - - - - - + - -  
E22 Environmental, UK  - - - - - - - -  
E23 Environmental, UK  - + - + - - - -  
E24 Environmental, UK  - + + - - - - -  
E25 Environmental, UK  - - + - - - - -  
E26 Environmental, UK  - + - + - - - + (2) 2; 2.6  
E27 Environmental, 
Portugal 
- + - - - - + -  
E28 Environmental, 
Portugal 
- + + - - - + -  
E29 Environmental, UK - + + - - - - -  
E30 Environmental, UK - + + + - - - + (4) 2; 2.4; 4; 6  
E31 Environmental, UK - + - - - - - + (1) 14.6 
(1)
Virulence characteristics, KP: Kanagawa phenomenon, Ure: urease, Lip: lipase, Pro: protease 
and PPL: Phospholipase activities and data of PCR virulence genes (tdh and trh) provided by A. 
Miah (Plymouth University) and C. Baker-Austin, CEFAS Laboratories, Weymouth, Dorset, UK.  
Chapter 4 
91 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                       M1  47  48   49  50   51 52   53  54  55  M1                     56   57   58   59   60 
     
 
Figure 4.1 Agarose gel electrophoresis of plasmid from V. parahaemolyticus.  
Lanes correspond to the following M1, 1Kb linear DNA ladder; M2 and M3, supercoiled 
DNA ladders; 1, E21; 2,E30; 3, R2; 4, C12; 5, C17; 6, E31, 7, C19; 8,C22; 9, C16; 10, 
C18; 11, C21; 12, E29; 13, E28; 14, E3; 15, C11; 16, C6; 17, C8; 18, C5; 19, E27; 20, E25; 
21, E4; 22, E12; 23, C14; 24, C15; 25, E16; 26, E9; 27, E19; 28, E20; 29, E5; 30, E1; 31, 
E15; 32,E13; 33,E22; 34,E17; 35, E10; 36, E2; 37, E23; 38, E24; 39, E26; 40, R1; 41, C1; 
42, C7; 43, C9; 44, C13; 45, E7; 46, E14; 47,C20; 48, C2; 49, C3; 50, C4; 51, C10; 52, E6; 
53, E8; 54, E18; 55, E11, 56, control negative; lanes 57-60, control positive as follow, 57, 
pUC18; 58-59, pBR322; 60, pBR328.  
  
M1  1   2    3    4    5    6     7    M   8   9 10 11  12 13 14  M    M  15 16 17 18 19 20 21  22     M2                 M3 
1 kb 
1.6 kb 
2 kb 
3 kb 
7 kb 
12 kb 
M1 23 24  25  26  27 28  29     M 30 31 32 33 34  35 36 37 38 39    M  40  41 42 43 44  45 46    M2                  M3 
12 kb 
2 kb 
1 kb 
2 kb 
5 kb 
10 kb 
8.7 kb 
38 kb 
55 kb 
2 kb 
3 kb 
5 kb 
10 kb 
16 kb 
75 kb 
16 kb 
55 kb 
2.7 kb 
4.2 kb 
4.8 kb 
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Figure 4.2 SDS-PAGE of soluble whole cell proteins from clinical V. 
parahaemolyticus isolates with different concentrations. 
M, protein marker (M.W. =8 kDa-220 kDa). 
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Figure 4.3 SDS-PAGE of soluble whole cell proteins from V. parahaemolyticus isolates. 
M, protein marker (M.W. =8 kDa-220 kDa), 1, C2; 2, C8; 3, E11; 4, E4; 5, E5; 6, E2; 7, E1; 8, R2; 9, C3; 10, C4; 11, C5; 12, C7; 13, E8; 
14, E22; 15, E19; 16, E13; 17, E14; 18, E3; 19, E6; 20, E7; 21, E12; 22, E15; 23; E16; 24, E25; 25, C15; 26, E24; 27, E26; 28, R1; 29, 
C1; 30, C6; 31, E17; 32, E21; 33, E18; 34, E23; 35, E20; 36, C9; 37, E9; 38, E10; 39, C10; 40, C11; 41, C12; 42, C13; 43, C14; 44, C16; 
45, C17; 46, C18; 47, C19; 48, C20; 49, C21; 50, C22; 51, E27; 52, E28; 53, E29; 54, E31; 55, E30.  
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Figure 4.4 SDS-PAGE of ECPs of reference strain of V. parahaemolyticus 
(R1) in different times. M, protein marker (M.W. = 8 kDa to 220 kDa). 
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Figure 4.5 SDS-PAGE of ECPs from V. parahaemolyticus isolates (one day). 
M, protein marker (M.W. =8 kDa-220 kDa), 1, C7; 2, C5; 3, E3; 4, E4; 5, E5; 6, E2; 7, R2; 8, C3; 9, C4; 10, E10; 11, E11; 12, E8; 13, 
C14; 14, C12; 15, E9; 16, E6; 17, E7; 18, E12; 19, E15; 20,E16; 21, C21; 22, E30; 23, E29; 24, E27; 25, E28; 26, E31; 27, C2; 28, C1; 29, 
C6; 30, C13; 31, E21; 32, E18; 33, E23; 34, E20; 35, R1; 36, C8; 37, C9; 38, C10; 39, C11; 40, E14; 41, E17; 42; E13, 43,C15; 44, E24; 
45, E26; 46, E25; 47, E1; 48, E22; 49, E19; 50, C16; 51, C17; 52, C18; 53, C19; 54, C20; 55, C22. 
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Figure 4.6 SDS-PAGE of ECPs from V. parahaemolyticus isolates (two days).  
M, protein marker (M.W. = 8 kDa-220 kDa), 1:E11, 2:E10, 3:E3, 4:E4, 5:E5, 6:E2, 7:E1; 8, R2; 9, C3; 10, C4; 11, E13; 12, E14; 13, E8; 
14, E12; 15, E19; 16, C5; 17, C7; 18, E9; 19, E6; 20,E7; 21, E22; 22, E15; 23, E16; 24, E25; 25, C15; 26, E24; 27, E26; 28, R1; 29, C1; 
30, C6; 31, C12; 32, C13; 33, C14; 34, E23; 35, E20; 36, C2; 37, C8; 38, C9; 39, C10; 40, C11; 41, E17; 42; E21, 43, E18; 44, C21; 45, 
E30; 46, E29; 47, E27; 48, E28; 49, E31; 50, C16; 51, C17; 52, C18; 53, C19; 54, C20; 55, C22. 
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4.4 Discussion:- 
4.4.1 Assay of Kanagawa haemolysis activity 
The percentages of strains of V. parahaemolyticus with haemolytic activity on 
Wagatsuma agar were negative 56.36%, weak 16.36%, moderate 18.18% and 
strong 9.09%. The results of this study can be compared with Wong et al., (1992) 
who studied haemolytic activity of V. parahaemolyticus isolated from seafood 
samples, and they found that the percentages of haemolytic activity were negative 
34.5%, weak 53.4%, moderate 3.9%-4.9% and strong 3.4%.  
In the present study, Kanagawa haemolysis activity was detected in 82.6% clinical 
isolates and 15.6% environmental isolates. The result for clinical isolates is 
supported by Hongping et al., (2011) who have isolated V. parahaemolyticus from 
clinical cases, fresh water and seafood, and detected KP as a positive result in 
88.66% of clinical isolates, but also in 76.67% of isolates from fresh water and 
46.67% isolates from seafood in China. Furthermore, Nishibuchi and Kaper (1995) 
have reported 90% of clinical cases exhibited β-haemolysis on Wagatsuma agar, 
and found about ≥2% of environmental isolates exhibited KP+. Kelly and Stroh 
(1989) have found that about 1% of environmental V. parahaemolyticus strains are 
KP+. The KP has not always been associated with the production of TDH 
(Nishibuchi and Kaper, 1985). Nowadays, the KP reaction is usually used as a 
marker for detecting pathogenic V. parahaemolyticus (Honda and Iida, 1993, 
Izutsu et al., 2008). However, Hondo et al., (1987) have recorded that KP- strains 
may also cause gastroenteritis.  
In the current study, although KP was associated with tdh gene, one clinical (C17) 
and two environmental (E14 and E21) that bore the tdh gene were found to be 
negative for KP. Suthienkul et al., (1995) who also demonstrated that some clinical 
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V. parahaemolyticus isolates having tdh rarely exhibit haemolytic reaction on 
Wagatsuma agar even if those strains have the tdh gene, probably because the 
tdh gene is not expressed.  
Conversely, three clinical (R1, C14 and C21) and one environmental (E11) that 
lacked the tdh amplicon, produced KP. These results support the idea that the 
Kanagawa phenomenon is not always associated with expression of TDH 
encoded by the tdh gene and that such isolates still cause food borne illness 
(Nishibuchi et al., 1985, Hoashi et al., 1990). Therefore, other factors may 
contribute to haemolytic activity (Izutsu et al., 2008). Another possibility is that the 
haemolysis might be caused by phospholipase activity as demonstrated by other 
bacterial species (Kreger et al., 1987).  
Furthermore, Chun et al., (1975), Honda et al., (1980) and Nishibuchi et al., (1985) 
have reported that there are many limitations with KP test, including difficulty of 
interpretation in some isolates, NaCl concentration, erythrocyte type used in 
Wagatsuma agar and pH variability. 
Recently, Rojas et al., (2011) have recorded that an environmental isolate which 
does not carry the tdh gene still produced haemolytic activity on Wagatsuma agar 
(KP+). The contribution of TDH to pathogenicity of V. parahaemolyticus remains 
unclear (Hiyoshi et al., 2010). Moreover, Hoashi et al., (1990) and Honda et al., 
(1983) have suggested that there are other virulence factors associated with 
pathogenicity of this bacterium. Canizalez-Roman et al., (2011) have 
demonstrated that the best incubation time to interpret the results of KP was at 48 
h; and furthermore, noted that KP is inaccurate and not the best tool to detect all 
virulent forms of V. parahaemolyticus.  
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4.4.2 Phospholipase activity 
Phospholipases can be virulence factors for many bacterial species that cause 
infection such as ePseudomonas aeruginosa, Listeria monocytogenes, Clostridium 
perfringens and Corynebacterium pseudotuberculosis (Songer, 1997). 
Furthermore, this enzyme has been considered as a virulence factor in many 
Vibrio species such as V. cholerae (Fiore et al., 1997). Therefore, in current work, 
all isolates were tested on egg yolk plates to assay phospholipase activity; 82.60% 
of clinical isolates of V. parahaemolyticus and 15.62% environmental isolates 
showed phospholipase activity. These results suggest that V. parahaemolyticus 
produces a phospholipase that might be involved in pathogenesis, and are 
supported by the finding of Guhathakurta et al., (1988) who demonstrated that 
phospholipase plays a role as a virulence factor in pathogenicity of V. 
parahaemolyticus.  
Other bacterial studies reported that phospholipase is an important virulence factor 
associated with pathogenicity, for example, Legionella species produces 
phospholipase A that contributes to severe pneumonia by destroying alveolar 
surfactant phospholipid in the lung (Flieger et al., 2000a, Flieger et al., 2000b). 
Amongst human pathogenic Vibrio species, phospholipase A plays a role in the 
pathogenesis of V. mimicus infection  (Lee et al., 2002b), and V. vulnificus 
infection (Koo et al., 2007). 
In the current study, of the 24 phospholipase positive isolates, 20 were also KP+ 
isolates, suggesting that there is a relationship between these two activities. 
Phospholipase acts as a haemolysin in members of Vibrionaceae that produce 
and secreted this enzyme (Taniguchi et al., 1985, Thornton et al., 1988). A number 
of authors have reported some relationship between haemolytic activity and 
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phospholipase activity in some vibrios, for example, toxigenic V. cholerae O139 
show phospholipase activity (Pal et al., 1997), furthermore, Shinoda et al., (1991) 
have reported that lecithin-dependent haemolysin of V. parahaemolyticus have 
phospholipase A2/lysophospholipase. Zhong et al., (2006) have found that there is 
a strong relationship between haemolysin of V. harveyi that plays a role in 
pathogenicity in fish and phospholipase activity. Moreover, some Vibrio 
phospholipases such V. vulnificus and V. mimicus demonstrate haemolytic activity 
(Testa et al., 1984, Lee et al., 2002b). Sun et al., (2007) have demonstrated that a 
mutation at the active site of phospholipase of V. harveyi haemolysins was 
responsible for the loss of haemolytic and phospholipase activities and its 
virulence in fish, suggesting that phospholipase enzyme might be played an 
important role in haemolysis and pathogenicity. Furthermore, phospholipase 
associates with different pathogenic process and contributes to intestinal 
destruction (Gustafson and Tagesson, 1990, Titball, 1993).  
Further studies are needed to identify the role of V. parahaemolyticus 
phospholipase in infection and disease. Furthermore, investigations will be needed 
to determine if phospholipase alone can lyse erythrocytes.  
4.4.3 Urease activity 
Urease is defined as an enzyme from bacteria, fungi or plants that catalyses the 
hydrolysis of urea to carbon dioxide and ammonia (Olivera-Severo et al., 2006). 
Urease activity contributes to the inhibition of mucus biosynthesis. It causes 
intestinal mucus to disassemble at the mucosal surface facilitating bacterial 
colonisation and possibly the formation of ulcers (Sidebotham and Baron, 1990). 
Releasing a high concentration of ammonium ions, the urease enzyme may exert 
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toxic effects at intercellular junctions leading to alterations in permeability of 
intestine mucosa (Hazell and Lee, 1986). 
The ability of bacteria to hydrolyse urea can be used to predict potential 
pathogenicity of these bacteria (Kelly and Stroh, 1989). Cai and Ni, (1996) have 
purified the enzyme from urease positive V. parahaemolyticus and tested it in vivo. 
The authors found that this enzyme caused intestinal fluid accumulation, 
suggesting that urease enzyme may play a role as a virulence factor and can be 
used as an indicator of pathogenicity. However, Kelly and Stroh (1989) have 
detected urease activity in clinical and environmental V. parahaemolyticus isolates 
that were negative for the KP reaction. 
In the present study, urease activity was tested on urea agar base plates. All 
clinical isolates of V. parahaemolyticus and 46.87% of environmental isolates 
produced this enzyme and the correlation between urease enzyme and trh gene 
was low. Park, (2004d) has reported that the activity of urease-positive V. 
parahaemolyticus was not related to the carriage of haemolysin genes. Conversely, 
the clinical strains of V. parahaemolyticus that produced urease correlated with the 
presence the trh gene (Park et al., 2000). Moreover, in Korea, Kim and Kim, (2001) 
have reported that urease positive environmental V. parahaemolyticus strains 
carry tdh and trh genes, and suggested that urease is an important enzyme and 
correlated to pathogenicity of those strains. Recently, Sujeewa et al., (2009) tested 
189 environmental V. parahaemolyticus isolates and found 41% exhibited urease 
positive. Furthermore, Honda, et al., (1992a) and Osawa, et al., (1996) also 
reported that no relationship exists with haemolysin genes and the ability of the 
isolates to hydrolyse urea, but it is possible to correlate with the trh gene. 
Moreover, not all urea positive isolates produce tdh and trh.  
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Of Vibrio species isolated from sea water, urease activity was found in 40 % for V. 
parahaemolyticus and 40 % for V. cholerae non-O1, 20% for V. vulnificus and 20% 
for V. furnissii, 5% for V. alginolyticus, 100% for V. metshnikovii and none for V. 
fluvialis (Baffone et al., 2001). 
It is recommended in the future work to purify and characterise the urease enzyme 
from V. parahaemolyticus to identify its role in virulence and pathogenicity of V. 
parahaemolyticus.  
4.4.4 Protease activity 
Proteases are important enzymes which can be involved in pathogenicity and 
hydrolyse the peptide bonds in proteins to produce smaller molecules (Rao et al., 
1998). Many Vibrio species produce protease enzymes that might contribute to the 
pathogenicity of those bacteria (Crowther et al., 1987, Chowdhury et al., 1990).  
In the present study, protease activity was tested on skim milk agar medium. The 
results show that protease activity was detected in 82.60% of clinical and 40.62% 
of environmental isolates of V. parahaemolyticus. Park, (2004d) have found 
proteases in 43 out of 52 (82%) environmental strains, and suggested that V. 
parahaemolyticus isolated from environment had protease as a main pathogenic 
factor, but not haemolysin. Furthermore, Wong et al., (1992) have found 87.4% of 
environmental isolates were protease positive. Protease enzymes are considered 
virulence factors and contribute to the pathogenicity in some Vibrio species 
(Miyoshi and Shinoda, 2000). Ottaviani et al., (2005) have suggested that 
proteases were the main virulence factor in clinical V. parahaemolyticus isolates 
that did not carry tdh and trh. Proteins with proteolytic activity that are secreted 
and produced by pathogenic bacteria can have a role in tissue damage and 
pathogenesis. For example, the metalloprotease of Helicobacter pylori might 
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contribute to proteolysis of different host proteins in vivo and thus is associated 
with pathogenesis to cause disease (Windle and Kelleher, 1997).  
Protease activity has been tested in Vibrio species isolated from seafood and 
aquacultured foods. Protease activity was found in 87.4% for V. parahaemolyticus, 
78.2% for V. alginolyticus, 91.4% for V. cholerae, 90.9% for V. fluvialis I, 100% for 
V. fluvialis II, 93.3% for V. mimicus, 76.7 % for Aeromonas hydrophila, 69.2% for A. 
caviae and 79.2% for A. sobria (Wong et al., 1992).     
Further investigation will be needed to determine if protease activity could 
contribute to pathogenicity by purifying this enzyme and testing in vivo and in vitro. 
4.4.5 Lipase activity 
Lipase is an enzyme produced and secreted by bacteria. It can catalyse both the 
synthesis and the hydrolysis of acylglycerols chain (Jaeger et al., 1999). Lipase 
activity was exhibited in six (26%) clinical and five (15.62%) environmental isolates 
of V. parahaemolyticus. This enzyme is therefore not useful to differentiate the 
virulent and avirulent isolates of this bacterium.  
However, lipases play a main role in pathogenesis of other bacteria such as A. 
hydrophila and A. salmonicida (Thornton et al., 1988). The lipase activity found in 
the present study did not correlate with haemolysis activity, as found by Zhong et 
al., (2006) in V. harveyi. Ranjitha et al., (2009) have purified and characterised a 
lipase enzyme from V. fischeri but generally, information about lipolytic enzymes 
produced by marine Vibrio species is especially limited. 
Studies about Vibrio species isolated from sea water report that lipase activity was 
found in 100 % for V. parahaemolyticus, V. vulnificus, V. alginolyticus, V. fluvialis, 
V. furnissii, V. metshnikovii  and 80 % for V. cholerae non-O1 (Baffone et al., 
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2001). Furthermore, Wong et al., (1992) have tested lipase activity in Vibrio 
species isolated from seafood and aquacultured foods and  lipase activity was 
found in 97.9% for V. parahaemolyticus, 98.1% for V. alginolyticus, 98.0% for V. 
cholerae, 95.7% for V. fluvialis I, 81.8% for V. fluvialis II, 97.7% for V. mimicus, 
81.5% for Aeromonas hydrophila, 69.2% for A. caviae and 82.4% for A. sobria. 
4.4.6 Plasmids and bacteriophages 
Mobile genetic elements such as plasmids and bacteriophages can encode 
virulence factors and play a role in pathogenesis (Betley et al., 1986, Davis and 
Waldor, 2000). In the current study, V. parahaemolyticus isolates were screened 
by using agarose gel electrophoresis to check for the presence of plasmids which 
might carry genes for virulence factors. Various plasmids were found at similar 
frequency in clinical and environmental isolates, suggesting that there was no link 
between plasmid carriage and pathogenicity. However, regarding geographical 
regions; the incidence of plasmids was higher among isolates from Spain (54.54%) 
than the isolates from other countries such as Norway (20 %), UK (28%) and 
Japan (25%).  
These results support those of Kelly and Stroh (1989) who found 15% and 13% of 
plasmid-bearing forms in clinical and environmental V. parahaemolyticus isolates, 
respectively, in the Pacific Northwest. Furthermore, Abbott et al., (1989) screened 
for plasmids in 16 V. parahaemolyticus isolates and about 30% were found to 
harbour such elements.  
In Japan, the incidence of plasmids in V. parahaemolyticus has been studied by 
Arai, et al., (1983) who have found plasmids in 8 out of 20 clinical isolates, 
however, they did not find any plasmids in strains from foods. In Bangladesh no 
strains isolated from patients had plasmids; however, they found plasmids in two 
Chapter 4 
108 
 
out of eight environment isolates. Arai, et al., (1983) have suggested that fresh 
isolates may have more plasmids, and most of the plasmids in V. 
parahaemolyticus are unstable and segregate into small fragments in the course 
of stabilisation. Consequently, these plasmids may lose their biological markers 
through these changes. 
Another study reported that there is no significant differences between plasmids 
isolated from clinical and environmental isolates of V. parahaemolyticus, thus the 
plasmid profiles method is not useful method for epidemiological studies (Kaufman 
et al., 2002). Depaola et al., (2003b) have used plasmids analysis to differentiate 
between virulent and avirulent V. vulnificus isolates; however, similar percentages 
have been found in clinical and environmental isolates of this organism. 
In the current study, there was no correlation between carriage of plasmids and 
putative virulence factors. These plasmids appear not to be involved in virulence 
because some strains lacking plasmids were shown to be virulent, for example, 
33.33% and 28.94% of KP+ and of urease positive V. parahaemolyticus had 
plasmids, respectively, suggesting that plasmids did not code for these factors, 
and that in the majority of the isolates virulence factors were not associated with 
the presence of plasmids. Guerry and Colwell (1977) reported plasmids detected 
in KP+ strains of V. parahaemolyticus could be involved in production of this 
haemolysin or other features that contributed with pathogenicity of these strains. 
Moreover, Kelly and Stroh (1989) found that KP+ V. parahaemolyticus did not carry 
any plasmids, and suggested that the presence of plasmids in this bacterium does 
not correlate with Kanagawa haemolysis.  
In the present study, bacteriophages were not found in any culture supernatant of 
isolates, suggesting that bacteriophage if present may be integrated into the 
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bacterial genome. Phages have been found in V. parahaemolyticus by other 
authors, for example, Iida et al., (2002) and Makino et al., (2003) have reported 
that a filamentous phage f237 integrates into the chromosome of V. 
parahaemolyticus. The pattern of genomic organisation of phage f237 is similar to 
that of the CTXø phage.  
In conclusion, no clear distinction between clinical and environmental isolates of V. 
parahaemolyticus could be made using plasmid analysis. Furthermore, the 
incidence of plasmids did not correlate with virulence of this bacterium. Future 
work could look at sequencing a number of clinical and environmental V. 
parahaemolyticus strains derived plasmids and to look for any relationships 
between them.  
4.4.7 Whole cell protein 
Fifty five V. parahaemolyticus isolates (23 clinical and 32 environmental) were 
phenotypically characterised by comparing whole cell soluble proteins separated 
by SDS-PAGE.  
The technique was not useful to differentiate between virulent and avirulent forms 
of V. parahaemolyticus. The whole cell protein patterns of all V. parahaemolyticus 
were similar; however, there were slight differences in the number of bands 
produced in some isolates but these differences were not related to virulence. 
Four environmental isolates (E12 and E13, E14, E15) produced extra band at 90 
kDa, E12 was negative for all enzyme activities tested, while, the others were only 
positive for urease and protease, suggesting that this band not related with 
pathogenicity of these isolates. A band at 60 kDa has been found in only one 
clinical (C1) and one environmental (E16) isolates, C1 was positive for urease, 
protease and phospholipase, while E16 was positive for only urease and protease 
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activity, there were some isolates that positive for at least three enzyme activities 
but did not have this band suggesting that this band probably not contributed to 
pathogenicity.  
Standard SDS-PAGE used in the present study was not useful to differentiate 
isolates. 2D SDS-PAGE is used to separate complex mixtures of proteins. 
However, it is possible that 2D SDS-PAGE may offer means to differentiate 
between virulent and avirulent forms, but it is expensive and time consuming, 
especially with large number of bacteria to analyse the whole cell protein and 
ECPs. O'Farrell, (1975) has reported that 2D SDS-PAGE provides more 
information than 1D SDS-PAGE and is capable of resolving thousands of proteins 
in one procedure. 2D SDS-PAGE permits simultaneous determination of 
approximate isoelectric points of proteins by isoelectric focusing in the first 
dimension and molecular weights of proteins by sodium dodecyl sulphate 
electrophoresis in the second dimension. Kabir, (1991) has demonstrated that 2D 
SDS-PAGE has a high resolving power compared to that offered by 1D SDS-
PAGE. More recently, 102 unique proteins were identified in Lactobacillus 
acidophilus NCFM by using the 2D SDS-PAGE based alkaline proteome 
(Majumder et al., 2012).  
Bhoumick, et al., (2008) have used SDS-PAGE for evaluation of protein profiles for 
typing V. parahaemolyticus isolated from seafood and comparison with other 
techniques. The protein profiles revealed a difference in intraspecies at the protein 
level but the differences between isolates was not as distinct as that found from 
DNA fingerprinting; authors have reported that the differences between V. 
parahaemolyticus isolates using the protein profiling method were not distinct as 
molecular typing methods such as RAPD-PCR. Therefore, the authors 
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recommended using molecular typing technique to detect the differences between 
the isolates.  
4.4.8 ECPs profile 
Many pathogenic Vibrio species are able to produce ECPs and these ECPs are 
found to be related to pathogenicity (Elston and Leibovitz, 1980, Nottage and 
Birkbeck, 1987). Maeda and Yamamoto, (1996) have reported that proteases are 
mostly detected in these ECPs and cause host tissue damage. Moreover, ECPs 
could also interfere with host defense factors. The ECPs of V. parahaemolyticus 
may be associated with the pathogenicity of this bacterium (Cheng et al., 2008).  
Comparative protein bands profile of ECPs was observed by SDS-PAGE. The 
results show this bacterium produces few bands at 24 hours. However, V. 
parahaemolyticus produces ECPs which were collected by harvesting a 2 day-old 
culture and found to be somewhat variable among the isolates this results are 
supported by Labreuche et al., (2006) who reported that ECPs protein bands 
numerous and prominent and could be mainly produced in two days. The results 
of the present study agree with Zhang and Austin, (2000) who have studied V. 
harveyi and they found the ECPs protein profile revealed a very great variety 
among the isolates of V. harveyi. Aguirre-Guzmán et al., (2004) have reported that 
Vibrio species that were isolated from the environment secrete numerous ECPs as 
virulence factors. These ECPs include haemolysin, protease and chitinase and 
have a toxic effect on shrimp (Stensvag et al., 1993, Liu et al., 1997, Lee et al., 
1997).  
In the present study, the ECPs that were harvested at 48 h produced more bands 
than those from 24 h in some isolates. Thus it was necessary to note if those 
ECPs were truly secreted or may be because of autolysis (lysis of the bacterial 
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cells and release of internal enzymes). A simple procedure was used to test the 
viability of bacterial cells in 24h and 48h by using trypan blue stain; the percentage 
of viability of V. parahaemolyticus cell was 77%, thus 23% nonviable cells in 24 h. 
A 66.5% for viable cells; nonviable cells were 33.5% in 48 h, suggesting that 
nonviable cell may produce bands detected by SDS-PAGE resulting from autolysis 
in some isolates but there is a good percentage 66.5% of viable cells.  
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CHAPTER 5 
CYTOTOXIC EFFECT OF VIBRIO 
PARAHAEMOLYTICUS EXTRACELLULAR 
PRODUCTS (ECPS) ON HUMAN COLORECTAL 
EPITHELIAL CELLS (CACO-2) AND CHINESE 
HAMSTER OVARY (CHO-K1) CELLS 
Results from this Chapter have been presented at Centre for Research in 
Translational Biomedicine, Plymouth University, April 2011 and SGM 
Autumn Conference 2011, Global disease burden of enterics Display, York, 
September 2011. Results from this chapter have also been published in 
European Journal of Clinical Microbiology and Infectious Diseases 31:431–
439 (Kadhim, et al., 2012) 
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Chapter 5: Cytotoxic Effect of Vibrio parahaemolyticus Extracellular 
Products (ECPs) on Human Colorectal Epithelial Cells (Caco-2) and Chinese 
Hamster Ovary (CHO-K1) Cells 
5.1 Introduction:- 
Studies have sought to ascertain the production both in vitro and in vivo of ECPs 
by various Vibrio species and their importance as potential virulence factors 
(Montero and Austin, 1999, Zorrilla et al., 2003). A large number of environmental 
Vibrio species are reported to produce extracellular toxic factors (Venkateswaran 
et al., 1991). Elston and Leibovitz, (1980) reported that there is a relationship 
between pathogenic Vibrio species isolated from oyster and their ability to produce 
ECPs. Aguirre-Guzmán et al., (2004) have demonstrated that a variety of Vibrio 
species isolated from the environment and marine organisms secrete several 
ECPs that have been demonstrated in vivo and in vitro as a main virulence factor 
for some fish pathogenic bacteria such as V. damsela (Fouz et al., 1993) and V. 
alginolyticus (Balebona et al., 1998). In the case of virulent V. parahaemolyticus, 
ECPs appear to play a role in the death of experimental animals, suggesting that 
this bacterium secrets one or more toxic factors (Liu et al., 2000). TDH is a 
membrane-active protein toxin free from carbohydrate and lipid (Honda and Iida, 
1993) which causes in vitro haemolysis and cell death, but also causes 
morphological changes (e.g. loss of the number of microvilli on the cell surface, 
followed by loss of cytoplasmic substances), and causes the death of various cell 
lines (Sakurai et al., 1976, Tang et al., 1995). In vivo, cytotoxicity of TDH may play 
a role in destroying intestinal epithelial cells, leading to bloody mucous stool 
(Honda and Iida, 1993). Moreover, TDH causes intestinal fluid secretion (Raimondi 
et al., 2000). TDH may act as an indicator of potential virulence of V. 
parahaemolyticus correlating with human pathogenicity (Miyamoto et al., 1969). 
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Matsuda et al., (2010) have demonstrated that TDH induces cytotoxicity in 
cultured cells and it is a major virulence factor of this organism. The toxicity of 
TDH and TRH are similar. Although, most published studies on the cytotoxicity of 
V. parahaemolyticus isolates are related to TDH or TRH (Raimondi et al., 2000, 
Tang et al., 1995). Lynch et al., (2005) and Park et al., (2004b) have reported that 
this bacterium has cytotoxic activity even in the absence of TDH and TRH.  
Elston (1980) demonstrated that ECPs have biological activities which may 
contribute to the disease development as aggressions enabling the bacteria to 
counteract the host defence systems. Lee et al., (2002a) have purified protease 
from supernatant of V. parahaemolyticus and found that protease caused in vivo 
haemorrhagic damage and death in mice after injection both intravenously and 
intraperitoneally.  
The aim of this study was to develop a cytotoxicity assay using ECPs and 
measuring release of lactate dehydrogenes (LDH) as an indicator of cell lysis in 
two types of cell lines. 
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5.2. Materials and methods:- 
5.2.1. Tissue culture and cell lines 
The role of ECPs (section 4.2.8) in cytotoxicity of V. parahaemolyticus was 
determined in the human colorectal epithelial cells (Caco-2) and Hamster Chinese 
ovary (CHO-K1) cells.  
Human colorectal epithelial cells (Caco-2) were grown in a 75-cm2 flask and 
maintained in Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, UK) 
(Appendix I) supplemented with 10% (v/v) fetal bovine serum (FBS), 5 mM 
glutamine, 100 μg/ml streptomycin and 100 U/ml penicillin (to prevent bacterial 
contamination) and incubated in an atmosphere containing 5% CO2 at 37°C for 21 
days for cell confluence. The medium was replaced every 2–3 days to remove 
waste products and provide new nutrients. After confluent growth, the cells were 
washed twice with 0.53 mM Versene solution and treated with 0.25% trypsin- 
EDTA solution (for cell dissociation and to remove adherent cells from the culture 
surface). Before exposure to ECPs, cells were washed with DMEM without phenol 
red. 
Chinese hamster ovary (CHO-K1) cells were cultured in 75-cm2 flasks in Ham 
nutrient mixture F-12 supplemented with 10% (v/v) fetal bovine serum (FBS) 
(Gibco, UK) at 37°C for 72 h. After confluent growth, cells were washed twice with 
phosphate-buffered saline (PBS) and treated with 0.25% trypsin- EDTA solution. 
5.2.2. Assay for cytotoxic activity 
The CytoTox96® Non-Radioactive Cytotoxicity Assay kit (Promega, UK) was used 
to test cytotoxic activity of the ECPs of V. parahaemolyticus isolates by monitoring 
release of lactase dehydrogenase (LDH) according to the manufacturer’s 
instructions as follows. 
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5.2.2.1. Optimisation of target cell number 
Because each target cell type has varying amounts of LDH, it was necessary to 
determine the optimum number of target Caco-2 and CHO-K1 cells to use in the 
assay.  
Serial dilutions of Caco-2 and CHO-K1 cells (0, 5,000, 10,000, 20,000, 40,000, 
80,000/100µl) were prepared in a V-bottom 96-well microtiter plates (Fisher 
Scientific International, Inc., UK), in triplicate. A triplicate set of wells for the culture 
medium background without cells was also prepared. In order to lyse cells, 15 µl of 
lysis solution (Appendix I) were added to all wells and then incubated in a 
humidified chamber for 45 min at 37°C and the plate was centrifuged at 500 x g for 
5 min. From all wells, 50 µl aliquots were transferred to a fresh flat bottom 96-well 
(enzymatic assay) plate. The substrate preparation and LDH reaction were 
performed in the dark. Frozen Assay Buffer was melted in a 37°C water bath and 
12 ml were added at room temperature to a bottle of Substrate Mix and gently 
shaken to dissolve the substrate. Next, 50 µl of the reconstituted Substrate Mix 
was added to each well of the plate and this was incubated for 30 min at room 
temperature. Finally, 50 µl of Stop Solution was added to each well. The 
absorbance at 490 nm was recorded using a Fusion Universal microplate analyser 
(Optimax, Molecular Devices UK Ltd.) after popping any large bubbles by using a 
syringe needle. The concentration of target cells was determined by yielding 
absorbance values at least two times the background absorbance of the medium 
control.  
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5.2.2.2 Cell-mediated cytotoxicity assay 
(i) Assay plate setup 
Approximately 5x103 trypsinised cells in 100 µl of the appropriate medium were 
dispensed into each well of the 96- well microtiter plates (Fisher Scientific 
International, Inc., UK), as determined in section (5.2.2.1). 
A 15 µl of volume of ECPs from 23 clinical and 32 environmental isolates was 
added to each experimental well in triplicate. A triplicate set of “spontaneous” well; 
received 15 µl of sterile culture medium to ascertain release in the absences of 
ECPs. A triplicate set of maximum LDH release wells received 15 µl of lysis 
solution (10X) to yield complete lysis of target cells (as determined by phase 
contrast microscopy).  
(ii) Cell culture and supernatant harvest  
The cytotoxicity assay plate was incubated at 37°C for 4 hours to ensure sufficient 
contact between target and effector cells based on the manufacturer’s instructions. 
The cells in maximum LDH release wells were then treated with lysis solution for 
45 min and the plate was centrifuged at 500 x g for 5 min. The substrate 
preparation and LDH reaction were performed as described in section (5.2.2.1). 
(iii) LDH measurement 
LDH measurement was performed as described in section (5.2.2.1), and 
determination of cytotoxicity calculations were based on the formula: % 
cytotoxicity=100 x ([optical density at 490 nm ‘OD490’ for experimental release ‘exp’ 
– OD490 for spontaneous release ‘spon’]/ [OD490 for maximum release ‘max’ – 
OD490 for spontaneous release]), where the spontaneous release was the amount 
of LDH released from the cytoplasm of untreated cells, while the maximum release 
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was the amount of LDH release from toxin untreated cells that were totally lysed 
with the lysis buffer included in the kit. 
(iv) Statistical analysis 
Statistical analysis was performed using the appropriate parametric (student’s t- 
test) and non-parametric (Mann-Whitney W-test) by using Statgraphics Centurion 
XVI.I 16.01 (Plymouth University, UK). A p < 0.05 was considered statistically 
significant (Appendix II).  
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5.3. Results  
The ECPs obtained from clinical and environmental isolates were tested for their 
cytotoxicity to both Caco-2 and CHO-K1 cells. The mean cytotoxicity value of 
clinical isolates was much greater than for environmental isolates (Figure 5.1). 
Clinical isolates showed 69.53% and 59.63% relative cytotoxicity in Caco-2 and 
CHO-K1 cells, respectively, while environmental isolates showed 17.48% and 
12.18% relative cytotoxicity in Caco-2 and CHO-K1 cells, respectively. The 
difference between the means of clinical and environmental isolates was 
significant at a p value of < 0.05. With each cell line (Caco-2 and CHO-K1), each 
isolate was tested on three different occasions using three replicates.  
The isolates were grouped according to their percentage cytotoxicity values; high (> 
50%), medium (28-49%) and low (0-27%) categories. Amongst clinical isolates, 21 
out of 23 (91%) showed high cytotoxicity, and 2 (8.69%) showed medium 
cytotoxicity. Amongst environmental isolates 2 out of 32 (6.25%) showed high 
cytotoxicity, 2 (6.25%) showed medium cytotoxicity and 28 (87.3%) showed low 
cytotoxicity on both Caco-2 and CHO-K1 cells (Figure 5.2). 
Table 5.1 relates the virulence characteristic of all isolates tested (previously 
described in Chapter 4) to their cytotoxicity that has been investigated in the 
present chapter. For example, clinical isolate C15 was positive for all five enzyme 
activities tested and caused 87% and 66% cytotoxicity on Caco-2 and CHO-K1 
cells respectively. Clinical isolate C1 was positive for only three enzyme activities 
(urease, protease and phospholipase) and caused 40% and 45% cytotoxicity on 
Caco-2 and CHO-K1 cells respectively. Likewise, clinical isolate C10 caused 42% 
and 47% cytotoxicity on Caco-2 and CHO-K1 cells respectively but was positive 
for urease, lipase and protease. However, cytotoxicity of ten environmental 
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isolates (E1, E4, E5, E6, E8, E10, E12, E17, E19 and E22) was less than 5% to 
both Caco-2 and CHO-K1; these isolates were negative for all enzymes tested and 
negative for both tdh and trh genes. Environmental reference strain NCTC (R2) 
was positive for urease, protease and phospholipase and caused 60.8% and 40% 
cytotoxicity on Caco-2 and CHO-K1 cells respectively. 
For statistical analysis, the differences in cytotoxicity of ECPs of V. 
parahaemolyticus isolates were compared: (i) KP+ (β-haemolysis) versus KP- (ii) 
Phospholipase+ versus phospholipase- isolates (iii) Protease+ versus protease- 
isolates (iv) Urease+ versus urease- (v) Lipase+ versus lipase- isolates (vi) tdh+ 
versus tdh- isolates (vii) trh+ versus trh- isolates (Figures 5.3-4, Tables 5.2-3). 
The mean cytotoxicity percentage of KP+ V. parahaemolyticus isolates was 
significantly higher (p < 0.05) than that for KP- isolates.  KP+ V. parahaemolyticus 
isolates exhibited 64.76% and 53.73% relative cytotoxicity on Caco-2 and CHO-K1 
cells respectively, whereas, KP- isolates exhibited 19.64% and 15.22% relative 
cytotoxicity on Caco-2 and CHO-K1 cells respectively. Similarly, cytotoxicity of 
phospholipase positive V. parahaemolyticus isolates on both cell types was 
significantly higher (p < 0.05) than cytotoxicity of phospholipase negative strains.  
Although there were significant differences (p < 0.05) between relative cytotoxicity 
of urease positive V. parahaemolyticus isolates (51.77% and 41.62% on Caco-2 
and CHO-K1 cells respectively) and urease negative of V. parahaemolyticus 
isolates (11.27% and 11.11% on Caco-2 and CHO-K1 cells respectively) (see 
Figures 5.3-4 and Tables 5.2-3), there were some environmental isolates with low 
cytotoxicity, for example, E23 caused 14.8% and 5% on Caco-2 and CHO-K1 cells 
respectively Table 5.1. Likewise, there were also significant differences between 
cytotoxicity of protease positive V. parahaemolyticus isolates and protease 
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negative isolates but there were some environmental isolates with low cytotoxicity, 
for example, E23 caused 14.8% on Caco-2 and 5% CHO-K1. The mean 
cytotoxicity percentage of lipase positive V. parahaemolyticus isolates was not 
significant.   
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Figure 5.1 Cytotoxic effects of ECPs of clinical and environmental isolates of 
V. parahaemolyticus on Caco-2 and CHO-K2 cell lines. Error bars represent 
the standard error of the mean.  
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Figure 5.2 Cytotoxicity (%, relative to complete chemical cell lysis) of Caco-2 and CHO-K1 cell lines with ECPs of Vibrio 
parahaemolyticus isolates. Error bars represent the standard error of the mean.   
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Table 5.1 Virulence characteristic and cytotoxicity of Vibrio 
parahaemolyticus isolates 
Strain 
 
Type and source  
(where known) 
Virulence Characteristics and virulence genes
2       Cytotoxicity % 
KP(β-haemolysis) Ure Lip     Pro PPL tdh trh Caco-2 CHO-K1 
R1 Clinical, NCIMB  
Reference Strain, UK 
+ + - - + - -     60.0 62.0 
C1 Clinical, Norway - + - + + - - 40.0 45.0 
C2 Clinical, Norway + + - + + + - 85.0 71.9 
C3 Clinical, Norway - + - - + - + 81.0 62.7 
C4 Clinical, Norway + + + + + + + 83.5 67.0 
C5 Clinical, Norway + + - + + + - 84.0 67.0 
C6 Clinical, Norway + + + + + + + 71.0 61.0 
C7 Clinical, Norway + + - + + + - 72.0 62.5 
C8 Clinical, Norway + + - + + + - 82.0 63.0 
C9 Clinical, Norway + + - + + + - 74.5 55.0 
C10 Clinical, Norway - + + + - - + 42.0 47.0 
C11 Clinical, Japan + + - - + + - 83.6 66.6 
C12 Clinical, Japan + + + + + + - 83.7 66.0 
C13 Clinical, Japan + + - + + + - 65.0 54.5 
C14 Clinical, Japan + + - - + - - 65.0 58.0 
C15 Clinical, UK + + + + + + - 87.0 66.0 
C16 Clinical, Spain + + - + + + - 64.6 51.7 
C17 Clinical, Spain - + - + - + - 65.0 52.0 
C18 Clinical, Spain + + - + + + - 61.9 61.0 
C19 Clinical, Spain + + + + + + - 64.0 64.0 
C20 Clinical, Spain + + - + + + - 60.0 60.5 
C21 Clinical, Italy + + - + - - + 55.8 52.0 
C22 Clinical, UK + + - + - + + 63.0 51.0 
R2 Environnemental, NCTC  
Reference Strain, UK 
- + - + + - - 60.8 40.0 
E1 Environmental, Spain - - - - - - - 0.6 5.0 
E2 Environmental, Spain - - - + - - - 19.8 4.7 
E3 Environmental, Spain  - - - + + - - 39.0 37.5 
E4 Environmental, Spain - - - - - - - 0.5 4.9 
E5 Environmental, Spain - - - - - - - 0.6 3.0 
E6 Environmental, Spain - - - - - - - 0.5 4.0 
E7 Environmental, UK + - - + + + - 20.5 19.5 
E8 Environmental, UK - - - - - - - 0.4 5.0 
E9 Environmental, UK + - - - + + + 86.6 62.0 
E10 Environmental, UK - - - - - - - 0.6 3.0 
E11 Environmental, UK + - - + - - - 19.0 3.0 
E12 Environmental, UK - - - - - - - 0.6 3.0 
E13 Environmental, UK - + - + - - + 18.0 5.7 
E14 Environmental, UK - + - + - + + 19.6 4.0 
E15 Environmental, UK - + - + - - + 20.0 9.8 
E16 Environmental, UK - + - + - - + 25.9 25.8 
E17 Environmental, UK  - - - - - - - 0.4 4.8 
E18 Environmental, UK + + - + + + - 24.5 11.0 
E19 Environmental, UK  - - - - - - - 0.4 4.0 
E20 Environmental, UK  + + - + - + - 28.0 29.5 
E21 Environmental, UK  - - - - - + - 0.5 5.0 
E22 Environmental, UK  - - - - - - - 0.1 4.0 
E23 Environmental, UK  - + - + - - - 14.8 5.0 
E24 Environmental, UK  - + + - - - - 22.0 13.7 
E25 Environmental, UK  - - + - - - - 0.6 4.5 
E26 Environmental, UK  - + - + - - - 26.7 12.0 
E27 Environmental, Portugal - + - - - - + 19.0 5.0 
E28 Environmental, Portugal - + + - - - + 27.0 20.0 
E29 Environmental, UK - + + - - - - 16.5 5.0 
E30 Environmental, UK - + + + - - - 24.7 15.8 
E31 Environmental, UK - + - - - - - 18.5 5.8 
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Figure 5.3 Cytotoxicity of ECPs of V. parahaemolyticus on Caco-2 cells 
depended on phenotypes (enzyme activity) and genotypes (known virulence 
gene). Error bars represent the standard error of the mean. Mean 
cytotoxicity percentages are noted in table 5.2. An asterisk indicates that the 
cytotoxicity difference between each group is significantly different (p < 
0.05).  
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Figure 5.4 Cytotoxicity of ECPs of V. parahaemolyticus on CHO-K1 cells 
depended on phenotypes (enzyme activity) and genotypes (known virulence 
genes). Error bars represent the standard error of the mean. Mean 
cytotoxicity percentages are noted in table 5.3. An asterisk indicates that the 
cytotoxicity difference between each group is significantly different (p < 
0.05). 
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Table 5.2 Cytotoxicity of ECPs of V. parahaemolyticus on Caco-2 cell line 
depended on virulence characteristics. 
 
Virulence characteristics 
Mean cytotoxicity percentages of V. 
parahaemolyticus isolates 
positive reactions negative reactions 
KP (β-haemolysis) 64.76 * 19.64 * 
Phospholipase 66.86 * 17.87 * 
Protease 50.66 * 21.41 * 
Urease 51.77 * 11.27 * 
Lipase 47.65 37.15 
tdh 62.35 * 22.65  * 
trh 47.30 36.76 
* An asterisk indicates that the cytotoxicity difference between each group is significantly different 
(p < 0.05). 
 
 
Table 5.3 Cytotoxicity of ECPs of V. parahaemolyticus on CHO-K1 cell line 
depended on virulence characteristics. 
 
Virulence characteristics 
Mean cytotoxicity percentages of V. 
parahaemolyticus isolates 
positive reactions negative reactions 
KP (β-haemolysis) 53.73 * 15.22 * 
Phospholipase 55.83 * 13.59 * 
Protease 40.81 * 18.83 * 
Urease 41.62 * 11.11 * 
Lipase 39.23 30.22 
tdh 51.08 * 18.32 * 
trh 36.51 30.63 
* An asterisk indicates that the cytotoxicity difference between each group is significantly different 
(p < 0.05). 
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 5.4 Discussion  
It was necessary to determine the cytotoxicity characteristics of ECPs of V. 
parahaemolyticus isolated from clinical and environmental samples to understand 
their possible pathogenic mechanisms. Cytotoxicity of ECPs to Caco-2 and CHO-
K1 cells was performed to assess the potential virulence of both clinical and 
environmental isolates of V. parahaemolyticus using quantity of LDH released. 
The isolates that show high cytotoxicity values are likely to be highly virulence, and 
the isolates that show medium and low cytotoxicity are medium and low virulence 
respectively. For the purposes of this work those isolates with more than 50% 
cytotoxicity were regarded as highly virulent strains and those with 28-49% were 
regarded as virulent strains but less virulence and those with less than 28% low 
virulence or avirulent.  
In general, the clinical isolates showed a higher level of cytotoxicity than the 
environmental isolates. A minority of environment isolates showed similar levels of 
cytotoxicity to the proven virulent clinical isolates and these environmental isolates 
may be potentially virulent, for example, E9 caused high cytotoxicity because this 
isolate has the major virulence factor tdh as well as trh, plus putative virulence 
factors KP haemolysis and phospholipase. Very similar, if not identical, results 
were obtained with the same set of isolates whose ECPs were tested for 
cytotoxicity against Caco-2 and CHO-K1 cell lines. As a group, clinical isolates 
were more cytotoxic than environmental isolates. These results agree with Yeung 
et al., (2007) who used cytotoxicity assay to differentiate between pathogenic and 
non-pathogenic V. parahaemolyticus strains by using a tissue culture-based assay.  
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The enzyme activities previously determined (Chapter 4) were compared with the 
cytotoxicity of ECPs in clinical and environmental V. parahaemolyticus isolates.  
Statistical analysis showed that for V. parahaemolyticus isolates urease, protease, 
phospholipase and Kanagawa haemolysis activities and possession of tdh positive 
reaction were significantly related to cytotoxicity to Caco-2 and CHO-K1 cells. The 
presence of the trh gene in either clinical (6/23) or environmental (7/32) isolates 
was low; therefore, mean cytotoxicity percentage of trh positive strains was not 
significant. Vongxay et al., (2008) have detected the trh gene in 3 of 25 clinical and 
7 of 191 environmental isolates and suggested that TRH and TDH are not the only 
virulence factors responsible for V. parahaemolyticus pathogenicity. Wong et al., 
(1992) have reported that the KP+ V. parahaemolyticus has been involved in 
gastroenteritis. However, some strains of KP- V. parahaemolyticus are involved in 
bacteraemia (Charlton et al., 1999). In the present study, some isolates lacked tdh 
and trh but showed cytotoxicity supporting the results of García et al., (2009) who 
reported that V. parahaemolyticus retained pathogenicity in the absence of tdh and 
trh genes. Moreover, pathogenic V. parahaemolyticus lacking tdh and trh genes, 
still demonstrated cytotoxic activity and death in a mouse model (Xu et al., 1994).  
The present study demonstrated that Kanagawa reaction and phospholipase gave 
similar but not identical correlations with cytotoxicity. For example, most V. 
parahaemolyticus isolates that were positive for KP also were positive for 
phospholipase but C1, C3, R2 and E3 were negative for Kanagawa reaction and 
positive for phospholipase and they were still cytotoxic (Table 5.1), suggesting that 
phospholipase may contribute to pathogenicity of these isolates tested. 
Phospholipases hydrolyse phospholipids that are present in the host cell 
membrane, contributing to membrane damage (Schmiel et al., 1998, Istivan and 
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Coloe, 2006); in other bacteria, phospholipases also play a role in nutrient 
digestion in the formation of bioactive molecules. For example, phospholipase in 
Clostridium perfringens (alpha-toxin) causes massive tissue destruction such as 
gas gangrene; and Listeria monocytogenes produces a phospholipase involved in 
food borne infection (Titball, 1993, Songer, 1997).  
In the present study, the mean cytotoxicity percentage exhibited by lipase positive 
V. parahaemolyticus isolates was similar to lipase negative isolates, suggesting 
that lipase does not contribute to the pathogenicity of V. parahaemolyticus. The 
cytotoxicity of protease positive V. parahaemolyticus isolates was significantly 
higher than protease negative isolates. However, Wong et al., (1992) have 
demonstrated that lipases and proteases of Vibrio species have a role in 
cytotoxicity of CHO-K1 cells. Lin and Lee, (1997) have reported that protease 
activity caused cytotoxicity to CHO-K1 cells. Furthermore, Sudheesh and Xu, 
(2001) have injected prawns with ECPs, containing protease, from a potentially 
pathogenic environmental V. parahaemolyticus strain and this caused mortality of 
all the prawns injected. The ECPs produced by many bacterial pathogens include 
proteases as virulence factors which lyse host cells (Lantz, 1997). Labreuche et al., 
(2006) have studied toxicity to oysters of ECPs from pathogenic V. aestuarianus. 
Most bacterial proteases can cause extensive host tissue disruption facilitating the 
propagation of the bacteria. Thus, proteases degrade host proteins to provide 
nutrients for growth of the bacteria (Maeda and Yamamoto, 1996). 
In the current study, urease enzyme activity was considered as a marker for 
cytotoxicity, but is unlikely to be responsible for cytotoxicity, although there was a 
significant difference between the mean cytotoxicity percentage of urease positive 
and negative V. parahaemolyticus isolates. Depaola et al., (2000) have reported 
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that urease positive V. parahaemolyticus strains and possession of trh and tdh 
genes did not enhance the virulence of those strains. However, Park, (2004c) has 
demonstrated that environmental urease positive V. parahaemolyticus strains 
caused mice mortality when injected, and these strains were recovered from 
viscera of injected mice, and they showed much higher mortality than haemolytic 
and protease positive strains (Park, 2004d).  
Importantly, it may be possible that collectively these enzyme activities have a role 
in cytotoxicity. In other words, there are at least two or three or more possible 
enzyme factors responsible for cytotoxicity. However, lack of one or more of these 
components may still leave the strain virulent. 
This chapter primarily verified the virulence of clinical isolates by analysing 
putative virulence factors which could possibly be used to differentiate between 
potentially pathogenic and non-pathogenic forms of V. parahaemolyticus. It clearly 
differentiates between virulent and avirulent isolates. However, this is not suitable 
for rapid identification of V. parahaemolyticus in foodstuffs as there is the need to 
isolate, grow the organism in broth and use the concentrated supernatant for 
cytotoxicity testing. There is no possibility for using this assay directly with 
foodstuffs without isolation due to the interference from other agents, both 
microbial and nutritional in the food. 
A different procedure has been developed by Yeung et al., (2007) to detect the 
presence of pathogenic V. parahaemolyticus directly from seafood using artificially 
inoculated (spiked) oyster homogenates with approximately 5 x 108 CFU of FSL-
Y1-024 culture. The authors have reported that this assay can be used to detect 
the presence of more than 105 cells of a pathogenic V. parahaemolyticus strain in 
an oyster matrix.     
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Similar assay (cytotoxicity by measuring the amount of lactate dehydrogenase 
released from different cell lines by the CytoTox96® Non-Radioactive Cytotoxicity 
Assay kit) can be used to test the cytotoxic activity for other bacteria, for example, 
this assay has been used to test the cytotoxic activity of V. vulnificus (Kim et al., 
2003b) and to test the cytotoxic effect of phospholipase that produced from V. 
mimicus using fish cell line (Lee et al., 2002b).   
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CHAPTER 6 
RANDOMLY AMPLIFIED POLYMORPHIC DNA 
(RAPD)-PCR AND DEVELOPMENT OF A 
MULTIPLEX POLYMERASE CHAIN REACTION (M-
PCR) FOR DETECTION AND IDENTIFICATION OF 
VIRULENT AND AVIRULENT FORMS OF VIBRIO 
PARAHAEMOLYTICUS 
Results from this Chapter have been presented at Vibrio 2010,  Biloxi, 
Mississippi, USA, November 2010, and SGM Autumn Conference 2011, 
Global disease burden of enterics Display, York, September 2011, Vibrio 
2011, Santiago de Compostela, Spain, November 2011, and Centre for 
Research in Translational Biomedicine (CRTB), Plymouth University, July 
2012. The results from this chapter have also been published in European 
Journal of Clinical Microbiology and Infectious Diseases 31:431–439 
(Kadhim, et al., 2012). 
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Chapter 6: Randomly Amplified Polymorphic DNA (RAPD)-PCR and 
Development of a Multiplex Polymerase Chain Reaction (M-PCR) for 
Detection and Identification of Virulent and Avirulent Forms of Vibrio 
parahaemolyticus 
6.1 Introduction 
The distinction between virulent and avirulent strains of a species may require the 
use of molecular typing methods; for example, randomly amplified polymorphic 
DNA polymerase chain reaction (RAPD-PCR) is a technique that may be used to 
produce a unique DNA band pattern to differentiate virulent strains from avirulent 
strains. It has been used by Warner and Oliver (1999) to distinguish virulent forms 
of V. vulnificus isolates by producing a unique DNA band profile in clinical isolates, 
and it is suggested that such DNA may play a role in the virulence of this 
bacterium. Furthermore, RAPD fingerprinting was developed as a useful tool in 
distinguishing the pathogenic and non-pathogenic isolates of V. harveyi 
(Hernández and Olmos, 2004, Alavandi et al., 2006). 
RAPD uses primers under low specificity conditions to produce PCR amplicon 
(Williams et al., 1990, Welsh and Mcclelland, 1990). RAPD-PCR can generate 
various fingerprint profiles with very little template DNA and an unlimited number 
of primers (Leal et al., 2004). The primers used are simple, short and randomly 
chosen without prior knowledge of the template DNA sequence (Blixt et al., 2003). 
Arbitrary DNA sequences are used as single primers which target unspecified 
genomic sequences to generate a genetic profile, therefore it does not require any 
sequence data (Caetano-Anolles et al., 1991). Hu et al., (1995) used two primers 
in the RAPD reaction and found that the two-primer RAPD tends to produce more 
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bands and of a smaller size than the standard RAPD technique using only one 
primer.  
There are simple, validated molecular methods for identification of the species V. 
parahaemolyticus. A toxR targeted by PCR for specific detection of V. 
parahaemolyticus producing a 368 bp amplicon has been developed by Kim et al., 
(1999). Okura et al., (2003) developed a new M-PCR targeting either orf8 or toxRS 
or both simultaneously, to detect the virulent strains of V. parahaemolyticus. 
Furthermore, Tarr et al., (2007) have used M-PCR by amplifying rpoB gene to 
identify four Vibrio species yielded the species-specific amplicon to produce 
product size 897 bp for V. parahaemolyticus, 248 bp for V. cholerae, 121 bp for V. 
mimicus and 410 bp for V. vulnificus in a single reaction. Another M-PCR which 
targets the gene coding for collagenase and specifically identifies three Vibrio 
species (V. parahaemolyticus, V. alginolyticus and V. cholerae O1 and O139) has 
been developed by Di Pinto et al., (2005). Moreover, Castroverde et al., (2006) 
have demonstrated a M-PCR to detect three types of Vibrio shrimp pathogens. Bej 
et al., (1999) have developed a M-PCR to target three genes, the species specific 
marker tlh gene to identify V. parahaemolyticus and pathogenicity marker tdh and 
trh (haemolysin) genes to detect the virulent forms of V. parahaemolyticus in the 
same tube of PCR reaction.  
This chapter describes a rapid and simple method for differentiating virulent 
clinical and mainly avirulent environmental isolates of V. parahaemolyticus, which 
led in turn to the development a M-PCR that can be used to reliably identify all 
isolates of the V. parahaemolyticus species tested and detect potentially virulent 
strains, simultaneously. To achieve this, a RAPD method was used with novel sets 
of arbitrary primers to identify unique RAPD bands in known virulent isolates and 
Chapter 6 
137 
 
their sequence information was used to develop the M-PCR-based method. The 
M-PCR method presented here combines the OMP-PCR and HTP-PCR with a 
ToxR-PCR allowing the identification of potentially virulent forms of V. 
parahaemolyticus. 
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6.2 Materials and methods  
6.2.1 RAPD-PCR of V. parahaemolyticus 
RAPD analysis was performed using the DNA obtained from 55 isolates of V. 
parahaemolyticus and RAPD Analysis Beads (Amersham Biosciences) and a set 
of P1 (5’-d [GGTGCGGGAA]-3’) and P5 (5’-d [AACGCGCAAC]-3’) 10-mer primers. 
For each reaction, a bead was resuspended in a 25 µl volume containing 1 unit 
Amplitaq DNA polymerase and Stoffel fragment, 0.4 mM of each dNTP, 2.5 μg 
BSA and buffer [3 mM MgCl2, 30 mM KCl and 10 mM Tris, (pH 8.3)]. For each 
reaction 25 pmol (5μl) of the appropriate primer and DNA template (10 ng) were 
added to generate optimum banding patterns for agarose gel electrophoresis. All 
RAPD-PCR reactions were performed in a Primus 96 plus thermal cycler (MWG 
Biotech) programmed for one cycle consisting of: 95°C for 5 min and 45 cycles 
consisting of 95°C for 1 min, 36°C for 1 min and 72°C for 2 min.  
6.2.2 Screening of RAPD primers using OPK singly and in pairs. 
RAPD-PCR was performed as above but with RAPD primers OPK. Genomic DNA 
from a panel of 4 isolates of V. parahaemolyticus was screened with 9 randomly 
chosen 10-mer oligonucleotide single primers (OPK1-7, OPK12 and OPK18) and 
30 primer pairs obtained from RAPD 10-mer kits (Eurofins MWG Operon, UK) 
(Table 6.1), and used to screen for unique banding patterns. The combination of 
OPK primers (30 reactions) used is shown in Figure 6.8.  
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Table 6.1 The sequences of OPK primers used in the RAPD-PCR 
Primer Sequence  %GC 
OPK-01 
OPK-02 
OPK-03 
OPK-04 
OPK-05 
OPK-06 
OPK-07 
OPK-08 
OPK-10 
OPK-11 
OPK-12 
OPK-13 
OPK-15 
OPK-18 
5’-CATTCGAGCC-3’ 
5’-GTCTCCGCAA-3’ 
5’-CCAGCTTAGG-3’ 
5’-CCGCCCAAAC-3’ 
5’-TCTGTCGAGG-3’ 
5’-CACCTTTCCC-3’ 
5’-AGCGAGCAAG-3’ 
5’-GAACACTGGG-3’ 
5’-GTGCAACGTG-3’ 
5’-AATGCCCCAG-3’ 
5’-TGGCCCTCAC-3’ 
5’-GGTTGTACCC-3’ 
5’-CTCCTGCCAA-3’ 
5’-CCTAGTCGAG-3’ 
60% 
60% 
60% 
70% 
60% 
60% 
60% 
60% 
60% 
60% 
70% 
60% 
60% 
60% 
  
Chapter 6 
140 
 
6.2.3 PCR-OMP  
PCR primers to detect the outer membrane protein (OMP) sequence of virulent 
isolates were constructed. VPOMP1 and VPOMP2 were designed as described in 
section 2.5 and PCR was performed as described in section 2.6. PCR conditions 
started with 1 cycle of pre-denaturation at 94°C for 5 min, followed by 30 cycles of 
denaturation at 94 °C for 1 min, annealing at 60°C for 1 min, and elongation at 
70°C for 2 min. The amplification ended with a final elongation at 70 °C for 5 min. 
Next, 10 µl of amplified PCR products were electrophoresed in 2 % agarose gels 
submerged in 1x TBE buffer (pH 8), with 100 bp DNA ladder (Invitrogen, UK). Gel 
electrophoresis was performed as described in section 2.9.  
6.2.4 PCR-HTP 
PCR primers VPHTP1 and VPHTP2 were designed as described in section 2.5. 
The PCR was performed as described in section 2.6. PCR conditions were as 
follows: one cycle consisting of 94°C for 5 min, 30 cycles consisting of 94°C for 1 
min, 59°C for 1 min, and 70°C for 2 min, and a final cycle consisting of 70°C for 5 
min. The PCR products were electrophoresed as described in section 2.9.  
6.2.5 Cloning and sequencing of DNA fragment  
PCR fragments were excised and extracted from electrophoresis gel by using an 
agarose gel extraction kit (Roche Applied Science, UK) as described in section 2.7 
and the amplified PCR product was purified by using the ‘High Pure PCR Product 
Purification Kit’ (Roche Applied Science, UK) according to the manufacturers’ 
instruction as described in section 2.8 and ligated into pGEM-T Easy vector 
(Promega, UK). The ligation product was transformed into E. coli JM109 as 
described in section 2.10.1-2 and cultured on LB/ampicillin/X-Gal/IPTG as 
described in section 2.10.3. Next, recombinant plasmid DNA was isolated from 
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white colonies showing inserts using the Miniprep Plasmid DNA Extraction Kit 
(Bio-Rad, Hemel Hempstead, UK) as described in section 2.10.4 and cloning was 
verified by digestion with restriction enzyme EcoR1 to ensure that the plasmid 
contained the DNA fragment of interest, as described in section 2.10.5. The cloned 
DNA was sequenced by MWG-Biotech Ltd., Germany. Computer analysis of the 
DNA sequence data was performed via the National Centre for Biotechnology 
Information (NCBI) using GenBank databases search and BLAST programs 
(NCBI). The nucleotide sequences were submitted to GenBank (accession 
numbers JX401366 and JX401367). 
6.2.6 Sequences of PCR products 
Both strands of 200 bp purified PCR-OMP product and 300 bp purified PCR-HTP 
were sequenced by MWG Biotech. For confirmatory purposes, amplicons derived 
from three isolates were sequenced. These sequences, together with the 
nucleotide sequences of V. parahaemolyticus RIMD 2210633 were aligned using 
the online programs using software Multalin version 5.4.1 http://www-archbac.u-
psud.fr/genomics/multalin.html (Corpet, 1988) sequences were also compared 
with those from other organisms in the GenBank database using the BLAST 
program at http://blast.ncbi.nlm.nih.gov (Altschul et al., 1990). 
6.2.7 DIG-DNA labelling probe 
The PCR-OMP product from the genome of reference strain R1 was used to 
develop a digoxigenin (DIG) labelled probe. Details of all the reagents used in this 
study can be found in Appendix I. The random primed method of labelling of DNA 
probe was performed according to the Roche instruction manual ‘DIG DNA 
Labelling and Detection Kit’. The PCR product was purified using the ‘High Pure 
PCR Product Purification Kit’ and DNA was quantified using the method described 
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in section 2.4. The purified PCR product (0.5-2 µg) was added to molecular grade 
water to a final volume of 15 µl and denatured by boiling in a water bath for 10 min 
and rapidly cooling on ice. Next 2 µl of Hexanucleotide Mixture (10x), 2 µl of dNTP 
Labelling Mixture and 1 µl of Klenow enzyme were added. The tube contents were 
vortexed, centrifuged briefly and incubated at 37°C for approximately 3 h, after 
which the reaction was stopped by adding 2 µl of 0.2 M EDTA solution. 
6.2.8 Preparation of dot-blot 
A 5 µl volume containing 200 ng (40 ng/ µl) of genomic DNA was denatured by 
boiling in a water bath for 10 min and kept on ice immediately. Denatured DNA 
was spotted onto a nylon membrane. After drying the membrane, the membrane 
was placed on Whatman 3 MM- paper soaked with 10 x SSC. The spotted DNA 
was fixed to the membrane by UV-crosslinking (Chromato-Vue cabinet, Module: 
CC-60 UVP Inc) for 5 min. Membrane was rinsed briefly in molecular grade water 
and air dried. 
6.2.9 DNA-DNA Hybridisation  
A 20 ml volume of preheated DIG Easy Hyb solution (Roche) (65 °C) was used for 
a prehybridisation wash of the blot in a roller bottle for 30 min at 65 °C with gentle 
agitation using a Hybridiser HB-1D (Techne, Ltd, UK). DIG labelled DNA probe 
was denatured by boiling for 5 min and immediately cooling on ice. Denatured 
DIG- labelled DNA probe was added to a preheated (65 °C) 5 ml volume of DIG 
Easy Hyb solution at a final concentration of about 25 ng/ ml and mixed well. 
Prehybridisation solution was discarded to be replacing with the probe/DIG Easy 
Hyb mixture and incubated overnight in the roller bottles at 65 °C with gentle 
agitation using the Hybridiser. Post hybridisation stringency washes were 
performed twice in 20 ml of 2x SSC containing 0.1% SDS for 5 min at RT followed 
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by two further washes in 10 ml of prewarmed 0.5x SSC containing 0.1 SDS for 15 
min at 65°C.  
6.2.10 Immunological detection  
After stringency washes, the membrane was rinsed in Washing Buffer (Appendix I) 
for 2 min, and then incubated in 100 ml of Blocking Solution (Appendix I) for 30 
min (for blocking of unspecific binding sites on the membrane). The membrane 
was placed in a solution containing anti-digoxygenin antibody conjugated to 
alkaline phosphatase diluted 1:5000 in Blocking solution for 2 h at RT (for binding 
to the DIG-labelled probe), followed by washing the membrane twice in 100 ml of 
Washing Buffer for 15 min to remove any unbound antibody. The membrane was 
equilibrated in 20 ml Detection Buffer for 3 min, followed by incubation in 10 ml of 
Colour Substrate solution (for visualisation of antibody-binding) in the dark until a 
coloured precipitate formed. The reaction was stopped by washing the membrane 
with sterile molecular grade water. An image of the developed membrane was 
captured onto a digital camera.  
6.2.11 Multiplex PCR amplifications 
Multiplex PCR amplification was performed on genomic DNA from each of the 
isolates of V. parahaemolyticus, other Vibrio species and non-Vibrio species by 
the simultaneous addition of three primer pairs in a 50 µl reaction mixture 
consisting of 30 pmol of each of the oligonucleotide primers, 0.2 mM of each 
deoxynucleoside triphosphate, 1x reaction buffer (Appendix I), 60 ng of DNA 
template, 2 U of Taq DNA Polymerase (Roche) and the reaction volume was 
made up to 50 µl using PCR grade water. The primer pairs used in this PCR were 
as follows:  
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VPOMP1        5’-GTCACGCGGCCAAACAAAGAGA-3’ and  
VPOMP2        5’-ACCGCATATCACTGTTGGCTGGG-3’  
VPHTP1         5'-GACATCCAATCTGCACGCAAC-3' and  
VPHTP2         5'-CCTTTCGCTTCGAGCAATCA-3'  
toxR1              5’-GTCTTCTGACGCAATCGTTG-3’ and  
toxR2              5’-ATACGAGTGGTTGCTGTCATG-3’ (Kim et al., 1999).  
PCR conditions were optimised for an initial denaturation of 3 min at 94°C followed 
by 30 cycles each having denaturation for 1 min at 94°C, annealing for 1 min at 
59°C, and extension for 2 min at 72°C, and a final extension step for 5 min at 72°C. 
The verification of the M-PCR products was performed by agarose gel 
electrophoresis as described in section 2.9. 
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6.3 Results  
6.3.1 RAPD-PCR using P1 and P5 primers 
This study builds upon the initial observation by Miah (2009) that RAPD performed 
with Amersham P1 and P5 primer set produces a unique band in some isolates of 
V. parahaemolyticus. This band was named band Y. In the present study, band Y 
was commonly observed as an approximately 600 bp fragment on electrophoresis 
of PCR products produced from clinical isolates and rarely from environmental 
isolates tested (Figure 6.1).  
The 600 bp amplified DNA fragment was purified from agarose gels and cloned 
into the vector pGEM using E. coli JM109 as the host organism and then plasmid 
DNA was extracted, after blue/white screening, from white colonies. The restriction 
enzyme EcoR1 and gel electrophoresis was used to verify cloning of the fragment 
(Figure 6.2). Derived sequences of the fragment are shown in Figure 6.3. BLAST 
analysis in comparison with sequences available at GenBank and EMBL (Altschul 
et al., 1990), revealed that the 600 bp sequence of the obtained RAPD-PCR 
fragment was identical to the sequences occupying 984020 bp to 984595 bp on 
chromosome 1 of V. parahaemolyticus RIMD 2210633 DNA (accession 
no.BA000031.2). The nucleotide sequence characterised as a gene encoding a 
putative outer membrane protein, with 100% homology for V. parahaemolyticus. At 
the protein level, OMP was similar to a putative outer membrane protein from V. 
alginolyticus (accession no. ZP_01260526.1, 93 % homology), and a conserved 
hypothetical protein of V. harveyi (accession no. ZP_06175389.1, 90 % homology). 
Based on the DNA sequence of gene omp, the specific primers VPOMP1 (5’-
GTCACGCGGCCAAACAAAGAGA-3’) and VPOMP2 (5’-
ACCGCATATCACTGTTGGCTGGG-3’) were developed. Using this primer pair, 
PCR was performed on genomic DNAs of a collection of 55 V. parahaemolyticus 
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isolates, together with 22 isolates of various other Vibrio species and five isolates 
of non-Vibrio. The expected 200 bp product was found in the 21 out of 23 clinical 
isolates of V. parahaemolyticus, including NCIMB reference strain R1 from clinical 
source and only 1 out of 32 environmental isolates. No band was seen with any of 
the other Vibrio and non-Vibrio species tested (Figure 6.4).  
The nucleotide sequence analysis confirmed the identity of PCR products. Multiple 
sequence alignments from three isolates have been analysed. The sequences of 
the three isolates showed two single nucleotide polymorphisms (SNPs) appeared 
at the third base of their codon. The SNPs do not translate into a different amino 
acid (Figure 6.5).  
The presence of the omp sequence was confirmed by DNA hybridisation. DIG 
labelled probe that developed from the specific PCR product of reference strain R1 
was hybridised successfully to most of the DNA samples from clinical forms and 
only to a few environmental isolates (Figure 6.6). The hybridisation results were 
compared with results of PCR, in all cases confirmed the PCR product results 
(Table 6.2). Very weak signals in dot blot analysis (even after repeat testing) were 
obtained with four environmental (E24, E30, E18 and E28) isolates that did not 
show any OMP-PCR amplicon. Additionally, one clinical isolate (C1) and three 
environmental (E20, E16 and E3) isolates that were shown to be positive by dot 
blot analysis but by PCR appeared negative. Other species yielded negative 
results (no hybridisation signals).  
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6.3.2 RAPD-PCR using OPK primers 
Initially, V. parahaemolyticus genomic DNA from two highly cytotoxic clinical 
isolates (C8 and C15) and two low cytotoxicity environmental isolates (E2 and E22) 
were screened with nine single primers OPK1-7, OPK12 and OPK18 in RAPD-
PCR reactions. These primers failed to produce unique bands to differentiate the 
test clinical and environmental isolates of V. parahaemolyticus (Figure 6.7). 
However, when 30 different OPK primer pairs were used with the same selected 
isolates, one pair OPK13 +15 produced a unique band with the clinical isolates 
(Figure 6.8). This amplicon was named band Z. When the OPK13+15 primer set 
was used on the complete collection of V. parahaemolyticus isolates, it was found 
that a unique band of approx. 310 bp was produced by the majority of clinical 
isolates, but not by the vast majority of environmental forms (Figure 6.9). The 
commercial kit of standardised Ready to Go beads were used to avoid pipetting 
steps and all ingredients for reactions, guaranteeing equal amounts and 
concentration. Patterns generated by this RAPD-PCR were reproducible in assays 
on different occasions; a comparison of repeat RAPD-PCR showed that band Z 
(indicated by arrows in Figure 6.10) was present in all repeated experiments. 
However, the band was present with variable intensity. 
The DNA from band Z was isolated and ligated into pGEM-T Easy vector and 
transformed into E. coli JM109. After blue/white screening, recombinant plasmid 
DNA was extracted from selected white colonies. Restriction enzyme analysis was 
used to verify the presence of expected size inserts within the clones (Figure 6.11) 
and selected recombinant plasmids were sequenced. BLAST analysis and 
comparison with the genome of V. parahaemolyticus RIMD 2210633 DNA 
(accession no.BA000031.2) showed identity with a 312 bp segment from base 
pairs 1812453 to 1812764 on chromosome 1. The nucleotide sequence was 
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analysed and found to be from a gene encoding a hypothetical protein (htp). The 
sequence of the 312 bp band Z was identical to the htp gene from V. 
parahaemolyticus. At the protein level, HTP was similar to proteins from V. 
alginolyticus (accession no. ZP_01259705.1, 62% homology), and V. harveyi 
(accession no. YP_001444888.1, 39% homology).  
Based on the DNA sequence of gene htp the specific primers VPHTP1 (5'-
GACATCCAATCTGCACGCAAC-3') and VPHTP2 (5'-
CCTTTCGCTTCGAGCAATCA-3') were developed (Figure 6.12). PCR was 
performed using this primer pair on genomic DNA of V. parahaemolyticus isolates, 
other Vibrio species and non-Vibrio species. The expected 300 bp product was 
produced by 19 out of 23 (82.6%) clinical isolates of V. parahaemolyticus, 
including clinical NCIMB reference strain R1 and only 2 out of 32 (6.25 %) 
environmental isolates (Figure 6.13). No band was seen with any of the other 
Vibrio and non-Vibrio species tested. 
The nucleotide sequence analysis confirmed the identity of PCR products. Multiple 
sequence alignments from three isolates have been analysis. The sequences of 
the three isolates showed five single nucleotide polymorphisms (SNPs) appearing 
at the third base of their codon. The SNPs do not translate into a different amino 
acid (Figure 6.14).  
In support of the PCR results, dot blot hybridisation confirmed the presence or 
absence of htp. All isolates that were positive in PCR were positive in dot blot 
analysis (Table 6.2). An additional two clinical (C6 and C9) and four environmental 
isolates (E28, E7, E9 and E16) were identified as possessing a htp gene 
sequence by dot blot hybridisation but not by PCR. Other species gave negative 
signals in dot blot analysis (Figure 6.15). 
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6.3.3 Multiplex PCR  
This M-PCR reliably identified all V. parahaemolyticus isolates tested and 
distinguished between known virulent and avirulent strains simultaneously (Figure 
6.16). The amplification of the species-specific toxR gene 367 bp segment was 
found in all V. parahaemolyticus isolates tested here. Out of 23 clinical isolates 
tested, 23 (100%) showed the presence of either omp or htp or both. Of these 17 
(73.91%) showed amplification of both omp and htp target sequences. Four 
clinical isolates (17.39%) showed amplification of the omp gene, but not the htp 
gene, whilst two clinical isolates (8.69%) exhibited amplification of htp but not omp. 
This showed that most clinical V. parahaemolyticus isolates contained both genes. 
But both omp and htp need to be targeted in PCR tests to detect all known virulent 
strains tested. Out of 32 environmental isolates none contained both omp and htp, 
Only 3 out of 32 (9.37%) environmental isolates showed amplification for either 
omp (1 = 3.12%) or htp (2 = 6.25%) genes. No amplification of omp or htp 
sequences was seen in other Vibrio species or non-Vibrio species tested.  
As described in Chapter 5, V. parahaemolyticus isolates were tested for 
cytotoxicity to the human Caco-2 and CHO-K1 cell lines and isolates that were 
positive for omp were strongly associated with cytotoxicity. It should be noted that 
isolates carrying htp were also associated with cytotoxicity (Table 6.3). 
A blind test was performed on a randomly chosen collection of isolates including 
known clinical, environmental (avirulent) and other species relabelled by Dr. 
Martyn Gilpin. The blind test successfully identified isolates tested with regards to 
whether they were V. parahaemolyticus or not, and whether they were likely to be 
virulent or avirulent (Figure 6.17).  
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Figure 6.1 RAPD-PCR fragment patterns for genomic DNAs of clinical and 
environmental V. parahaemolyticus strains with primer pair P1 and P5. 
Lanes 1, negative control; 2, E coli BL21 (control DNA); 3, C2; 4, C4; 5, C5; 6, C7; 7, C8; 
8, E16; 9, E22; Lane M, molecular size marker (100 bp DNA Ladder). Arrowhead indicates 
approximately 600-bp fragments commonly found in the virulent strains.  
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a)  
 
 
 
 
b)  
 
Figure 6.2 Agarose gel electrophoresis: (a) Recombinant E. coli plasmid 
after extraction; Lanes 1-4 plasmid extracted from blue colonies (non-
recombinant); Lanes 5-8 plasmid extracted from white colonies (clones); (b) 
Restriction enzyme analysis to verify the presence of expected size inserts 
(band Y) within the plasmid of clones. M, 100bp; Lanes 1-4, non-
recombinant; 5, C2, 6; C2; 7, C8; 8, C8. 
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> dbj|BA000031.2|  Vibrio parahaemolyticus RIMD 2210633 DNA, chromosome 1, 
complete sequence 
Length=3288558 
Features in this part of subject sequence: 
putative outer membrane protein 
Score = 1134 bits (614), Expect = 0.0  
Identities = 617/617 (100%), Gaps = 0/617 (0%) 
Strand=Plus/Plus 
 
Query  94      CGCGCAACCAGATATCTTTACTCATATCCCAATGAACTCCAGCTCCTACGTTAAACAGTG  153 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984112  CGCGCAACCAGATATCTTTACTCATATCCCAATGAACTCCAGCTCCTACGTTAAACAGTG  984171 
 
Query  154     CGCCAGAGTCGTCAGTCACTTTCTGGGCATTTGGAACATACATTTCTGCTTGAGTCCCCA  213 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984172  CGCCAGAGTCGTCAGTCACTTTCTGGGCATTTGGAACATACATTTCTGCTTGAGTCCCCA  984231 
 
Query  214     AAGCGGTCACGCGGCCAAACAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATA  273 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984232  AAGCGGTCACGCGGCCAAACAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATA  984291 
 
Query  274     CCGCTGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTTTAGCGTGTCGTTCT  333 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984292  CCGCTGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTTTAGCGTGTCGTTCT  984351 
 
Query  334     TAAGCTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAAT  393 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984352  TAAGCTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAAT  984411 
 
Query  394     AGCCCCAGCCAACAGTGATATGCGGTGTGGACCACTCATTGTCTCTGTCTGATCCAAAAT  453 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984412  AGCCCCAGCCAACAGTGATATGCGGTGTGGACCACTCATTGTCTCTGTCTGATCCAAAAT  984471 
 
Query  454     ACGGCGTATCGAAACCAACGTTACCAGTACCCAGATAAAAATAAGATTGATGAGTTTGTT  513 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984472  ACGGCGTATCGAAACCAACGTTACCAGTACCCAGATAAAAATAAGATTGATGAGTTTGTT  984531 
 
Query  514     CTTGAGCAGCAAAAGTCGGCACACTGATGGTCAAGGCAGACAATAATAGGATGGCGTTTT  573 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984532  CTTGAGCAGCAAAAGTCGGCACACTGATGGTCAAGGCAGACAATAATAGGATGGCGTTTT  984591 
 
Query  574     TCATAACTTGACGATAACCTTTGTAAAAGACCGTTGTAATGATTTGTGTTAATATTAATT  633 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984592  TCATAACTTGACGATAACCTTTGTAAAAGACCGTTGTAATGATTTGTGTTAATATTAATT  984651 
 
Query  634     TAATCAATAAGATAGATGGTGCTTATCATATCAGTTTTTGTTCAAAGGTAGTGATTTTCG  693 
               |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  984652  TAATCAATAAGATAGATGGTGCTTATCATATCAGTTTTTGTTCAAAGGTAGTGATTTTCG  984711 
 
Query  694     AGTGGGAATTGTTGCGC  710 
               ||||||||||||||||| 
Sbjct  984712  AGTGGGAATTGTTGCGC  984728 
/translation="MKNAILLLSALTISVPTFAAQEQTHQSYFYLGTGNVGFDTPYFG 
SDRDNEWSTPHITVGWGYYVNQYLAFEGVLRYSQNELKNDTLKTDLDLHYYQAGMSAV 
LTSDNLGDTPLSLFGRVTALGTQAEMYVPNAQKVTDDSGALFNVGAGVHWDMSKDIWL 
RAEYIYNVADMGFEDFYDSYEGLQISLGKRF". Predicting of the molecular weight of the 
protein sequence is 21.45 kDa. 
Showing 576 bp region from base 984020 to 984595 
ORIGIN       
        1 ctagaagcgt tttcctaagc ttatttgtag accttcatag ctgtcgtaaa agtcttcaaa 
       61 acccatatct gcgacattgt agatgtactc tgcgcgcaac cagatatctt tactcatatc 
      121 ccaatgaact ccagctccta cgttaaacag tgcgccagag tcgtcagtca ctttctgggc 
      181 atttggaaca tacatttctg cttgagtccc caaagcggtc acgcggccaa acaaagagag 
      241 tggtgtgtcg cctaagttgt cactggtcaa taccgctgac atgcctgctt ggtaatagtg 
      301 caaatccaaa tctgttttta gcgtgtcgtt cttaagctcg ttttgggagt aacgaagcac 
      361 accttcaaac gcaaggtatt gattaacata atagccccag ccaacagtga tatgcggtgt 
      421 ggaccactca ttgtctctgt ctgatccaaa atacggcgta tcgaaaccaa cgttaccagt 
      481 acccagataa aaataagatt gatgagtttg ttcttgagca gcaaaagtcg gcacactgat 
      541 ggtcaaggca gacaataata ggatggcgtt tttcat 
 
Figure 6.3 Nucleotide sequences of the gene omp identified in RAPD-PCR of 
clinical V. parahaemolyticus product.  
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Figure 6.4 Agarose gel electrophoresis of PCR amplified products using 
virulence-specific primers, VPOMP1 and VPOMP2. 
Lanes M, 100-bp molecular mass marker. (a) Lane 1, negative control; Lanes 2-12 clinical 
V. parahaemolyticus as follow (2, C4; 3, C5; 4, C6; 5, C7; 6, C8; 7, C12; 8, C15; 9, C16; 
10, C17; 11, C18; 12, C22); Lane 13, NCIMB Reference strain (R1); Lane 14, NCTC 
Reference strain (R2); Lanes 15-28 environmental V. parahaemolyticus as follow (15, E31; 
16, E2; 17, E3; 18, E6; 19, E7; 20, E8; 21, E5; 22, E10; 23, E20; 24, E13; 25, E15; 26, 
E12; 27, E14; 28, E11). (b) Lanes 1-9 clinical as follow (1, C9; 2, C11; 3, C13; 4, C14; 5, 
C21; 6, C20; 7, C19; 8, C10; 9, C1); Lane10, negative control; Lanes (11-28) 
environmental V. parahaemolyticus as follow (11, E1; 12, E4; 13, E6; 14, E16; 15, E17; 16, 
E18; 17, E19; 18, E21; 19, E22; 20, E23; 21, E24; 22, E27; 23, E30; 24, E29; 25, E28; 26, 
E26; 27, E25; 28, E9). (c) Lanes 1- 2 clinical isolates as follow (1, C2; 2, C3); Lanes 3-24 
Vibrio species as follow (3, VC; 4, VM; 5-10, VA1-VA6; 11-16, VA1-VA6; 17-21, VH1-VH5; 
22-23, VN1-VN2; 24, VS; 25, negative control; Lanes, 26-30 non-Vibrio.  
M  1    2   3   4   5   6   7   8   9  10  11 12  13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 M 
a 
600 bp 
2072 bp 
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 M  1   2   3   4   5   6    7  8  9  10  11  12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 M 
b 
200 bp 
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c 
M    1     2   3   4   5  6  7 8  9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 M   26 27 28 29 30  M 
c 
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                      1                       10                         20                          30                          40                          50                          60 
                   +--------+---------+---------+---------+---------+---------+  
RIMD 2210633       GGTCACGCGGCCAAACAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATACCGC 
R1                 --TCACGCGGCCAAACAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATACCGC 
C15                ---CACGCGGCCAAGCAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATACCGC 
E9                 ---CACGCGGCCAAACAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATACCGC 
CONSENSUS          ggtcACGCGGCCAAaCAAAGAGAGTGGTGTGTCGCCTAAGTTGTCACTGGTCAATACCGC 
                      *********** ********************************************* 
           
                     61                       70                         80                          90                         100                        110                       120 
                   +--------+---------+---------+---------+---------+---------+ 
RIMD 2210633       TGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTTTAGCGTGTCGTTCTTAAG 
R1                 TGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTTTAGCGTGTCGTTCTTAAG 
C15                TGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTCTAGCGTGTCGTTCTTAAG 
E9                 TGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTCTAGCGTGTCGTTCTTAAG 
CONSENSUS          TGACATGCCTGCTTGGTAATAGTGCAAATCCAAATCTGTTTtTAGCGTGTCGTTCTTAAG 
                   ***************************************** ****************** 
 
                     121                     130                       140                       150                        160                       170                       180 
                   +--------+---------+---------+---------+---------+---------+ 
RIMD 2210633       CTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAATAGCC 
R1                 CTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAATAGCC 
C15                CTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAATAGCC 
E9                 CTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAATAGCC 
CONSENSUS          CTCGTTTTGGGAGTAACGAAGCACACCTTCAAACGCAAGGTATTGATTAACATAATAGCC 
                   ************************************************************ 
 
                     181                    190                       200          206                   
                   +--------+---------+-----+ 
RIMD 2210633       CCAGCCAACAGTGATATGCGGT   
R1                 CCAGCCAACAGTGATATGCGGTA   
C15                CCAGCCAACAGTGATATGCG--  
E9                 CCAGCCAACAGTGATATGCGGTATAA   
CONSENSUS          CCAGCCAACAGTGATATGCGgt  
                                         ********************    
 
 
Figure 6.5 Alignment of the OMP sequence in isolates of V. 
parahaemolyticus RIMD 2210633 is a sequenced clinical strain under 
accession number BA000031.2.  
Sequences E9 and C15 are from environmental and clinical isolates respectively and R1 
is NCTC reference strain. Consensus regions are shown in red and denoted by asterisk; 
black and blue show deletions or substitutions. 
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Figure 6.6 Dot blot hybridisation of V. parahaemolyticus isolates and other 
species with Probe targeted OMP. 
 
  
R1             C2             C3               C4           C5         C6 
C17           C18             C9             C11        C12      C13 
C14           C15            C20            E1           E2         E10 
E24           E30           E18           E28            E4          E5 
C19           C16           C21              C22         E31         E29 
E27           E21            E26              E22         E23           E9 
 E3             E25            R2               E11         E15           E7 
VH2            VV1           VN             VS          VH1 
C1            C7            C8             C10         E12 
E6             E8            E16            E13        E14 
E20           E19          E17            VC         VM 
 VV2           VV3         VA1            VA2       VA3 
Chapter 6 
156 
 
Table 6.2 Vibrio parahaemolyticus isolates tested shown results of PCR and 
dot blot 
Strain 
 
Type and source  
(where known) 
              Omp(200bp) 
 
htp (300bp) 
 
  PCR product    Dot blot  PCR product            Dot blot 
R1 Clinical, NCIMB Reference 
Strain, UK 
+ +  + + 
C1 Clinical, Norway - +  + + 
C2 Clinical, Norway + +  + + 
C3 Clinical, Norway + +  + + 
C4 Clinical, Norway + +  + + 
C5 Clinical, Norway + +  + + 
C6 Clinical, Norway + +  - + 
C7 Clinical, Norway + +  + + 
C8 Clinical, Norway + +  + + 
C9 Clinical, Norway + +  - + 
C10 Clinical, Norway - -  + + 
C11 Clinical, Japan + +  + + 
C12 Clinical, Japan + +  + + 
C13 Clinical, Japan + +  + + 
C14 Clinical, Japan + +  + + 
C15 Clinical, UK + +  + + 
C16 Clinical, Spain + +  + + 
C17 Clinical, Spain + +  + + 
C18 Clinical, Spain + +  + + 
C19 Clinical, Spain + +  + + 
C20 Clinical, Spain + +  + + 
C21 Clinical, Italy + +  - - 
C22 Clinical, UK + +  - - 
R2 Environmental, NCTC 
Reference Strain, UK 
- -  - - 
E1 Environmental, Spain - -  - - 
E2 Environmental, Spain - -  - - 
E3 Environmental, Spain  - +  + + 
E4 Environmental, Spain - -  - - 
E5 Environmental, Spain - -  - - 
E6 Environmental, Spain - -  - - 
E7 Environmental, UK - -  - + 
E8 Environmental, UK - -  - - 
E9 Environmental, UK + +  - + 
E10 Environmental, UK - -  - - 
E11 Environmental, UK - -  - - 
E12 Environmental, UK - -  - - 
E13 Environmental, UK - -  - - 
E14 Environmental, UK - -  - - 
E15 Environmental, UK - -  - - 
E16 Environmental, UK - +  - + 
E17 Environmental, UK  - -  - - 
E18 Environmental, UK - (+/-)  - - 
E19 Environmental, UK  - -  - - 
E20 Environmental, UK  - +  + + 
E21 Environmental, UK  - -  - - 
E22 Environmental, UK  - -  - - 
E23 Environmental, UK  - -  - - 
E24 Environmental, UK  - (+/-)  - - 
E25 Environmental, UK  - -  - - 
E26 Environmental, UK  - -  - - 
E27 Environmental, Portugal - -  - - 
E28 Environmental, Portugal - (+/-)  - + 
E29 Environmental, UK - -  - - 
E30 Environmental, UK - (+/-)  - - 
E31 Environmental, UK - -  - - 
+, Positive; -, negative; (+/-), very week 
  
Chapter 6 
157 
 
 
 
 
 
 
 
 
Figure 6.7 Agarose gel electrophoresis of RAPD-PCR: (a and b) RAPD single 
primer (OPK) screening of clinical isolates (C8 and C15) and environmental 
isolates (E2 and E22), Lanes M, 1Kb and 100bp Ladders. 
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Figure 6.8 Agarose gel electrophoresis of RAPD-PCR: (a-f) RAPD double 
primer screening of clinical isolates (C15 and C8) and environmental isolates 
(E2 and E22), Lanes M, 1Kb and 100bp Ladders. 
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Figure 6.8 continued  
 
OPK5+18 
 
OPK6+7 
 
OPK3+18 
 
OPK3+7 
 
OPK3+5 
 
      C   C   E   E   C   C  E   E  C   C  E   E   C   C  E   E   C  C  E  E   
M   1    2   3   4    5   6   7   8   9  10  11 12 13 14  15 16 17 18 19 20  M 
 
OPK7+18 
 
OPK6+18 
 
OPK5+7 
 
OPK5+6 
 
OPK2+6 
 
       C  C   E   E    C   C   E  E   C  C   E   E   C   C  E    E   C  C  E   E   
M   1    2   3    4    5   6   7    8   9  10  11  12 13 14  15  16 17 18 19 20  M 
c 
d 
Chapter 6 
160 
 
 
 
 
 
 
 
 
 
                          
Figure 6.8 continued  
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Figure 6.9 RAPD-PCR fragment patterns for genomic DNAs of clinical and 
environmental V. parahaemolyticus isolate with primer pair OPK13 and 
OPK15.  
(a) Lane1 to 16 correspond to the following isolates: 1; NCIMB reference strain R1, 2; 
C16,3; C18, 4; C19, 5; C22, 6; E26,7; E5, 8; E27, 9; E29, 10; E30, 11; E31, 12; E1, 13; 
E6,14; E3, 15; E12, 16; E13, 17, no primer control, 18, no template control; 19, E. coli 
BL21; 20, E. coli Cla. (b) Lanes1 to 20 correspond to the following isolates:- R2; 2, C2; 
3,C4; 4, C5; 5,C7; 6, C10; 7, C14; 8, C11; 9, C3; 10, C12; 11, C1; 12, C9; 13, C13; 14, 
C21; 15, C17; 16, C6; 17, C20; 18, control without template. (c) Lanes1 to 20 correspond 
to the following isolates:-  1, R1; 2, E10; 3, E14; 4, E16; 5, E19; 6, E11; 7, E23; 8, E9; 9, 
E28; 10, E20; 11, E15; 12, E4; 13, E24; 14, E17; 15, E8; 16, E25; 17, E18, 18, E7; 19, 
E21; 20, control without template; Lanes M, 100 bp ladders with the sizes of selected 
markers indicated by the arrows. 
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Figure 6.9 continued  
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   C17                                                                            C13 
 
                                                                          
C1                                                                            C12 
 
Figure 6.10 Reproducibility of RAPD fingerprinting profiles in 17 isolates of 
V. parahaemolyticus. Reference arrow on the left shows the position of an 
approximately 310 bp amplicon (band Z). 
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Figure 6.10 continued  
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Figure 6.10 continued  
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Figure 6.10 continued  
 
 
 
Chapter 6 
167 
 
 
 
a)  
 
 
 
                                                 M   1   2   3   4   5   6 
b)  
 
Figure 6.11 Agarose gel electrophoresis: (a) Recombinant E. coli plasmid 
after extraction; M,1Kbp; Lanes 1-4 plasmid extracted from white colonies 
(clones); Lanes 5-6 plasmid extracted from blue colonies (non-recombinant); 
(b) Restriction enzyme analysis to verify the presence of expected size 
inserts (band Z) within the plasmid of clones. M, 100bp; Lane 1, C2; 2, C2; 3, 
C5; 4, C5; 5-6, non-recombinant. 
  
Insert 
(band Z) 
 
M  1  2   3  4  5  6  
Vector 
 
3054 bp 
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dbj|BA000031.2|  Vibrio parahaemolyticus RIMD 2210633 DNA, chromosome 1, complete 
sequence Length=3288558 
 
 Features in this part of subject sequence: 
   hypothetical protein 
 
 Score =  568 bits (307), Expect = 0.0   
 Identities = 307/307 (100%), Gaps = 0/307 (0%) 
 Strand=Plus/Plus 
 
Query  62       TCTAATGACATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAA  121 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1812456  TCTAATGACATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAA  1812515 
 
Query  122      CAACGTGAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCTTACTCTCTTCA  181 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1812516  CAACGTGAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCTTACTCTCTTCA  1812575 
 
Query  182      TCAGAAAACAAACAGGCACGCATGAGCTCAAAGCGAGAACTAAGCGAATGTTTAAACCAG  241 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1812576  TCAGAAAACAAACAGGCACGCATGAGCTCAAAGCGAGAACTAAGCGAATGTTTAAACCAG  1812635 
 
Query  242      TTCGCGAGCCTTGAATCTTGCAATCAAGTCTTGGATTTTGAAAAGCCAACTGGATTTGAG  301 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1812636  TTCGCGAGCCTTGAATCTTGCAATCAAGTCTTGGATTTTGAAAAGCCAACTGGATTTGAG  1812695 
 
Query  302      AAGCAAAGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGC  361 
                |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1812696  AAGCAAAGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGC  1812755 
 
Query  362      GAAAGGT  368 
                ||||||| 
Sbjct  1812756  GAAAGGT  1812762 
 
/translation="MSNDIQSARNSQPIHGLEQVEQRELAPQGTFQGRKVTLLSSSEN 
KQARMSSKRELSECLNQFASLESCNQVLDFEKPTGFEKQSAAIEKLFERKIDVIARSER". Predicting of the 
molecular weight of the protein sequence is 11.69 kDa. 
 
 
Showing 312 bp region from base 1812453 to 1812764 
ORIGIN       
        1 atgtctaatg acatccaatc tgcacgcaac agccaaccca ttcacggatt ggagcaagta 
       61 gaacaacgtg aacttgcgcc acaaggaacg tttcaaggtc gcaaagtgac cttactctct 
      121 tcatcagaaa acaaacaggc acgcatgagc tcaaagcgag aactaagcga atgtttaaac 
      181 cagttcgcga gccttgaatc ttgcaatcaa gtcttggatt ttgaaaagcc aactggattt 
      241 gagaagcaaa gcgctgctat cgaaaagctt tttgagcgaa agatagatgt gattgctcga 
      301 agcgaaaggt aa 
 
Figure 6.12 Nucleotide sequence of clinical V. parahaemolyticus isolate that 
produced band Z. 
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Figure 6.13 Agarose gel electrophoresis of PCR amplified products using 
virulent specific primers, VPHTP1 and VPHTP2. 
Lanes M, 100-bp molecular mass marker; (a) Lane 1, negative control; Lanes 2-12 clinical V. 
parahaemolyticus as follow (2, C3; 3, C4; 4, C5; 5, C1; 6, C9; 7, C2; 8, C6; 9, C11; 10, C7; 11, C10; 
12, C8); Lanes 13-28 environmental V. parahaemolyticus as follow (13, R2; 14, E4; 15, E1; 16, E2; 
17, E3; 18, E6; 19, E7; 20, E8; 21, E5; 22, E10; 23, E9; 24, E13; 25, E15; 26, E12; 27, E14; 28, 
E11). (b) Lane1, negative control; Lanes 2-12 clinical as follow (2, C12; 3, C15; 4, C16; 5, C18; 6, 
C20; 7, C21; 8, C17; 9, C19; 10, C14; 11, C13; 12, C22); Lanes (13-27) environmental V. 
parahaemolyticus as follow (13, E18; 14, E19; 15, E23; 16, E24; 17, E29; 18, E30; 19, E16; 20, 
E17; 21, E25; 22, E26; 23, E31; 24, E28; 25, E27; 26, E22; 27, E21); Lane 28, V. cholerae. (c) 
Lane 1, negative control; 2, NCIMB Reference strain (R1); Lane 3, environmental isolate (E20); 
Lanes 4-28 Vibrio species and non-Vibrio as folow: (4, VM; 5-9, VA1-VA5; 10-11, VN1-VN2; 12, VS; 
13-18, VA1-VA6; 19-23, VH1-VH5; 24-25, Aeromonas; 26, E. coli; 27, K. pneumoniae; 28, 
Pro.vulgaris.   
a 
b 
c 
M   1    2   3   4   5   6   7    8   9  10  11 12 13 14 15 16  17 18 19 20 21 22 23 24 25 26 27 28  M 
M   1   2   3    4   5   6   7    8   9  10  11  12 13 14 15 16  17 18 19 20 21 22 23 24 25 26 27 28  M 
 M   1   2   3    4   5    6    7    8   9  10  11  12 13 14 15 16  17 18 19 20 21 22 23 24 25 26 27 28  M 
2072 
300 
100 
600 
300 
600 
600 
300 
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                                                         1                       10                         20                          30                          40                          50                          60 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210633       GACATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAACAACGT 
R1                   CATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAACAACGT 
C16                  CATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAGCAACGT 
C9                   -ATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAACAACGT 
CONSENSUS            cATCCAATCTGCACGCAACAGCCAACCCATTCACGGATTGGAGCAAGTAGAaCAACGT 
                      ************************************************** ****** 
 
                                                         61                      70                         80                          90                         100                        110                       120 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210633       GAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCTTACTCTCTTCATCAGAA 
R1                 GAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCTTACTCTCTTCATCAGAA 
C16                GAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCCTACTCTCTTCATCAGAA 
C9                 GAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCTTACTCTCTTCATCAGAA 
CONSENSUS          GAACTTGCGCCACAAGGAACGTTTCAAGGTCGCAAAGTGACCtTACTCTCTTCATCAGAA 
                   ****************************************** ***************** 
 
                                                        121                     130                      140                        150                       160                        170                       180 
                                                         +--------+---------+---------+---------+---------+---------+ 
 
RIMD 2210633       AACAAACAGGCACGCATGAGCTCAAAGCGAGAACTAAGCGAATGTTTAAACCAGTTCGCG 
R1                 AACAAACAGGCACGCATGAGCTCAAAGCGAGAACTAAGCGAATGTTTAAACCAGTTCGCG 
C16                AACAAACAGGCACGCATGAGCTCAAAGCGAGAACTGAGCGAATGTTTAAACCAGTTCGCG 
C8                 AACAAACAGGCACGCATGAGCTCAAAGCGAGAACTAAGCGAATGTTTAAACCAGTTCGCG 
CONSENSUS          AACAAACAGGCACGCATGAGCTCAAAGCGAGAACTaAGCGAATGTTTAAACCAGTTCGCG 
                   *********************************** ************************ 
                                                         
                                                        181                    190                      200                        210                       220                        230                       240 
                                                         +--------+---------+---------+---------+---------+---------+ 
 
RIMD 2210633       AGCCTTGAATCTTGCAATCAAGTCTTGGATTTTGAAAAGCCAACTGGATTTGAGAAGCAA 
R1                 AGCCTTGAATCTTGCAATCAAGTCTTGGATTTTGAAAAGCCAACTGGATTTGAGAAGCAA 
C16                AGCCTTGAATCGTGCAATCAAGTGTTGGATTTTGAAAAGCCAACTGGATTTGAGAAGCAA 
C8                 AGCCTTGAATCTTGCAATCAAGTCTTGGATTTTGAAAAGCCAACTGGATTTGAGAAGCAA 
CONSENSUS          AGCCTTGAATCtTGCAATCAAGTcTTGGATTTTGAAAAGCCAACTGGATTTGAGAAGCAA 
                   *********** *********** ************************************ 
 
                                                        241                   250                      260                        270                       280                        290                       300 
                                                         +--------+---------+---------+---------+---------+---------+ 
RIMD 2210633       AGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGCGAAAGG 
R1                 AGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGCGAAAG 
C16                AGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGCGAAA- 
C8                 AGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGCGAAAG 
CONSENSUS          AGCGCTGCTATCGAAAAGCTTTTTGAGCGAAAGATAGATGTGATTGCTCGAAGCGAAAg 
                   **********************************************************  
 
 
Figure 6.14 Alignment of the HTP sequence in isolates of V. 
parahaemolyticus. RIMD 2210633 is a sequenced clinical strain under 
accession number BA000031.2.  
Sequences C16 and C8 are from clinical isolate and R1 is an NCTC reference strain. 
Consensus regions are shown in red and denoted by asterisk; black and blue show 
deletions or substitutions. 
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Figure 6.15 Hybridisation signals of V. parahaemolyticus isolates and other 
species with probe targeted HTP. 
  
C12                C13                C14                C11                     E6 
E30                E10                E19                 E17                     E7 
E9                 E28                E21                 E16                      E8 
VC                VM                 VV1                VV2                    VV3 
  R1                R2                 C5                C6              C1              C2          
  C3                C4                E26               E11              C7              C8          
 C22              C21              E12                 E13             E14          E15          
  C9               E1                 E5                  E4                E2             E3          
  C10               C15               C16              C17            C18             C19         
  C20                E23                E24              E22             E25            E27         
  E18              E31                 E20              E29             VH1            VH2         
  VS               VN                 VA1              VA2            VA3             VH3 
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Figure 6.16 Agarose gel electrophoresis of multiplex PCR amplified products 
using three primer pairs.  
Lanes M, 100-bp molecular mass marker. (a) Lane 1, control negative; 2-10 clinical isolates(2, R1; 3, C9; 4, 
C1; 5, C10; 6, C21; 7, C22; 8, C7; 9, C18; 10, C2); 11-20 environmental isolates (11, E9; 12, E3; 13, E1; 14, 
E2; 15, E10; 16, E30; 17, E31; 18, E4; 19, E5; 20, E8). (b) Lane 1, control negative; Lanes, 2-12 clinical 
isolates (2, C20; 3, C19; 4, C11; 5, C12; 6, C13; 7, C14; 8, C17; 9, C16; 10, C3; 11, C4; 12, C5);Lanes, 13-28 
environmental isolates (13, E11; 14, E12; 15, E16; 16, E21; 17, E22; 18, E23; 19, E24; 20, E25; 21, E26; 22, 
E27; 23, E28; 24, E29; 25, R2; 26, E13; 27, E14; 28, E15). (c) Lane 1, control negative; Lanes 2-3 clinical 
isolates (2, C8, 3, C6); Lanes 4-9 environmental isolates (4, E20; 5, E19; 6, E18; 7, E17; 8, E6; 9, E7) lanes 
10-20, other Vibrio species (10, VC; 11, VM; 12-17, VV1-VV6; 18-19, VN1-VN2; 20, VS. (d) Lane 1, control 
negative without template DNA; 2,clinical isolate (C15); 3-13 other Vibrio species (lanes, 3-8, VA1-VA6; 9-13, 
VH1-VH5).; 14-17 Aeromonas; 18-24 non Vibrio (lanes 18-19, Pf1-2; 20, St; 21, Pv; 22, Kp; 23-24, Ec1-Ec2); 
25, control negative without primers. 
M   1   2    3   4   5   6    7   8   9  10  11 12 13 14 15 16  17 18 19 20  M 
300 bp 
600 bp 
2072 bp 
a 
M  1   2   3   4   5   6   7   8  9  10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 M 
b 
M   1   2    3   4   5    6    7   8   9  10 11 12 13 14 15 16 17 18 19 20  M 
c 
M   1   2     3   4    5    6    7    8   9   10  11 12  13 14 15   M      16 17 18 19 20 21 22 23 24 25   M 
d 
367 bp 
300 bp 
200 bp 
300 bp 
600 bp 
100 bp 
600 bp 
300 bp 
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Table 6.3 List of Vibrio parahaemolyticus isolates tested in this study and 
results of multiplex PCR 
Strain 
 
Type and source  
(where known) 
                          PCR product  
 
Percentage of  
Cytotoxicity % 
toxR(367bp) Omp(200bp) htp(300bp) Caco-2           Cho-k1 
R1 Clinical, NCIMB Reference Strain, UK + + +  60.0 H
1
 62.0 H 
C1 Clinical, Norway + - +  40.0 M
2
 45.7 M 
C2 Clinical, Norway + + +  85.0 H 71.9 H 
C3 Clinical, Norway + + +  81.0 H 62.7 H 
C4 Clinical, Norway + + +  83.5 H 67.0 H 
C5 Clinical, Norway + + +  84.0 H 67.0 H 
C6 Clinical, Norway + + -  71.0 H 61.0 H 
C7 Clinical, Norway + + +  72.0 H 62.5 H 
C8 Clinical, Norway + + +  82.0 H 63.0 H 
C9 Clinical, Norway + + -  74.5 H 55.0 H 
C10 Clinical, Norway + - +  42.0 M 47.0 M 
C11 Clinical, Japan + + +  83.6 H 66.6 H 
C12 Clinical, Japan + + +  83.7 H 66.0 H 
C13 Clinical, Japan + + +  65.0 H 54.5 H 
C14 Clinical, Japan + + +  65.0 H 58.0 H 
C15 Clinical, UK + + +  87.0 H 66.0 H 
C16 Clinical, Spain + + +  64.6 H 51.7 H 
C17 Clinical, Spain + + +  65.0 H 52.0 H 
C18 Clinical, Spain + + +  61.9 H 61.0 H 
C19 Clinical, Spain + + +  64.0 H 64.0 H 
C20 Clinical, Spain + + +  60.0 H 60.5 H 
C21 Clinical, Italy + + -  55.8 H 52.0 H 
C22 Clinical, UK + + -  63.0 H 51.0 H 
R2 Environmental, NCTC Reference 
Strain, UK 
+ - -  60.8 H 40.0 M 
E1 Environmental, Spain + - -  0.6 L
3
 5.0 L 
E2 Environmental, Spain + - -  19.8 L 4.7 L 
E3 Environmental, Spain  + - +  39.0 M 37.5 M 
E4 Environmental, Spain + - -  0.5 L 4.9 L 
E5 Environmental, Spain + - -  0.6 L 3.0 L 
E6 Environmental, Spain + - -  0.5 L 4.0 L 
E7 Environmental, UK + - -  20.5 L 19.5 L 
E8 Environmental, UK + - -  0.4 L 5.0 L 
E9 Environmental, UK + + -  86.6 H 62.0 H 
E10 Environmental, UK + - -  0.6 L 3.0 L 
E11 Environmental, UK + - -  19.0 L 3.0 L 
E12 Environmental, UK + - -  0.6 L 3.0 L 
E13 Environmental, UK + - -  18.0 L 5.7 L 
E14 Environmental, UK + - -  19.6 L 4.0 L 
E15 Environmental, UK + - -  20.0 L 9.8 L 
E16 Environmental, UK + - -  25.9 L 25.8 L 
E17 Environmental, UK  + - -  0.4 L 4.8 L 
E18 Environmental, UK + - -  24.5 L 11.0 L 
E19 Environmental, UK  + - -  0.4 L 4.0 L 
E20 Environmental, UK  + - +  28.0 M 29.5 M 
E21 Environmental, UK  + - -  0.5 L 5.0 L 
E22 Environmental, UK  + - -  0.1 L 4.0 L 
E23 Environmental, UK  + - -  14.8 L 5.0 L 
E24 Environmental, UK  + - -  22.0 L 13.7 L 
E25 Environmental, UK  + - -  0.6 L 4.5 L 
E26 Environmental, UK  + - -  26.7 L 12.0 L 
E27 Environmental, Portugal + - -  19.0 L 5.0 L 
E28 Environmental, Portugal + - -  27.0 L 20.0 L 
E29 Environmental, UK + - -  16.5 L 5.0 L 
E30 Environmental, UK + - -  24.7 L 15.8 L 
E31 Environmental, UK + - -  18.5 L 5.8 L 
1
H, Highly virulent; 
2
M, virulent; 
3
L, low virulence or avirulent 
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               L   A  B  C  D  E  F  G  H  I  J               L   K  M  N  O  P  Q  R   S  T  U 
            
Figure 6.17 Blind test for M-PCR, isolates A-U were subjected to the M-PCR 
and their likely identification is recorded below. 
Lanes L, 100-bp molecular mass marker; lane A, Environmental.; B, Clinical; C, 
Environmental.; D, Environmental; E, Clinical; F, Clinical; G, Clinical; H, Environmental; I, 
Environmental; J, other species; K, Clinical; M, Clinical; N, Clinical; O, Environmental.; P, 
Environmental; Q, Clinical; R, Clinical; S, Environmental; T, Clinical; U, other species.  
 
200 bp 
300 bp 
600 bp 
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6.4 Discussion 
6.4.1 RAPD-PCR using P1 and P5 primers 
Molecular typing methods can be used to identify markers of virulence or 
pathogenicity for detection purposes, but before their use it is necessary to have 
gleaned which isolates are likely to be virulent or avirulent. In the case of V. 
parahaemolyticus, this information is likely to be related to the source of the 
isolates (i.e. clinical or environmental). Currently this information is corroborated 
by performing tests for the presence of putative virulence factors such as tdh and 
trh. Molecular typing tests such as pulsed-field gel electrophoresis (PFGE), 
ribotyping, tDNA, enterobacterial repetitive intergenic consensus (ERIC) or RAPD-
PCR can then be used to identify markers which differentiate virulent and avirulent 
forms of the species. These methods can also be used for the characterisation of 
pandemic clones, for example, Khan et al., (2002) have used ERIC-PCR to 
identify the V. parahaemolyticus O3:K6-specific DNA segment.  
Previous work done by Miah (2009) used RAPD-PCR to identify a unique DNA 
fragment produced in the majority of clinical isolates of V. parahaemolyticus. In the 
current study, this fragment has been utilised to create a PCR-based method for 
differentiating many clinical isolates from environmental isolates of V. 
parahaemolyticus. 
RAPD-PCR with random primers P1 and P5 of most V. parahaemolyticus clinical 
isolates DNA showed a unique band Y at approximately 600 bp, which was 
purified from agarose gels, cloned and sequenced and used to design a specific 
primer set in this study. Using data from the sequence information for band Y, 
primer pair VPOMP1 and VPOMP2 was designed to amplify a 200 bp section of a 
gene encoding a yet uncharacterised outer membrane protein. This PCR band 
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was produced by 21 out of 23 (91%) of clinical (virulent) isolates tested and only 1 
out of 32 environmental (mainly avirulent) isolates tested, the latter rate being in-
line with previous studies to determine the likely capacity to cause disease 
amongst environmental strains (Cook et al., 2002, Hervio-Heath et al., 2002, Islam 
et al., 2004). While not 100% for all clinical isolates, this new PCR detected known 
virulent isolates better than any of the current individual PCR tests for tdh and trh 
positive strains. While the tdh and trh genes have been considered as a virulence 
marker genes of V. parahaemolyticus for some time (Tada et al., 1992). Baffone et 
al., (2005) have found that a limited number of environmental strains of V. 
parahaemolyticus are mostly responsible for V. parahaemolyticus food-borne 
diseases.  
The current study shows that of clinically recognised isolates of V. 
parahaemolyticus tested 91% produced the 200 bp PCR-OMP product, suggesting 
that this new PCR test would be of value to detect strains potentially pathogenic to 
humans. These results support the notion that tdh and trh genes are not always 
present in pathogenic forms of V. parahaemolyticus (Nishibuchi and Kaper, 1990).  
Unfortunately, detailed information on the sources of the clinical isolates or indeed 
the immune status of the patients suffering from infection with V. parahaemolyticus 
used in this study was not available. However, each was isolated from human 
cases of gastroenteritis. A possible explanation for the existence of clinical isolates 
that lack the 200bp PCR product (or any other putative virulence factor) is that 
some patients may have been immunocompromised and therefore, more 
susceptible to less virulent strains. Conversely, it should also note that a positive 
detection of a gene sequence by PCR does not necessarily mean that a gene 
product will be produced phenotypically. Likewise, a positive hybridisation and a 
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negative PCR could indicate differences in sequence at the primer binding sites. 
Moreover, it should be recognised that virulence in any bacterium will rarely be 
defined by a single gene. 
Outer membrane proteins of bacteria play an important role during infection and 
induction of host immune response (Qian et al., 2008). Furthermore, the OMP 
NhhA of Neisseria meningitides is important for colonisation and meningococcal 
disease, the importance of this protein has been studied in vitro where this NhhA 
mediates attachment of bacteria to cells, as well as in vivo, the impact of NhhA on 
pathogenesis of bacteria has been demonstrated in a murine model of 
meningococcal disease by showing lethality using CD6 transgenic mice (Sjölinder 
et al., 2008). Krachler et al., (2011) have reported that a multivalent adhesion 
molecule has been found as an OMP in V. parahaemolyticus and it has a role in 
attachment to Caco-2 and HeLa cells, suggesting that contributes to pathogenesis.  
While the current study developed a PCR which detects nearly all virulent V. 
parahaemolyticus isolates, it is realised that the number of isolates used is 
relatively small and thus represents a preliminary, but informative, study. The 200 
bp PCR-OMP offers the possibility of screening environments or seafood and 
other foodstuffs for the presence of potentially pathogenic forms of V. 
parahaemolyticus. Furthermore, the nature and role of this OMP in this bacterium 
and its contribution to virulence needs to be studied more. 
Sequencing of PCR products and sequence analysis for homology was performed 
to verify the identity of PCR products and confirm the results. Sequence analysis 
of three isolates showed that single nucleotide polymorphisms (SNPs) did not alter 
the translated amino acid. 
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In this study, it was necessary to confirm a PCR-OMP product (200bp) by 
hybridisation analysis, very few isolates were positive for hybridisation and 
negative for PCR that may be caused by nucleotide mismatches or a lack of 
primer target sites or other reasons (Miah, 2009).  
6.4.2 RAPD-PCR using OPK primers 
In recent years, a number of molecular methods have been used for detection and 
identification of V. parahaemolyticus. In this study, RAPD-PCR was used with 
random primers OPK13 and OPK15 to identify a target DNA sequence which 
differentiated most clinical and environmental tested. To the author’s knowledge, 
there did not appear any publish studies that used this random primer pair. Most 
clinical isolates produced a unique band at approximately 310 bp (band Z), which 
was purified from agarose gels, cloned and sequenced. This sequence codes for a 
hypothetical protein whose function is currently not known. A specific primer set 
VPHTP1 and VPHTP2 was designed to specifically amplify a 300 bp section of the 
gene htp encoding a hypothetical protein. This 300 bp PCR product was produced 
by 19 out of 23 (82.6%) of clinical (virulent) isolates tested and only 2 out of 32 
environmental (mainly avirulent) isolates. No band was seen with any of the other 
species of Vibrio and non-Vibrio strains tested. 
Okura et al., (2004) have similarly used arbitrarily primed- PCR with random 
primer P2 (5’-d[GTTTCGCTCC]-3’) to investigate a unique band (approximately 
930 bp) in pandemic strains of V. parahaemolyticus corresponding to a 
hypothetical protein, which was found to be 80% homologous to the Mn2+ and 
Fe2+ transporter of the NRAMP family of V. vulnificus. Okura et al., (2004) then 
designed primers to detect a specific amplicon at 235 bp, which was a useful 
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diagnostic tool to distinguish the pandemic group from other V. parahaemolyticus 
strains. 
The results of the current study suggest that RAPD shows promising ability to 
differentiate between clinical and environmental (predominantly avirulent) isolates 
of V. parahaemolyticus. It should be noted that some environmental isolates will 
have the capacity to cause disease. It may be that different primer sets might be 
able to distinguish virulent from avirulent isolates completely and be developed 
into a quick PCR based test.  
6.4.3 Multiplex PCR  
This study developed a multiplex PCR to identify all V. parahaemolyticus isolates 
tested by producing species specific fragment toxR gene (367 bp) and reveal 
potentially virulent forms by detecting either omp (200 bp) or htp (300 bp) 
sequences or both. Thus the multiplex PCR method was simultaneously used to 
identify V. parahaemolyticus and targeted both omp and htp genes in a single 
PCR reaction. This multiplex PCR detected 3 (9.37%) in environment isolates.  
The presence of both omp and htp correlated with high cytotoxicity. Isolates which 
did not carry either omp or htp, i.e. the majority of the environmental isolates, 
showed low cytotoxicity, with one exception, the NCTC reference strain R2. This is 
environmentally sourced and did not give a positive PCR for either omp or htp, but 
showed a level of cytotoxicity on a par with many of the clinical (virulent) isolates 
tested here. It is likely that either omp or htp, or both, act merely as markers for 
cytotoxicity, i.e. are not directly responsible for cytotoxicity. Perhaps they are 
located on a genetic region or element which when acquired also carries a gene or 
genes for cytotoxic products. Maybe in R2 the marker genes have become 
detached and lost from any cytotoxic genes, but the latter remain and are active. 
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Alternatively, R2 may contain a hitherto new or separate cytotoxic activity, 
unrelated to omp or htp.  
Previously, between 6% (Shirai et al., 1990, Cook et al., 2002) and 9% (Cabrera-
Garcia et al., 2004) of environmental V. parahaemolyticus isolates have been 
designated as potentially pathogenic, so the findings of the current study are in 
line with others.  
This PCR shows great promise to be used as a suitable tool to identify V. 
parahaemolyticus and detect potentially virulent forms. Moreover, it could be used 
in epidemiological studies and investigations into the abundance of potentially 
virulent forms of V. parahaemolyticus in various environmental habitats. 
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Chapter 7: General Discussion and Recommended Future Work 
7.1 General discussion 
Vibrio parahaemolyticus is a human gut pathogen associated with ingestion of 
seafood. Only certain strains of the species, carrying virulence factors rarely found 
in environmental strains, cause disease in humans that associated with 
consumption of seafood causing acute diarrhoea and vomiting.  However, it is 
likely that most V. parahaemolyticus isolates from the marine environment are 
harmless.  Virulent strains of V. parahaemolyticus have become a major cause of 
food borne disease. Therefore, the extensive studies of this bacterium are 
interesting and necessary because identification and detection of the virulent 
forms of human pathogenic Vibrio species such as V. parahaemolyticus in the 
seafood samples is important in the food industry.  
It is important to know whether food samples contain pathogenic or non-
pathogenic bacteria. For example, the presence of pathogenic E. coli O157:H7 in 
food is a danger and can cause disease (Karmali, 2009). If the batches of food 
contain only non-pathogenic strains that means these strains are harmless and 
should not result in discard of that food batch. Likewise, virulent and avirulent V. 
parahaemolyticus exist, therefore, if V. parahaemolyticus is present in batches of 
seafood, it is necessary to know whether it is virulent or avirulent, instead of 
discarding the batches straight away. It appears that there is no single genetic 
determinant necessary and sufficient for virulence of this bacterium to occur 
(Yeung and Boor, 2004), and many studies have reported that there are likely to 
be many factors involved in V. parahaemolyticus pathogenicity. 
This thesis focused on the development of methods for differentiating between 
virulent (mainly clinical) and avirulent (mainly environmental) isolates of V. 
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parahaemolyticus. Virulence was gauged by the capacity of the isolates to 
produce cytotoxic extracellular products and lyse mammalian cell lines. The LDH 
assay detected cell lysis and differentiated between virulent (clinical) and mainly 
avirulent (environmental) isolates of this bacterium and could therefore be used to 
screen for the presence of potentially virulent forms in the environment. The 
phenotypes and genotypes of isolates tested could be associated with the 
enhanced cytotoxic effects of V. parahaemolyticus isolates tested. 
In many European countries, pathogenic Vibrio species are present in estuarine 
and costal water and in shellfish (Barbieri et al., 1999, Baffone et al., 2001, Hervio-
Heath et al., 2002, Cavallo and Stabili, 2002). In recent years, the incidence of V. 
parahaemolyticus infections and the risk by this pathogen have increased 
dramatically in Europe, for example in Spain and France (Martinez-Urtaza et al., 
2005, Quilici et al., 2005). Pathogenic V. parahaemolyticus has been detected in 
French bivalve molluscs in France by Rosec et al., (2009). V. parahaemolyticus 
has also been detected in blue mussels (Mytilus edulis) that harvested from the 
German Wadden Sea, suggested that potentially pathogenic V. parahaemolyticus 
has considered as a public health and potential human health risk (Lhafi and 
Kühne, 2007). Another study in Norway has reported that potential pathogenic V. 
parahaemolyticus has been detected in M. edulis (Bauer et al., 2006). Furthermore, 
Serracca et al., (2011) have detected pathogenic strains of V. parahaemolyticus in 
fishes collected from estuarine waters in Italy and reported that the potential 
human health risk related with consumption of raw or undercooked fishes.   
Response of V. parahaemolyticus to environmental conditions such as climate 
change provides a valuable insight into understanding increasing levels of this 
bacterium in Europe, high temperatures and low salinity have been led to increase 
Chapter 7 
184 
 
incidence of potential virulent V. parahaemolyticus in European countries such as 
in Spain (Martinez-Urtaza et al., 2008), France (Julie et al., 2010) and Brazil 
(Sobrinho et al., 2010). Furthermore, Collin and Rehnstam-Holm, (2011) have 
reported that potential human pathogenic Vibrio species including V. 
parahaemolyticus, V. cholerae and V. vulnificus in the Sound between Sweden 
and Denmark are common at water temperature above 17 °C. 
Investigating the presence of virulence factor determinants by PCR shows that the 
presence of the tdh gene or trh gene, (or both) are considered as diagnostic 
markers for pathogenic isolates of V. parahaemolyticus (Nordstrom et al., 2007). 
However, it has been noted that these virulence genes are absent in some 
pathogenic strains. Thus, some V. parahaemolyticus isolates lack TDH and TRH, 
but remain pathogenic (Nishibuchi et al., 1992, Xu et al., 1994, Park et al., 2000).  
Recently, V. parahaemolyticus strains lacking tdh and/or trh caused outbreaks in 
Southern Chile (García et al., 2009) therefore, there is a need to investigate other 
possible genes responsible for their virulence. Conventional phenotypic and 
molecular techniques are widely used for identification and detection of total and 
virulent strains of this organism. PCR is extensively used to help conventional 
bacteriological tests, and it gives benefit for identification of Vibrio species and 
detection of pathogenic strains. So while, TDH has been recognised as a marker 
for discriminating pathogenic from non-pathogenic strains (Honda and Iida, 1993) 
it does not do so completely. Moreover, Bilung et al., (2005b) isolated 62 V. 
parahaemolyticus from 100 samples of cockles in Malaysia and detected by PCR 
the tdh gene in only 2 isolates and trh gene in only 11 isolates. Vongxay et al., 
(2008) have reported that the trh gene has been detected in 3 out of 25 clinical 
and 7 out of 191 environmental isolates of V. parahaemolyticus; and they 
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suggested that there are factors other than TDH for virulence. Although some 
isolates of V. parahaemolyticus lack the tdh gene they still appear to be 
pathogenic; however, the overall mechanism associated with pathogenicity of this 
bacterium is not understood and remains unclear (Makino et al., 2003, Boyd et al., 
2008). Consideration of the tdh gene as a marker to predict the virulent forms of V. 
parahaemolyticus is better than the trh gene has been reported (Kaper et al., 
1984). Studies have reported that other Vibrio species also harbour trh-like genes 
highly homologous with trh gene from V. parahaemolyticus for example, it has 
been detected in V. alginolyticus (Gonza´Lez-Escalona et al., 2006, Rosec et al., 
2012) and Aeromonas veronii (Raghunath et al., 2010). Furthermore, Masini et al., 
(2007) have detected trh gene in V. alginolyticus and V. harveyi isolated from 
bathing water Conero Riviera. Similar observation was reported by Nishibuchi and 
Kaper, (1995) for tdh gene and V. hollisae, V. mimicus and V. cholerae non-O1.  
In the current study, the putative virulence factors of V. parahaemolyticus isolates 
have been investigated and surveyed as possible virulence factors to find patterns 
that might distinguish clinical (virulent) and environmental (mainly avirulent) 
isolates and to identify better markers for distinguishing these groups (Chapter 4), 
the results showed that 14 isolates from clinical sources and one environmental 
isolate could produce haemolysis, urease, protease and phospholipase, however, 
lipase activity did not appear to contribute to the pathogenicity of the isolates 
tested. High cytotoxicity remained evident in virulent strains and was considered 
as quantitative evidence for the virulence of these isolates. It could be seen that 
most of phospholipase positive isolates produced haemolytic activity, and most 
isolates that were positive for these two activities showed high cytotoxicity but 
there are isolates which did not produce these two enzymes but showed high 
cytotoxicity, for example C17 isolate showed cytotoxicity of 65% and 52% on 
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Caco-2 and CHO-K1, respectively (Chapter 5), suggesting that haemolytic activity 
and phospholipase activity may play a role in most, but not all, of V. 
parahaemolyticus pathogenicity.  
However, in the current study, there were some protease positive environmental 
isolates which showed less than 20% cytotoxicity on Caco-2 and CHO-K1, 
suggesting that the protease enzyme in these isolates might not be involved in 
cytotoxicity or in other isolates a different protease plays a role in pathogenicity. 
Likewise all clinical isolates and 15 environmental isolates were positive for urease, 
but some of these urease positive environmental isolates showed low cytotoxicity. 
It would appear that urease activity is essential for pathogenicity but not 
cytotoxicity.  
Plasmids and bacteriophages (Chapter 4) were also studied to investigate if their 
presence in V. parahaemolyticus isolates tested was linked to the carriage of 
virulence factors. The presence of plasmids was found not to be correlated with 
virulence factors and pathogenicity and therefore of no use to differentiate 
between clinical and environmental isolates of V. parahaemolyticus. Twedt et al., 
(1981) isolated plasmids in 2 of 14 KP+ and 1 of 17 KP- and suggested that the 
presence of plasmid did not correlate with the pathogenicity of V. 
parahaemolyticus isolates they tested. Furthermore, Isaki et al., (1983) have 
reported that there was no correlation found between the presence of plasmid and 
KP reaction.  
When SDS-PAGE was used to analyse whole cell protein bands, protein profiles 
could not be used to differentiate clinical (virulent) and environmental (mainly 
avirulent) isolates of V. parahaemolyticus. The whole cell protein patterns of 
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clinical V. parahaemolyticus are generally identical to environmental isolates. 
There are some drawbacks of standard SDS-PAGE method describing as follow: 
1- It is hard to detect two proteins with similar size apart from each other. 
2- A complex protein mixture with some abundant protein, it is hard to detect 
less abundant proteins if they are about the same size of the abundant 
ones. 
3- The SDS treatment denatures the protein and gives the protein negative 
charge; it does not detect a protein in its natural state.  
Studying genomes of bacteria have contributed to understand the mechanisms 
that involved in their virulence and pathogenicity by generating and comparing 
whole genome sequencing, this started in mid-1990 with the automation of Sanger 
sequencing and the completion of Haemophilus influenza (Fleischmann et al., 
1995) and Mycoplasma genitalium (Fraser et al., 1995). High throughput 
sequencing has increased the amount of completed genomes of bacteria and the 
speed of DNA sequencing. This technology has been used to investigate the 
origins and potential pathogenic of E. coli O104:H4 that caused outbreak in 
Germany in 2011 (Rasko et al., 2011, Rohde et al., 2011), and V. cholerae that 
caused cholera outbreak in Haiti (Chin et al., 2011). Furthermore, Gonzalez- 
Escalona et al., (2011) have used this technology to sequence genome of clinical 
V. parahaemolyticus strain 10329. 
There are several molecular typing systems for investigating the differences 
between the bacterial isolates; however, the main criteria to choose the typing 
methods are their reproducibility, typeability, constancy, cost and simplicity of 
performance. PFGE is a gold standard technique that has been used for molecular 
typing of V. parahaemolyticus (Martinez-Urtaza et al., 2004), but it is expensive 
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and time-consuming. RAPD-PCR is quick, cheap, relatively simple to achieve and 
was used in this study to initially differentiate V. parahaemolyticus clinical (virulent) 
isolates from the environment (mainly avirulent) isolates (Chapter 6). It has been 
found that an outer membrane protein and a hypothetical protein may play a role 
in the pathogenicity of virulent strains of V. parahaemolyticus or are markers for 
pathogenic strains. 
The outer membrane protein (OMP) of enteric bacteria is one of the numerous 
factors that many allow attachment of enteric pathogens to the intestinal 
epithelium of the host (Nikaidol and Vaara, 1985). Aeckersberg et al., (2001) have 
reported that the relationship between OMPs of Vibrio and pathogenicity is an 
important issue, but it remains unresolved yet. OMPs of V. fischeri act as 
adhesions and play a role in symbiotic colonisation (Aeckersberg et al., 2001). The 
OMP of V. harveyi contributes to bacterial adherence (Ningqiu et al., 2008). 
Provenzano and Klose, (2000) have reported that OMPs are important for V. 
cholerae pathogenesis providing bile salt resistance and survival of the bacteria in 
the intestine. Sperandio et al., (1995) and Chakrabarti et al., (1996) have 
suggested that OmpU acts a potential adherence factor in V. cholerae. On the 
contrary, Nakasone and Iwanaga (1998) have suggested that OmpU does not 
contribute to the adhesion of this pathogen to the epithelia cells. OmpU is also 
reported to play an important role in the pathogenicity of V. splendidus in oysters 
(Marylise et al., 2010). An OMP has also been implicated in the disease processes 
of V. tubiashii (Beaubrun et al., 2008). Moreover, Broberg et al., (2011) have 
reported that an OMP was essential for preliminary contact of V. parahaemolyticus 
with various cell lines.  
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The OMP-PCR and the HTP-PCR separately did not detect all the known clinical 
virulent forms tested. Because of this limitation, in the current study, a M-PCR was 
developed to allow the simultaneous detection of toxR, omp and htp in a single 
tube, with the expected amplicon sizes of 367 bp for toxR, 300 bp for htp and 200 
bp for omp using 3 pairs of primers. This M-PCR was able to identify V. 
parahaemolyticus and detect all the virulent forms tested so far. A number of 
workers have found that a M-PCR approach is a useful and rapid tool, for example, 
development of M-PCR detection of haemolysin genes (tlh, tdh and trh) was 
reliable and quicker than bacteriological methods for monitoring and occurrence of 
virulent strains of V. parahaemolyticus in seafood in Turkey (Terzi et al., 2009). 
Another M-PCR developed by Kaufman et al., (2002) targeting three genes (tlh, 
tdh and trh) along with urease production could be used as a useful tool for 
monitoring V. parahaemolyticus in shellfish and detect potential pathogenic strains. 
The cytotoxic effect of ECPs of V. parahaemolyticus isolates has been tested in 
the present study. In general, the clinical isolates exhibited greater LDH release 
from Caco-2 and CHO-K1 than the majority of environmental isolates. However, 
the strains of V. parahaemolyticus that were positive for the 200 bp (omp) or/ and 
300 bp (htp) PCR product caused significantly (p < 0.05) more (the mean of the 
percentage of cytotoxicity values 67.4%) than for those that lacked these two 
fragments (mean 13.9%). Another cell line, CHO-K1 was also used for cytotoxicity 
test and found that the strains of V. parahaemolyticus that were positive for the 
OMP-PCR or/ and HTP-PCR caused also significantly (p < 0.05) more (the mean 
of the percentage of cytotoxicity values 57.4%) than for those that lacked these 
two fragments (mean 8.9%). Thus by using Caco-2 and CHO-K1 cell lines, it was 
shown that the mean of the percentage of cytotoxicity of V. parahaemolyticus 
ECPs was significantly greater for isolates that produced the 200 bp PCR-OMP 
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or/and 300 bp PCR-HTP products than for those that lacked these fragments, 
however, the environmental isolate (E20) carried the htp gene, but lacked the omp 
gene but exhibited a certain degree of cytotoxicity 28% on Caco-2 and 29.5% on 
CHO-K1 cells. Importantly, these results found quantitative evidence for enhanced 
virulence-associated characteristics of OMP and HTP group isolates compared to 
those of other V. parahaemolyticus strains, since the quantity of LDH released is 
relative to the degree of the host cell membrane damage (Nachlas et al., 1960). 
Based on cytotoxicity to Caco-2 cell line, Yeung et al. (2007) also differentiated 
virulent and avirulent strains and the cytotoxicity of clinical isolates was 
significantly different (p ≤ 0.05) from food isolates. Raimondi et al. (2000) reported 
that the high TDH concentration had been demonstrated to induce cytotoxicity in 
Caco-2 cells, but in the present study there is a high cytotoxic effect of ECPs in 
isolates that produced the 200 bp or/and 300 bp fragments even though in some 
instances, one or more of the tdh and trh genes may have been absent. 
The present work suggested that the cytotoxicity test based on LDH release from 
two types of cell lines was useful to determine the virulence of V. 
parahaemolyticus isolates; however, the presence of a single virulence gene alone 
or production of one of the putative virulence factors alone cannot be used as a 
mean for determining the potential virulence of strains, suggesting that multiple 
virulence factors contribute to the pathogenicity of this bacterium.  
Avirulent strains of Vibrio species are considered to provide a main reservoir of 
known virulence genes. The mobility and successful transfer of virulence genes 
may lead to new virulent strains by transformation of avirulent forms to virulent 
strains. For example, the tdh gene can be transferred horizontally between V. 
hollisae and Vibrio other species including, V. cholerae, V. mimicus and V. 
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parahaemolyticus (Nishibuchi et al., 1996). The marine habitat harbours many 
virulence genes scattered among vibrios in the environment (Xie et al., 2005). 
The presence of a number of virulence related genes have been reported in both 
clinical and environmental isolates of V. parahaemolyticus. However, the 
relationship between V. parahaemolyticus isolated from the marine environment 
and from clinical sources is unclear (Pan et al., 2007). The pathogenicity of V. 
parahaemolyticus may perhaps involve the synergistic interactions between 
several factors that have been studied in the current work. Furthermore, some 
clinical V. parahaemolyticus isolates from patients who are immunocompromised 
or have underlying liver disease or those with diabetes mellitus may lack one or 
more known putative virulence factors, but still cause disease in these individuals.  
The current M-PCR suggested that 9.37% of environmental isolates tested are 
likely to be potentially virulent. This result is supported by many studies that report 
that amongst environmental isolates potential pathogen isolates, exist at a low rate, 
for example 5% (Hervio-Heath et al., 2002), 6% (Caburlotto et al., 2009) and 10.5 % 
(Rojas et al., 2011).  
The M-PCR assay was successfully used to identify V. parahaemolyticus and 
detect potentially virulent forms targeting three genes simultaneously in a single 
reaction, and it is a rapid and cheap method for the seafood industry and would 
reduce the infection caused by V. parahaemolyticus by ensuring seafood safety, 
and reduce waste by only removing batches of food that had virulent V. 
parahaemolyticus present.  
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7.2 Recommended future work 
The studies described in this work have not included isolates from the entire world, 
thus a larger number of clinical and environmental of V. parahaemolyticus isolates 
from more diverse geographical sources would be recommended for future work.  
A future line of research could investigate whether virulent V. parahaemolyticus 
isolates possess lysogenic bacteriophage that encoded virulence factors, as for 
example, occurs with lysogenic CTXø bacteriophages carrying the cholera toxin 
that is found in O1 and O139 serotypes of V. cholerae (Waldor and Mekalanos, 
1996, Faruque et al., 1998). 
Further analysis of the exact nature of extracellular proteins produced by V. 
parahaemolyticus may well unravel the virulence exhibited by this organism. 
Define the functional role of ECPs. The ECPs need to be investigated further by 
purification and identification of proteins in ECPs, and to study their biological 
activities. The determination of whether ECPs production plays a crucial role in the 
disease needs to be studied in vivo as well as in vitro; using fish infection 
experiments instead of using cell lines.  
Further work is required to investigate whether omp or htp are virulence factors or 
merely markers of virulence. Determining the contributions of OMP and HTP and 
their possible role in pathogenicity needs to be studied more. The role of omp and 
htp genes in virulence may be investigated by creating mutants within the omp 
or/and htp genes of the virulent isolates and test them for cytotoxicity.  
Although the reliability of this M-PCR needs further evaluation with more clinical 
and environmental strains, this type of PCR may well prove to be the most 
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accurate way to identify V. parahaemolyticus and differentiate potentially so far 
devised virulent forms.  
Development of NGS technologies to assess the distinct genomic differences 
between pathogenic and non-pathogenic strains of V. parahaemolyticus is needed 
in future work.   
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APPENDIX I 
MEDIA, REAGENTS, SOLUTIONS AND SUPPLIERS 
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Appendix I: Media, Reagents, Solutions and Suppliers  
I.1 Bacteriological media 
The bacteriological media were sterilized by autoclaving under these conditions, 
15 pounds of pressure per square inch (Psi) and 121 °C. 
Luria-Bertani medium (LB) 
Per litre of ddH2O (pH 7.5): 
Tryptone                                   10 g 
Yeast extract                              5 g 
Sodium Chloride                       10 g 
Contained the same components as stated in the LB media although LB agar with 
the addition of 1.5% (w/v) agar 
Marine salts broth (MSB) 
Marine Broth 2216 powder was purchased as pre-mixed media from Becton 
Dickinson, distributors for Difco Labs. A 37.4 g of medium was dissolved in 1L of 
ddH2O, boiled for 1 min to completely dissolve the powder and autoclaved. 
Approximate formula per litre (pH 7.6 at 25 ºC) 
Peptone                                       
Yeast Extract                               
Ferric Citrate                                
Sodium Chloride                        
Magnesium Chloride                    
Magnesium Sulphate                   
Calcium Chloride                          
Potassium Chloride                      
Sodium Bicarbonate                     
Potassium Bromide                      
Strontium Chloride                    
Boric Acid                                  
Sodium Silicate                           
Sodium Fluoride                          
Ammonium Nitrate                       
Disodium Phosphate                   
5.00 g 
1.00 g 
0.10 g 
19.45 g 
5.90 g 
3.24 g 
1.80 g 
0.55 g 
0.16 g 
0.08 g 
34.0 mg 
22.0 mg 
4.0 mg 
2.4 mg 
1.6 mg 
8.0 mg 
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Marine salts agar (MSA) 
Marine Broth 2216 powder (37.4 g) of media was dissolved in 1L of ddH2O with 
the addition of 1.5% w/v agar. 
Tryptone soya broth (TSB) 
TSB powder was purchased as pre-mixed media from Oxoid; 30g of media was 
dissolved in 1 L of ddH2O, the pH adjusted to 7.5 and then autoclaved. The 
formula of the resulting media is as follows:                                                                                                                      
Tryptone (casein digest USP) 
Soya peptone 
Sodium chloride 
Dibasic potassium phosphate 
Dextrose 
17.0 g 
3.0 g 
5.0 g 
2.5 g 
2.5 g 
Tryptone soya agar (TSA) 
TSA powder was purchased as pre-made media from Oxoid. 37g of media was 
dissolved in 1 L of ddH2O, the pH adjusted to 7.5 and then autoclaved. TSA 
contained the same components as stated in the TSB media although TSA with 
the addition of 1.5% (w/v) agar. 
TCBS agar  
TCBS Cholera Medium (CM0333) powder was purchased as pre-made media 
from Oxoid. A 88 g of media was dissolved in 1 L of ddH2O (pH 8.6 ± 0.2 at 25ºC). 
The formula of the resulting media is as follows: 
Yeast extract                                 
Bacteriological peptone               
Sodium thiosulphate                    
Sodium citrate                              
Ox Bile                                           
Sucrose                                        
Sodium chloride                           
Ferric citrate                                   
Bromothymol blue                          
Thymol blue                                    
Agar                                                
5.00 g 
10.00 g 
10.00 g 
10.00 g 
8.00 g 
20.00 g 
10.00 g 
1.00 g 
0.04 g 
0.04 g 
14.0 g 
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HiCromeTM Vibrio agar  
HiCromeTM Vibrio Medium (92323) powder was purchased as pre-mixed from 
Sigma. A 67.5g of media was dissolved in 1 L of ddH2O. The formula of the 
resulting media is as follows:                                                                                                                                                                                                               
Peptic digest of animal tissue 
Sodium chloride 
Sodium thiosulfate 
Sodium citrate 
Sodium cholate 
Chromogenic mixture 
Agar 
10.0 g 
25.0 g 
5.0 g 
6.0 g 
1.0 g 
5.5 g 
15.0 g 
pH 8.5 ± 0.2 at 25ºC 
Wagatsuma agar (WA)  
Yeast extract 
Peptone 
NaCl 
Mannitol 
Crystal violet 
Agar 
3 g 
10 g 
70 g 
10 g 
0.001 g 
15 g 
All above ingredient, except blood, was suspended in distilled water (950 ml) and 
boiled to dissolve agar. The pH was adjusted to 8.0 and steam sterilised (30 min). 
A volume of 50 ml of rabbit blood cells was added to the cooled (45 ºC) medium. 
Phospholipase assay medium 
Sudheesh and Xu, (2001) 
peptone 10 g 
NaCl 30 g 
Agar 15 g 
Egg yolk 2.5% 
The medium was made up with distilled water to  1L 
All above ingredient, except Egg yolk, were suspended in distilled water and boiled 
to dissolve agar and autoclave (30 min). A 2.5% of Egg yolk Emulsion was added 
to the cooled (45 ºC) medium. 
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Urea agar base medium 
Based on Atlas, (1997) 
NaCl 30 g 
Na2HPO4 1.2 g 
Pepton 1 g 
Glucose 1 g 
KH2PO4 0.8 g 
Agar 15 g 
Distilled water 950 ml 
Urea solution 40% 
All above ingredient, except urea solution, was suspended in distilled water 950 ml 
and boiled to dissolve agar, mixed thoroughly and autoclave (30 min).  A volume 
of 50 ml of Urea solution was added to the cooled (45 ºC) medium. 
Protease assay medium 
Depended on Wong et al., (1992) 
Skim milk 15 g 
NaCl 30 g 
Agar 15 g 
The medium was made up with distilled water to 1L 
Lipase assay medium 
Depended on Wong et al., (1992)  
Peptone 10 g 
NaCl 30 g 
Agar 20 g 
CaCI2, H20 0.1 g 
Tween 80 1 % 
The medium was made up with distilled water to 1 L 
SOC medium (100 ml), filter sterilize, pH 7.0 
Tryptone 2 g 
Yeast extract 0.5 g 
NaCl 1M 1 ml 
KCl 1M 0.25 ml 
Glucose 2M 1 ml 
Stock Mg
2+
 2M containing (MgCl2.6H2O, 20.33 g and 
MgSo4.7H2O, 24.65 g). 
1 ml 
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I.2 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) 
solutions:  
Resolving gel buffer 
Trizma-base 0.75 M (pH 8.8)  
SDS 0.2% w/v 
Stacking gel buffer  
Trizma-base 0.25 M (pH 6.8)  
SDS 0.2% w/v 
SDS gel-loading buffer  
Trizma-HCl 0.5 M (pH 6.8)  
SDS 2% 
Bromophenol blue 0.1% 
2-mercaptoethanol 5% 
Glycerol 10% 
Electrophoresis buffer-1000 ml (pH 8.3)  
Trizma-base 25 mM 
Glycine 250 mM 
SDS 0.1% 
Resolving gel 12.5 % 
Acrylamide/bis-acrylamide 30%, 4.4 ml  
Resolving gel buffer 5.2 ml 
ddH2O 1.74 ml 
APS 10%, 60 µl 
TEMED 30 µl 
Stacking gel 5% 
Acrylamide/bis-acrylamide 30%, 0.7 ml 
Stacking gel buffer 2 ml 
ddH2O 1.3 ml 
APS 10%, 50 µl 
TEMED 15 µl 
Staining  
Commassi brilliant blue R-250 0.125% 
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Methanol 40% (v/v) 
Acetic acid 7% (v/v) 
Destained  
Methanol 40 % (v /v) 
Acetic acid 7% (v/v) 
1.3 Extraction of genomic DNA  
Bacterial genomic DNA was extracted by using a genomic DNA extraction kit 
(Qiagen, Ltd., UK). Details of the contents of each solution are unknown. 
1.4 Cytotoxic activity 
Lysis solution (10X) 
Triton®X-100  9 % (v/v) in water 
Stop solution 
Acetic acid 1M 
Substrate mixture 
L-(+)-lactic acid 0.05M 
p-iodonitrotetrazolium violet 7x10-4 M 
Nicotinamide Adenine Dinucleotide Sodium (NAD) 3x10-4 M in 0.2 M Tris buffer 
(pH 8.2)  
Dulbecco's Modified Eagle Medium (D-MEM) (1X) without Phenol red 
D-glucose 4.5 g/l 
L-glutamine 5 mM 
HEPES buffer 25 mM 
Dulbecco's Modified Eagle Medium (D-MEM) (1X) with Phenol red 
D-glucose 4.5 g/l 
L-glutamine 5 mM 
Sodium Pyruvate 110 mg/l 
Phenol Red Indicator 
Trypsin, 0.25% (1X) with EDTA 4Na, liquid  
Trypsin is widely used for dissociation of tissues and cell monolayers 
Trypsin (1:250) 2.5 g/l 
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EDTA.4Na 0.38 g/l 
Phenol Red 
Hanks' Balanced Salt Solution without CaCl2, MgCl  
Dulbecco's Phosphate Buffered Saline (D-PBS) (1X), liquid 
Calcium Chloride (CaCl2) (anhyd.) 0.901 mM 
Magnesium Chloride (MgCl2-6H2O) 0.493 mM 
I.5 Plasmid extraction solutions 
A- Bimboim and Doly, (1979) 
B&D solution I 
Glucose 50 mM 
Trizma HCl 25 mM 
EDTA 10 mM 
pH 8.0 
B&D solution II  
NaOH (1 ml) 0.2 M 
SDS (1 ml) 1 M 
B&D solution III  
Potassium acetate (60 ml), 5 M (pH 4.8) 
Glacial acetic acid (11.5 ml) 
dd H2O (28.5 ml) 
B- Pedraza and Díaz Ricci, (2002):- 
Lysis buffer:  
This solution was prepared by using TBE buffer 
Sucrose           10 g 
RNase             10 µg 
Lysozyme        1 µg 
I.6 General molecular biology reagents  
Gel loading solutions 
(1) General gel loading (x6) solution (Sigma): 
Bromophenol blue      0.25% (w/v) 
Xylene cyanole FF     0.25% (w/v) 
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Sucrose                      40% (w/v) 
(2) Tracking buffer (x6) for RAPD (Amersham Biosciences) 
Glycerol 30% 
Bromophenol bule 0.125% 
Tris-HCl 20 mM (pH 8.0)  
TE buffer, pH 8.0  
Tris-base 10 mM 
EDTA 1 mM 
TBE buffer (5x)-1000 ml 
TBE was made up at 5X strength according to the following recipe and was then 
diluted to 1 X: 
Trizma base 54 g 
Boric acid 27.5 g 
EDTA 0.5 M (pH 8.0) 20 ml 
I.7 PCR 
10x PCR reaction buffer 
10 x buffer consisted of (15 mM MgCl2, 100 mM Tris-HCl, 500 mM KCl, pH 8.3) 
PCR Grade Nucleotide 
10 mM dNTP solution 
Phosphate buffered saline 
One tablet (Oxoid) dissolved in 100 ml ddH2O.Sterilised by autoclaving as 
mentioned in section 1.1. 
I.8 Blue /White Screening  
X-Gal solution  
5-bromo-4-chloro-3-indolyl -β-D-galactoside (X-gal) made up as stock solution 50 
mg/ml in N, N’ -dimethyformamide (DMF) and sterilized by filtration (Whatman, 
0.45 µm) and covered with aluminium foil and stored at -20 °C. 
IPTG solution 
Isopropyl -β-thiogalctopyranoside (IPTG) made up as stock solution 100 mM in 
molecular biology water. Filter sterilized and stored at 4 °C. 
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LB plate with ampicillin/X-Gal/IPTG  
LB medium was prepared as described in section I.1. A volume of 20 µl of X-Gal, 
100 µl of IPTG and ampicillin at final concentration 100 µg/ml were added to the 
cooled (45 °C) medium. 
I.9 Agarose Gel DNA Extraction Kit 
The kit contents are as follows: 
Silica matrix 
Vial (1) with a pretreated spherical silica matrix  
Agarose solubilisation buffer 
Vial (2) with 60 ml agarose solubilisation buffer contains sodium perchlorate. 
Nucleic acid binding buffer  
Vial (3) 100 ml binding buffer contains sodium perchlorate. 
Washing buffer  
Vial (4) with 20 ml washing buffer, add 80 ml absolute ethanol  
I.10 PCR product purification kit solutions 
PCR product was purified using the ‘High Pure PCR Product Purification Kit’ 
supplied by Roche; all buffers were kept at room temperature. Details of the 
content of each solution are as follows: 
Binding Buffer 
Guanidine-thiocyanate 3 M 
Tris-HCl 10 mM 
Ethanol 5% (v/v) 
pH 6.6 
Washing Buffer 
(Final concentrations after adding of 40 ml ethanol) 
NaCl 20 mM 
Tris-HCl 2 mM (pH 7.5)  
Elution Buffer  
Tris-HCl 10 mM 
pH 8.5  
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I.11 DNA Labelling and Detection 
DIG DNA Labelling and Detection Kit that supplied by Roche was used to label 
DNA. Details of the content of each solution are as follows: 
Hexanucleotide Mix  
10 x concentrated hexanucleotide mixture containing: 
Random hexanucleotides 62.5 A260 units/ml (1.56 mg/ml) 
Tris-HCl 500 mM 
MgCl2 100 mM 
Dithioerythritol (DTE) 1 mM 
BSA 2 mg/ml 
pH 7.2 
dNTP Labelling mixture 
10 x concentrated dNTP labelling mixture containing: 
dATP 1 mM 
dGTP 1 mM 
dCTP 1 mM 
dTTP 0.65 mM 
DIG-11-dUTP 0.35 mM 
pH 7.5  
Klenow enzyme, labelling grade 
Klenow enzyme (2U/µl) 
Anti-Digoxigenin-AP Conjugate 
Polyclonal sheep anti-digoxigenin  
Fab-fragment, conjugated to alkaline phosphatase 750 U/ml 
NBT/BCIP 
10 x concentrated stock solution 
Unlabelled control DNA 1 
pBR328 (100 µg/ml) 20 µl 
pBR328 is digested separately with Bam HI, BgI 1 and Hinf 1 
Unlabelled control DNA 2 
pBR328 (200 µg/ml) 20 µl 
Linearised with Bam HI 
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Labelled control DNA  
pBR328 DNA (5 µg/ml) 50 µl 
Linearised with Bam HI 
DNA Dilution Buffer 
Herring sperm DNA (50 µg/ml) in 10 mM Tris-HCl, 
EDTA 1mM 
pH 8.0 at 20 °C 
20x SSC 
Per litter of molecular grade water (it was diluted to 10x, 5x, 2x, or 0.5x strength as 
required with sterile molecular grade water 
Sodium chloride                 175.32 g 
Sodium citrate                    88.23g 
pH 7 
DIG wash and Block Buffer Set (Roche) 
Washing Buffer  
10x stock and 1x working solution were prepared with sterile molecular grade 
water 
Maleic acid 0.1 M 
NaCl 0.15 M 
Tween 20, 0.3% (v/v) 
pH 7.5  
Blocking solution  
10x stock and 1x working solution were prepared with malic acid buffer 
Detection buffer 
Tris-HCl 0.1 M  
NaCl 0.1 M  
pH 9.5  
Malic acid buffer 
It was used for dilution of blocking reagent 
Maleic acid 0.1 M 
NaCl 0.15 M 
Adjusted with NaOH to pH 7.5 
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I.12 Molecular weight marker 
1.12.1 ColorBurst™ Electrophoresis Marker molecular weight 8 kDa-220 kDa  
 
 
4-20% Tris-Glycine 
  
3µl      5µ     7µl 
8 kDa 
12 kDa 
20 kDa 
30 kDa 
45 kDa 
60 kDa 
100 kDa 
220 kDa 
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1.12.2 100 bp DNA ladder 
100 bp DNA ladder (Invitrogen) (0.5 µg/lane) ranged from 100-1500 bp in 100bp 
increments, plus a 2072 bp fragment. The 600 bp band is 2-3 times brighter than 
the others. 
 
1.12.3 1kb Ladder 75-12,216 bp Gibco (Invitrogen) (0.5 µg/lane)1 kb Ladder 
ranged from 75bp to 12,216 bp in various increments. 
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1.13 Suppliers 
Bio-Rad Laboratories Ltd. 
Bio-Rad House 
Maxted Road 
Hemel Hempstead 
Hertfordshire HP2 7DX 
Tel: 0800 181134 
www.bio-rad.com 
 
fisher Scientific UK Ltd 
Bishop Meadow Road, Loughborough, 
Leicestershire LE11 5RG 
http://www.fisher.co.uk  
 
Invitrogen / Gibco 
Invitrogen Ltd 
Fountain Drive Inchinnan Business Park 
Paisley 
PA4 9RF 
www.Invitrogen.com 
 
MWG Biotech 
Eurofine MWG Operon  
318 Worp Road Raynes Park 
London 
SW20 8QU 
http://www.mwg-biotech.com 
 
Oxoid Limited 
Wade Road 
Basingstoke 
Hampshire 
RG24 8PW 
http://www.oxoid.com 
 
Qiagen Ltd. 
Qiagen House  
Fleming Way 
Crawley 
West Sussex 
RH10 9NQ 
www1.qiagen.com 
Roche Molecular Biochemicals 
Bell Lane 
Lewes 
East Sussex 
BN7 1LG 
www.biochem.roche.com 
 
Sigma-Aldrich Company Ltd 
Fancy Rd 
Poole 
Dorset 
BH12 4QH 
www.sigmaaldrich.com 
 
Thermo Fisher Scientific 
ABgene House 
Blenheim Road 
Epsom 
Surrey 
KT19 9AP 
www.thermofisher.com 
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Appendix II: Additional Data and Images 
II.1 Quantification of genomic DNA extracted from V. parahaemolyticus 
II.1 Bacterial DNA quantification  
Genomic DNA from bacteria was extracted and quantified by comparison with 
lambda DNA standards on agarose gels (0.8%) (Section 3.8). The DNA 
concentration was determined by comparison with a range of the following known 
amounts of standard bacteriophage λ: 0.552 µg, 0.276 µg and 0.138 µg and using 
‘UV Photo’ software (UVi-Tech).  Alternatively DNA was quantified with a 
NanoDrop 100 spectrophotometer. Optical density was measured at 260 and 280 
nm. 
 
a)  
 
b)  
 
 
c)  
Figure II.1 Quantification of DNA extracted from V. parahaemolyticus cultures.  
Panel a: lanes 1-10 correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ 
standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate E20, 5; DNA from isolate E1, 6; DNA 
from isolate E13, 7; DNA from isolate R1, 8; DNA from isolate C1, 9; DNA from isolate C4, 10; DNA from 
isolate C3. Lane M: 1kb ladders (0.3 µg).  Panel b: lanes 1-9 correspond to the following, 1; 0.552 µg of 
λ standard DNA, 2; 0.276 µg of λ standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate 
E10, 5; DNA from isolate C2, 6; DNA from isolate E26, 7; DNA from isolate E23, 8; DNA from isolate R2, 
9; DNA from isolate E6. Lane M: 1kb ladders (0.3 µg).  Panel c: lanes 1-10 correspond to the following, 
1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA 
from isolate E12, 5; DNA from isolate E14, 6; DNA from isolate E15, 7; DNA from isolate E3, 8; DNA 
from isolate E4, 9; DNA from isolate E16, 10; DNA from isolate E22. Lane M: 1kb ladders (0.3 µg).  
 
 M      1      2      3       4      5      6      7       8      9      10    
 M       1       2      3        4      5       6       7       8      9          
 M      1     2     3      4     5      6     7      8     9    10         
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d)  
 
 
e)  
 
 
f)  
 
 
g)  
 
 
h)  
 
Figure II.1: Cont. 
Panel d: lanes 1-10 correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ 
standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate E2, 5; DNA from isolate E5, 6; DNA 
from isolate E7, 7; DNA from isolate E8, 8; DNA from isolate E9, 9; DNA from isolate C5, 10; DNA from 
isolate C6. Lane M: 1kb ladders (0.3 µg).  Panel e: lanes 1-9 correspond to the following, 1; 0.552 µg of 
λ standard DNA, 2; 0.276 µg of λ standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate 
E11, 5; DNA from isolate E17, 6; DNA from isolate E18, 7; DNA from isolate C7, 8; DNA from isolate C8, 
9; DNA from isolate C9, DNA from isolate C10. Lane M: 1kb ladders (0.3 µg).  Panel f: lanes 1-10 
correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ standard DNA, 3; 0.138 µg 
of λ standard DNA, 4; DNA from isolate E19, 5; DNA from isolate E21, 6; DNA from isolate C11, 7; DNA 
from isolate C12, 8; DNA from isolate C13. Lane M: 1kb ladders (0.3 µg). Panel g: lanes 1-10 
correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ standard DNA, 3; 0.138 µg 
of λ standard DNA, 4; DNA from isolate E24, 5; DNA from isolate E25, 6; DNA from isolate E27, 7; DNA 
from isolate C14, 8; DNA from isolate C15, 9; DNA from isolate C16, 10; DNA from isolate C17. Lane M: 
1kb ladders (0.3 µg).  Panel h: lanes 1-12 correspond to the following, 1; DNA from isolate E28, 2; 
0.552 µg of λ standard DNA, 3; 0.276 µg of λ standard DNA, 4; 0.138 µg of λ standard DNA, 5; DNA 
from isolate E29, 6; DNA from isolate E30, 7; DNA from isolate E31, 8; DNA from isolate C18, 9; DNA 
from isolate C19, 10; DNA from isolate C20, 11; DNA from isolate C21, 12; DNA from isolate C22. Lane 
M: 1kb ladders (0.3 µg).   
M     1     2     3      4     5     6      7      8     9     10 
M       1     2       3      4      5      6       7      8      9     10 
   M        1        2        3         4       5       6          7      8      
   M     1      2      3     4     5     6      7      8     9     10   
   M     1      2      3     4     5     6      7      8     9     10    11   12  
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a)  
 
b)  
 
 
c)  
Figure II.2 Quantification of DNA extracted from Vibrio spp. cultures.   
Panel a: lanes 1-10 correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg 
of λ standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate VC, 5; DNA from isolate 
VM, 6; DNA from isolate VV1, 7; DNA from isolate VV2, 8; DNA from isolate VV3, 9; DNA from 
isolate VV4, 10; DNA from isolate VV5. Lane M: 1kb ladders (0.3 µg).  Panel b: lanes 1-9 
correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ standard DNA, 3; 
0.138 µg of λ standard DNA, 4; DNA from isolate VV6, 5; DNA from isolate VA1, 6; DNA from 
isolate VA2, 7; DNA from isolate VA3, 8; DNA from isolate VA4, 9; DNA from isolate VA5. Lane M: 
1kb ladders (0.3 µg).  Panel c: lanes 1-12 correspond to the following, 1; 0.552 µg of λ 
standard DNA, 2; 0.276 µg of λ standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate 
VA6, 5; DNA from isolate VH1, 6; DNA from isolate VH2, 7; DNA from isolate VH3, 8; DNA from 
isolate VH4, 9; DNA from isolate VH5 10; DNA from isolate VN1, 11; DNA from isolate VN2, 12; 
DNA from isolate VS. Lane M: 1kb ladders (0.3 µg).  
  
   M    1     2    3    4    5    6     7     8    9    10   11   12  
   M   1   2   3   4   5   6   7  8   9  10    
   M   1    2   3   4    5    6   7   8    9    
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a)  
 
 
 
b)  
 
Figure II.3 Quantification of DNA extracted from non-Vibrio spp. cultures.  
Panel a: lanes 1-9 correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 
µg of λ standard DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate Ah1, 5; DNA 
from isolate Ah2, 6; DNA from isolate As1, 7; DNA from isolate As2, 8; DNA from isolate 
Pf1, 9; DNA from isolate Pf2, 10. Lane M: 1kb ladders (0.3 µg).  Panel b: lanes 1-9 
correspond to the following, 1; 0.552 µg of λ standard DNA, 2; 0.276 µg of λ standard 
DNA, 3; 0.138 µg of λ standard DNA, 4; DNA from isolate St, 5; DNA from isolate Kp, 6; 
DNA from isolate Ec1, 7; DNA from isolate Pv, 8; DNA from isolate Ec2, 9; DNA from 
isolate Sa. Lane M: 1kb ladders (0.3 µg). 
 
 
 
 
 
 
 
 
   M   1   2   3   4      5   6   7   8   9   
   M    1     2     3           4     5     6     7    8    9     
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Table II.1 Genomic DNA concentrations determined from agarose gels (Fig. II.1). 
Isolates not in Fig.II.1 were quantified with a UV spectrophotometric.  
Isolate DNA conc. (ng/µl) Isolate DNA conc. (ng/µl) 
R1  
C1 
C2 
C3 
C4 
C5 
C6 
C7 
C8 
C9 
C10 
C11 
C12 
C13 
C14  
C15 
C16 
C17 
C18 
C19 
C20 
C21 
C22 
R2 
E1 
E2 
E3 
E4 
E5 
E6 
E7  
E8 
E9 
E10 
E11 
E12 
E13 
E14 
E15 
E16 
E17 
E18 
E19 
E20 
395.2 
58.4 
191.1 
150.5 
466.5 
154.3 
283.2 
150.2 
108.7 
55.7 
235.5 
260.5 
90.6 
199.6 
80.1 
243.2 
204.8 
69.6 
503.9 
360 
49 
58 
90.5 
343.8 
53.1 
127.8 
101.9 
113.3 
229.1 
377.6 
332.5 
281.3 
226.9 
238.3 
167.8 
90.6 
662.1 
122.3 
150.4 
151.8 
151.8 
390.8 
490.1 
396.2 
E21 
E22 
E23 
E24 
E25 
E26 
E27 
E28 
E29 
E30 
E31 
VC 
VM 
VV1 
VV2 
VV3 
VV4 
VV5 
VV6 
VA1 
VA2 
VA3 
VA4 
VA5 
VA6 
VH1 
VH2 
VH3 
VH4 
VH5 
VN1 
VN2 
VS 
Ah1 
Ah2 
As1 
As2 
Pf1 
Pf2 
Sa 
St 
Pv 
Kp 
Ec1 
Ec2 
61.3 
256.2 
79.2 
311.1 
88.6 
187.9 
78 
231 
88.5 
334 
234 
101 
67 
250.9 
183.1 
386.3 
90 
130 
78 
102 
69.9 
155.5 
134.6 
123 
87.9 
67 
89.6 
70 
56 
98.8 
88.9 
79.8 
32 
23.9 
15 
12.7 
21.6 
90 
54.9 
10 
23 
15.9 
45 
89.9 
120 
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II.2 Additional gel images relevant to Chapter 4 
                                  M     2µl   4µl   8µl  10µl 12µl 16µl 18µl  20µl 
 
Figure II.4 SDS-PAGE of soluble whole cell proteins from a clinical V. 
parahaemolyticus isolate (C1) with different concentrations.  
M, protein marker (M.W. =8 kDa to 220 kDa). 
                                   M     2µl    4µl    8µl  10µl  12µl 16µl  18µl   20µl 
 
 
Figure II.5 SDS-PAGE of soluble whole cell proteins from an environmental V. 
parahaemolyticus isolate (E16) with different concentrations.  
M, protein marker (M.W. =8 kDa-220 kDa). 
 
 
60 kDa 
30 kDa 
100 kDa 
20 kDa 
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                                  M      2µl     4µl   8µl  10µl  12µl  16µl  18µl  20µl 
 
 
Figure II.6 SDS-PAGE of soluble whole cell proteins from a clinical V. 
parahaemolyticus isolate (C7) with different concentrations.  
M, protein marker (M.W. =8 kDa-220 kDa). 
 
                                    M     2µl    4µl    8µl  10µl  12µl  16µl  18µl  20µl 
 
Figure II.7 SDS-PAGE of soluble whole cell proteins from a clinical V. 
parahaemolyticus isolate (C4) with different concentrations.  
M, protein marker (M.W. =8 kDa-220 kDa).  
100 kDa 
20 kDa 
100 kDa 
20 kDa 
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II.3 Statistical analysis relevant to Chapter 4 
Chi-Square Test: KP+, KP-  
 
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
         KP+    KP-  Total 
    1     19      4     23 
       10.04  12.96 
       8.006  6.198 
 
    2      5     27     32 
       13.96  18.04 
       5.754  4.455 
 
Total     24     31     55 
 
Chi-Sq = 24.412, DF = 1, P-Value = 0.000 
 
Chi-Square Test: Ure+, Ure-  
 
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
        Ure+   Ure-  Total 
    1     23      0     23 
       15.89   7.11 
       3.180  7.109 
 
    2     15     17     32 
       22.11   9.89 
       2.286  5.110 
 
Total     38     17     55 
 
Chi-Sq = 17.685, DF = 1, P-Value = 0.000 
 
Chi-Square Test: Lip+, Lip-  
 
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
        Lip+   Lip-  Total 
    1      6     17     23 
        4.60  18.40 
       0.426  0.107 
 
    2      5     27     32 
        6.40  25.60 
       0.306  0.077 
 
Total     11     44     55 
 
Chi-Sq = 0.915, DF = 1, P-Value = 0.339 
1 cells with expected counts less than 5 
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Chi-Square Test: Pro+, Pro-  
 
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
        Pro+   Pro-  Total 
    1     19      4     23 
       13.80   9.20 
       1.959  2.939 
 
    2     14     18     32 
       19.20  12.80 
       1.408  2.112 
 
Total     33     22     55 
 
Chi-Sq = 8.419, DF = 1, P-Value = 0.004 
 
 Chi-Square Test: PPL+, PPL-  
 
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
        PPL+   PPL-  Total 
    1     19      4     23 
       10.04  12.96 
       8.006  6.198 
 
    2      5     27     32 
       13.96  18.04 
       5.754  4.455 
 
Total     24     31     55 
 
Chi-Sq = 24.412, DF = 1, P-Value = 0.000 
 
Chi-Square Test: tdh+, tdh-  
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
        tdh+   tdh-  Total 
    1     17      6     23 
        9.62  13.38 
       5.665  4.072 
 
    2      6     26     32 
       13.38  18.62 
       4.072  2.927 
 
Total     23     32     55 
 
Chi-Sq = 16.736, DF = 1, P-Value = 0.000 
 
Chi-Square Test: trh+, trh-  
Expected counts are printed below observed counts 
Chi-Square contributions are printed below expected counts 
 
        trh+   trh-  Total 
    1      6     17     23 
        5.44  17.56 
       0.058  0.018 
 
    2      7     25     32 
        7.56  24.44 
       0.042  0.013 
 
Total     13     42     55 
 
Chi-Sq = 0.132, DF = 1, P-Value = 0.717 
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Correlations: KP, tdh  
 
Pearson correlation of KP and tdh = 0.741 
P-Value = 0.000 
 
Correlations: Ure, trh  
 
Pearson correlation of Ure and trh = 0.280 
P-Value = 0.03 
 
Correlations: plasmid, KP  
 
Pearson correlation of KP and plasmid = 0.011 
P-Value = 0.934 
 
  
Correlations: plasmid, tdh  
 
Pearson correlation of tdh and plasmid = -0.120 
P-Value = 0.383 
 
  
Correlations: plasmid, Ure  
 
Pearson correlation of Ure and plasmid = -0.120 
P-Value = 0.381 
 
  
Correlations: plasmid, trh  
 
Pearson correlation of trh and plasmid = -0.206 
P-Value = 0.132 
 
 
 
 
II.3 Statistical analysis relevant to Chapter 5 
Two-Sample Comparison - Caco Clin & Caco Env 
 
Comparison of Means 
 
95.0% confidence interval for mean of Caco Clin: 69.5381 +/- 3.42343   [66.1147, 72.9615] 
95.0% confidence interval for mean of Caco Env: 17.4866 +/- 3.91195   [13.5746, 21.3985] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 52.0516 +/- 5.41566   [46.6359, 57.4672] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 18.9787   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 46.6359 to 57.4672.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
 
 220 
 
Comparison of Medians 
Median of sample 1: 68.48 
Median of sample 2: 18.18 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 127.464 
   Average rank of sample 2: 51.0417 
 
   W = 244.0   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
 
Two-Sample Comparison - Caco KP+ & Caco KP- 
 
Comparison of Means 
 
95.0% confidence interval for mean of Caco KP+: 64.7686 +/- 5.12078   [59.6478, 69.8894] 
95.0% confidence interval for mean of Caco KP-: 19.6483 +/- 4.41773   [15.2306, 24.066] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 45.1203 +/- 6.6953   [38.425, 51.8156] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 13.3072   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 38.425 to 51.8156.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 67.895 
Median of sample 2: 18.48 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 121.229 
   Average rank of sample 2: 53.4032 
 
   W = 595.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
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Two-Sample Comparison - Caco UR+ & Caco UR- 
 
Comparison of Means 
95.0% confidence interval for mean of Caco UR+: 51.7708 +/- 4.78097   [46.9898, 56.5518] 
95.0% confidence interval for mean of Caco UR-: 11.2739 +/- 6.31226   [4.96166, 17.5862] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 40.4969 +/- 8.24776   [32.2491, 48.7446] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 9.69551   P-value = 2.24304E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 32.2491 to 48.7446.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 60.45 
Median of sample 2: 1.24 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 103.044 
   Average rank of sample 2: 38.1961 
 
   W = 622.0   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
Two-Sample Comparison - Caco PPL+ & Caco PPL- 
Comparison of Means 
95.0% confidence interval for mean of Caco PPL+: 66.8646 +/- 4.64112   [62.2235, 71.5057] 
95.0% confidence interval for mean of Caco PPL-: 17.8773 +/- 3.89509   [13.9822, 21.7724] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 48.9873 +/- 5.97691   [43.0104, 54.9642] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 16.1842   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 43.0104 to 54.9642.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
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Comparison of Medians 
Median of sample 1: 68.865 
Median of sample 2: 17.88 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 124.618 
   Average rank of sample 2: 50.7796 
 
   W = 351.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
 
Two-Sample Comparison - Caco Pro+ & Caco Pro- 
Comparison of Means 
95.0% confidence interval for mean of Caco Pro+: 50.6645 +/- 5.0673   [45.5972, 55.7318] 
95.0% confidence interval for mean of Caco Pro-: 21.4126 +/- 7.31562   [14.097, 28.7282] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 29.252 +/- 8.54313   [20.7088, 37.7951] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 6.76119   P-value = 1.81643E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 20.7088 to 37.7951.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 57.27 
Median of sample 2: 3.755 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 102.475 
   Average rank of sample 2: 53.7879 
 
   W = 1339.0   P-value = 1.43423E-10 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
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Two-Sample Comparison - Caco Lip+ & Caco Lip- 
 
Comparison of Means 
 
95.0% confidence interval for mean of Caco Lip+: 47.6503 +/- 10.958   [36.6923, 58.6083] 
95.0% confidence interval for mean of Caco Lip-: 37.1544 +/- 5.30858   [31.8458, 42.463] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 10.4959 +/- 11.8541   [-1.35824, 22.3501] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 1.74838   P-value = 0.0822816 
   Do not reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from -1.35824 to 22.3501.  Since the interval contains the value 0, there is not a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is not less than 0.05, we cannot reject the null hypothesis.   
 
Comparison of Medians 
Median of sample 1: 46.97 
Median of sample 2: 27.73 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 96.8485 
   Average rank of sample 2: 79.5379 
 
   W = 1721.0   P-value = 0.0628648 
   Do not reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is greater than or equal to 0.05, there is not a statistically significant difference 
between the medians at the 95.0% confidence level. 
 
 
Two-Sample Comparison - Caco tdh+ & Caco tdh- 
Comparison of Means 
95.0% confidence interval for mean of Caco tdh+: 62.3517 +/- 6.18497   [56.1668, 68.5367] 
95.0% confidence interval for mean of Caco tdh-: 22.6518 +/- 4.63173   [18.02, 27.2835] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 39.7 +/- 7.51257   [32.1874, 47.2125] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 10.4349   P-value = 3.53133E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 32.1874 to 47.2125.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
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A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 68.12 
Median of sample 2: 19.86 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 117.833 
   Average rank of sample 2: 57.9635 
 
   W = 908.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
Two-Sample Comparison - Caco trh+ & Caco trh- 
Comparison of Means 
95.0% confidence interval for mean of Caco trh+: 47.3079 +/- 8.90681   [38.4011, 56.2148] 
95.0% confidence interval for mean of Caco trh-: 36.7606 +/- 5.59758   [31.163, 42.3581] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 10.5474 +/- 11.1463   [-0.598866, 21.6937] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 1.86854   P-value = 0.0634821 
   Do not reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from -0.598866 to 21.6937.  Since the interval contains the value 0, there is not a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is not less than 0.05, we cannot reject the null hypothesis.   
Comparison of Medians 
Median of sample 1: 46.97 
Median of sample 2: 27.515 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 97.0897 
   Average rank of sample 2: 78.6389 
 
   W = 1907.5   P-value = 0.0351847 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
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in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
  
Two-Sample Comparison - CHO Clin & CHO Env 
Comparison of Means 
95.0% confidence interval for mean of CHO Clin: 59.6314 +/- 1.94802   [57.6834, 61.5795] 
95.0% confidence interval for mean of CHO Env: 12.1842 +/- 2.84031   [9.34386, 15.0245] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 47.4473 +/- 3.7132   [43.7341, 51.1605] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 25.2318   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 43.7341 to 51.1605.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 61.21 
Median of sample 2: 5.76 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 129.094 
   Average rank of sample 2: 49.8698 
 
   W = 131.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
Two-Sample Comparison - CHO KP+ & CHO KP- 
Comparison of Means 
95.0% confidence interval for mean of CHO KP+: 53.7301 +/- 4.37219   [49.3579, 58.1023] 
95.0% confidence interval for mean of CHO KP-: 15.2224 +/- 3.64138   [11.581, 18.8637] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 38.5078 +/- 5.60727   [32.9005, 44.115] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 13.5607   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 32.9005 to 44.115.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
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A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 61.21 
Median of sample 2: 5.76 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 120.535 
   Average rank of sample 2: 53.9409 
 
   W = 645.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
Two-Sample Comparison - CHO PPL+ & CHO PPL- 
Comparison of Means 
95.0% confidence interval for mean of CHO PPL+: 55.8318 +/- 3.65356   [52.1782, 59.4854] 
95.0% confidence interval for mean of CHO PPL-: 13.5953 +/- 3.32348   [10.2718, 16.9187] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 42.2365 +/- 4.92335   [37.3132, 47.1599] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 16.94   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 37.3132 to 47.1599.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
Comparison of Medians 
Median of sample 1: 61.255 
Median of sample 2: 5.76 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 125.271 
   Average rank of sample 2: 50.2742 
 
   W = 304.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
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Two-Sample Comparison - CHO Pro+ & CHO Pro- 
Comparison of Means 
95.0% confidence interval for mean of CHO Pro+: 40.8176 +/- 4.76495   [36.0526, 45.5825] 
95.0% confidence interval for mean of CHO Pro-: 18.838 +/- 5.97901   [12.859, 24.817] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 21.9795 +/- 7.55087   [14.4287, 29.5304] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 5.74787   P-value = 2.18783E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 14.4287 to 29.5304.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 49.39 
Median of sample 2: 5.76 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 98.5101 
   Average rank of sample 2: 59.7348 
 
   W = 1731.5   P-value = 3.28365E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
Two-Sample Comparison - CHO UR + & CHO UR – 
 
Comparison of Means 
95.0% confidence interval for mean of CHO UR +: 41.6224 +/- 4.52674   [37.0956, 46.1491] 
95.0% confidence interval for mean of CHO UR -: 11.1151 +/- 4.41331   [6.70178, 15.5284] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 30.5073 +/- 7.3494   [23.1579, 37.8567] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 8.19666   P-value = 2.28026E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 23.1579 to 37.8567.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
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two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 50.91 
Median of sample 2: 4.55 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 100.75 
   Average rank of sample 2: 43.3235 
 
   W = 883.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
 
Two-Sample Comparison - CHO Lip+ & CHO Lip- 
 
Comparison of Means 
95.0% confidence interval for mean of CHO Lip+: 39.2352 +/- 9.40938   [29.8258, 48.6445] 
95.0% confidence interval for mean of CHO Lip-: 30.2234 +/- 4.48393   [25.7395, 34.7073] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 9.01174 +/- 10.0457   [-1.03392, 19.0574] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 1.7714   P-value = 0.0783638 
   Do not reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from -1.03392 to 19.0574.  Since the interval contains the value 0, there is not a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is not less than 0.05, we cannot reject the null hypothesis.   
 
Comparison of Medians 
Median of sample 1: 49.7 
Median of sample 2: 24.545 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 100.394 
   Average rank of sample 2: 78.6515 
 
   W = 1604.0   P-value = 0.0294519 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
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Two-Sample Comparison - CHO tdh+ & CHO tdh- 
Comparison of Means 
95.0% confidence interval for mean of CHO tdh+: 51.0893 +/- 5.0786   [46.0107, 56.1679] 
95.0% confidence interval for mean of CHO tdh-: 18.3239 +/- 4.159   [14.1649, 22.4829] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 32.7654 +/- 6.47759   [26.2878, 39.243] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 9.98821   P-value = 2.6116E-7 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from 26.2878 to 39.243.  Since the interval does not contain the value 0, there is a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is less than 0.05, we can reject the null hypothesis in favor of the alternative.   
 
Comparison of Medians 
Median of sample 1: 60.91 
Median of sample 2: 5.76 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 116.848 
   Average rank of sample 2: 58.6719 
 
   W = 976.5   P-value = 0 
   Reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is less than 0.05, there is a statistically significant difference between the 
medians at the 95.0% confidence level. 
 
Two-Sample Comparison - CHO trh+ & CHO trh- 
Comparison of Means 
95.0% confidence interval for mean of CHO trh+: 36.5133 +/- 8.04655   [28.4668, 44.5599] 
95.0% confidence interval for mean of CHO trh-: 30.6367 +/- 4.70662   [25.9301, 35.3434] 
95.0% confidence interval for the difference between the means 
   assuming equal variances: 5.87659 +/- 9.50537   [-3.62879, 15.382] 
 
t test to compare means 
   Null hypothesis: mean1 = mean2 
   Alt. hypothesis: mean1 NE mean2 
      assuming equal variances: t = 1.22079   P-value = 0.223928 
   Do not reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a t-test to compare the means of the two samples.  It also constructs confidence intervals or bounds for 
each mean and for the difference between the means.  Of particular interest is the confidence interval for the difference 
between the means, which extends from -3.62879 to 15.382.  Since the interval contains the value 0, there is not a 
statistically significant difference between the means of the two samples at the 95.0% confidence level.   
 
A t-test may also be used to test a specific hypothesis about the difference between the means of the populations from 
which the two samples come.  In this case, the test has been constructed to determine whether the difference between the 
two means equals 0.0 versus the alternative hypothesis that the difference does not equal 0.0.  Since the computed P-
value is not less than 0.05, we cannot reject the null hypothesis.  
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Comparison of Medians 
Median of sample 1: 48.24 
Median of sample 2: 20.91 
 
Mann-Whitney (Wilcoxon) W-test to compare medians 
   Null hypothesis: median1 = median2 
   Alt. hypothesis: median1 NE median2 
 
   Average rank of sample 1: 90.3846 
   Average rank of sample 2: 80.7143 
 
   W = 2169.0   P-value = 0.270061 
   Do not reject the null hypothesis for alpha = 0.05. 
 
The StatAdvisor 
This option runs a Mann-Whitney W-test to compare the medians of the two samples.  This test is constructed by 
combining the two samples, sorting the data from smallest to largest, and comparing the average ranks of the two samples 
in the combined data.  Since the P-value is greater than or equal to 0.05, there is not a statistically significant difference 
between the medians at the 95.0% confidence level.  
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